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SUMMARY
Since the virtual eradication of many infectious diseases in
civilised populations, diseases which are at least partially genetic
have increased in their importance as the primary cause of death and
morbidity. Much concern has been expressed that current and future
medical practices might further increase the burden on medical services
of genetic diseases by causing increases in their incidence. In this
thesis a study has been made of eugenic, as well as dysgenic, effects
of some of these possible practices.
Single generation changes in disease incidence and gene frequency
have been calculated for practices acting alone and in combination.
No attempt has been made to calculate possible effects of changes in
existing forces such as mutation and natural selection. All the
changes calculated are those which would result from the new practices
acting alone and this makes it possible to measure the relative effects
of the new forces.
Formulae for calculating possible changes have been derived for
AR, AD, XR and MF diseases and graphs drawn to illustrate the effects
of the practices for diseases of early onset where affected individuals
have low fitness. The theoretical changes calculated suggest that
with the possible exception of AD diseases and AR diseases where there
is heterozygote advantage the overall effect of the practices is likely
to be a decrease in disease incidence in one generation. The estimated
changes in gene frequency indicate that there is likely to be a longer
term decrease in incidence of AR diseases but there might be an Increase
in incidence of AD and XR diseases,
The realisation of these theoretical changes is dependent upon
the feasibility of the practices for particular diseases, the proportion
of individuals ascertained and the proportion of these individuals
adopting a particular practice. At present the practices are only
possible for a limited number of diseases but prospects seem hopeful
for their extension to other diseases particularly those with AR and
XR modes of inheritance. Most individuals to whom the practices
would be relevant are only ascertained at a stage when their subsequent
adoption of any of the practices would have a minimal effect on the
overall disease incidence. There is much scope for detecting more
individuals at risk by contacting relatives in families with AD and
XR diseases or by screening to detect heterozygous carriers in
recessive diseases. The results of the follow-up studies discussed
in section (3) indicate that couples would use the new practices if
they were available.
Thus it seems that with advances in medical research and the
detection of more individuals at risk these theoretical changes might
actually occur. However in many cases the changes might be limited
by some of the factors discussed in section (10) particularly cost
and availability of resources.
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(1) INTRODUCTION
Genetic diseases have increased in relative importance in recent
years both as a cause of death and as a cause of morbidity. The
development of treatments for many infectious diseases by the intro¬
duction of new drugs and the improvement in living1 conditions have
resulted in a sharp decline in infant mortality. Genetic diseases,
which are far less amenable to treatments of this kind have increased
in their relative importance as a cause of childhood death. It is
also likely that many older people, now affected by genetic diseases,
would have died in earlier times from infectious diseases, before the
genetic disease produced recognisable symptoms.
Gordon (1971) reports that the total infant mortality rate in the
U.S.A. has fallen from 101 to 25 per 1000 live births between 1916 and
1935. He also calculates that in 1910 there were six infant deaths
from diarrheal diseases (enteritis, colitis and dysentry) for every
death from congenital malformations. Now the reverse is true,
darter (1956) examined the causes of deaths of children having post
mortem examinations in London hospitals between 1914 and 1954. In
1914 only 16 per cent of deaths could be attributed to genetic or
partly genetic causes and over 68 per cent were primarily non genetic.
The other deaths were due to diseases of unknown causation. About
half the children in this group died from neoplasms. In 1954 38 per
cent were due wholly or partly to genetic causation and only 15
per cent were non genetic. The latter result is similar to that
obtained by Roberts, Chavez and Court (1970) in a study of the
causes of death of 1041 children in Newcastle hospitals between 1960
and 1966 in which they found that genetically determined disease
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contributed 42 per cent of the total mortality in childhood.
The great majority of genetic diseases are rare, most having
frequencies of much less than 1 in 1000 live births. Although each
one is rare there are a large number of them. McKusick (1971) has
cou-LcL
catalogued 1876 genetic disorders and traits which^show Mendelian
inheritance and there are many diseases which are at least partly
genetic. Stevenson (1961) has estimated that some five per cent of
all live born children have some defect which is partially or wholly
genetically determined. This figure includes 2.5 per cent of children
with some macroscopic abnormality (2 per cent partially genetic and
0.5 per cent due to a single gene substitution) and 0.8 per cent who
will develop a disease after birth due to a single gene trait. Taking
the figure of five per cent of children with some defect, in combination
with the estimate of Roberts et_ al_ (1970), would suggest that these
children are about eight times more likely to die in childhood than
normal children.
Genetic disease imposes a burden on society because of the necessity
for expensive, often long drawn out, episodes of treatment, which may
require institutionalisation. Stevenson (1959) has made rough estimates
of the call on medical services in Northern Ireland by persons suffering
from genetic diseases. Excluding mental illnesses such as schizophrenia,
these persons are responsible for about three per cent of consultations
with general practitioners, seven per cent of consultations with
specialists and occupy about five per cent of hospital beds.
There are specific burdens imposed upon the family of a child with
a genetic disease, in additional to the problem of management of a
3.
chronically sick child. Murphy (1969) defines 'burden' as 'the total
amount of distress that an affected child engenders'. This will
depend upon the age of onset of the disease, its severity and its
duration. Tips and Lynch (1063) studied adult kindred members of
families into which children with genetic or suspected genetic diseases
had been born. They found that there were tensions and conflicts
within the family resulting from distorted concepts of genetic causation
and from problems of reproductive and sexual adjustment. Ho (1971)
found that the presence of a child with Down's syndrone in a family
was a distinct burden to the child's brothers and sisters and a
feeling of shame was aroused amongst them. Since many of the children
affected with genetic diseases die in childhood there is pain and
sorrow in the families following the death of the child. In Ho*s
study all the families reported that they regarded the death of the
child in the same way as if a normal child had died and acted as such.
Not only does genetic disease impose a burden on society at
possible.
present but this burden may increase. In addition to the' genetic
effect of ionising radiations and chemical mutagens, recently intro¬
duced medical and social practices such as improved treatment and
selective abortion are potentially capable of leading to an increase in
the incidence of genetic diseases and in the frequency of the corres¬
ponding deleterious alleles.
Although this potential for increase in the frequency of deleterious
alleles is well known many authors seem to be relatively unconcerned.
For example Medawar (1965) argues that the rate of genetic deterioration
will be very slow and that during this time solutions will certainly
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be found to cope with these difficulties. He states that 'present
day skills are sufficient for present day ills*. However if the
tools are available now they can be used now to alleviate suffering
and cost to society both in the short term and in the long terra.
Crow (1973) argues this course since although there are many reasons
not to rush headlong into a eugenics program, such as society*s
uncertainty about desirable ends and doubts about our ability to
foresee all the consequences, much is already known about specific




The practices whose effects will be considered in this thesis
have been chosen because they are being: adopted by an increasing
number of individuals at present, or because concern has been expressed
about their possible effects in the future. It is not claimed that
these are the only practices which will operate now, or in the future,
but they are some of the most important ones. They have been divided
into two classes
(A) Dysgenic - resulting in an increase in
frequency of deleterious alleles.
(B) Eugenic - resulting in a decrease in
frequency of deleterious alleles.
In both (A) and (B) the change in disease incidence in any generation
may not always be in the same direction as the change in gene frequency.
(A) Dysgenic practices
1. Improved treatment
With improved treatment affected individuals will have better
survival rates and their reproductive fitness may be inproved. Ibis
will result in more deleterious alleles being passed on to the next
generation.
2. Selection of mate
It may be possible for Individuals of a particular genotype to
avoid having an affected child by selecting a marriage partner of a
particular genotype. In AD (autosomal dominant) and XR (x-1inked
recessive) diseases all individuals with the deleterious allele will
be at risk of having an affected child, regardless of their mtte's
6.
genotype.
In AR (autosomal recessive) diseases however, heterozygous
carriers can avoid having affected offspring by selecting a mate who
is homozygous normal. Ihis would result in a decrease in disease
incidence but an increase in gene frequency due to the birth of
additional heterozygotes.
3. Selective abortion with reproductive compensation
If couples at risk of having an affected child were to practise
selective abortion of affected fetuses or, in XR diseases, of male
fetuses, there would be a reduction in disease incidence in the next
generation. However if additional offspring were born to compensate
*
for those aborted (reproductive compensation) some of these would be
unaffected carriers of the deleterious allele (except in AD diseases
with complete penetrance). There would therefore be an increase in
gene frequency.
The size of the changes would depend upon whether couples adopted
the practice prospectively (before the birth of an affected child) or
retrospectively (after the birth of an affected child). In the latter
case the changes might be smaller because only a proportion of the
offspring of couples at risk are born after the first affected child
(see page G 5j.
(B) Eugenic Practices
4. Family limitation by carriers
If heterozygous carriers of deleterious alleles were detected
before they reproduced they might decide to have a reduced number of
offspring whether or not there was a high risk of any child being
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affected. This would result in a decrease in both the disease incidence
and the frequency of the deleterious allele in the next generation.
5. Family limitation by carriers at risk
Heterozygous carriers at risk of having an affected child might
decide to limit their family size. This would apply to all carriers
in AD and XR diseases but only to heterozygotes married to another
heterozygote in AR diseases. As in (3) the changes in disease
incidence and gene frequency would depend upon whether couples adopted
the practice prospectively or retrospectively.
6. Family limitation by slbs of affected individuals
Normal sibs of affected individuals might have a reduced family
size because of fear of having an affected child even though they
might not actually be at risk. Some of these sibs would be carriers
of the deleterious allele (except in AD diseases with complete pene¬
trance) and there would therefore be a decrease both in disease
incidence and gene frequency in the next generation.
7. Artificial insemination for spouses of carrier males
If carrier males were detected before they had any children their
spouses might make use of AI (artificial insemination) by donor
sperm. This would result in a decrease in both disease incidence and
gene frequency in the next generation.
8. Artificial insemination for spouses of carrier amies at risk
Spouses of carrier males at risk of having an affected child
might make use of AI by donor sperm. This would apply to all carrier
males in AD diseases but only to those married to a carrier female in
AR diseases. It would not be applicable to XR diseases. Changes in
disease incidence and gene frequency would depend upon whether adoption
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of the practice was prospective or retrospective.
9. Selection abortion without reproductive compensation
As stated earlier if couples at risk of having: an affected child
were to practise selective abortion of certain fetuses there would be
a reduction in disease incidence in the next generation. If no
additional offspring were born, family size would be reduced and there
would be a decrease in gene frequency also.
Inter-relationships of practices and their effects on the gene pool
Figure 2.1 illustrates the inter-relationships of the various
practices which could affect the frequency of a deleterious AH gene.
For diseases of other modes of inheritance some of these practices
would not be relevant e.g. selection of mate in AD diseases.
Note - For consistency the numbering system, used in this section for
the various practices, will be used in all remaining sections
of the thesis.
Figure 2.1 Diagram to illustrate the relationship
between new practioes affecting the
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(3) LITERATURE REVIEW
This thesis is concerned with the possible effects of various
medical and social practices on the incidence of genetic diseases and
the frequency of the corresponding deleterious alleles. Many authors
have discussed certain aspects of this general topic in the past and
the area of work is reviewed and discussed in this section. The
studies can be broadly classified into two categories:-
Theoretical studies - dealing mainly with formulae and
predictions for rates of increase in
the frequencies and for new equilibrium
frequencies of deleterious alleles.
Practical studies - dealing with the actual reproductive
performance of families with genetic
disease.
THEORETICAL STUDIES
Most of the theoretical work on this topic has considered the
effect of a single practice acting in isolation and has mainly been
concerned with possible dysgenic practices, such as improved treatment
and selection of mates. Other workers have considered possible eugenic
practices, such as family limitation by carriers and artificial
insemination and practices which may be dysgenlc or eugenic, such as




Carter (1072), Morton (1071) and others have examined the effects
of improving the fitness of affected individuals dor diseases of
10.
different modes of Inheritance,
(a) AD diseases
(i) Short-term changes
CJarter (1972) for example, estimates that for a lethal AD disease
an increase in the fitness of affected indivuduals to unity could
increase the disease incidence to ri times its initial value in
generation n_after the introduction of the treatment.
(ii) L95§^term_changes
Morton (1971) has derived formulae for the number of generations
required to get half-way to a new equilibrium gene frequency when
there is a change in the coefficient of selection against affected
individuals. For example for an AD disease it can be calculated that
if the coefficient of selection was originally 0.75 and this was
rr> ^Lti-pVuiA
rcduoed by a factor of 1/n it would take ii generations for the gene
frequency to go half-way to its new equilibrium value. The equili¬
brium gene frequency would be n_ times the initial frequency.
(b) AR diseases
(i) §bort-term_changes
In contrast to AD diseases there would only be a slow build up in
incidence of AR diseases. Carter (1972) estimates that it would take
of the order of 100 generations for the incidence of the disease to
double for an increase in fitness from zero to one. WOolf and Goodwin
(1967) have calculated that it would take of the order of 140 generations
for the frequency of the gene for phenylketonuria to double (the disease
incidence would then be four times the original Incidence). This
assumes that affected Individuals originally had fitness of zero and the
11.
g-ene was maintained solely by mutation.
(ii) Long-term changes
Using the same parameters as in (ail) above it can be calculated
from the formulae of Morton (1971) that it would take l30Vn gener¬
ations to go half-way to the new equilibrium gene frequency. This
would be about 3 Vn times the initial frequency if there was no
heterozygote advantage. If there was heterozygote advantage the
time required would be much shorter.
Thrner (1968) has considered what effects improved fitness would
have on the 'genetic load*. The'genetic load'can be considered in
this context as the percentage of the population eliminated by
selection due to the locus. If the heterozygote has a large advantage
over the normal homozygote the load at the new equilibrium will be
slightly less than initially. If however, there is little hetero-
zygote advantage the load may be several times greater at the new
equilibrium. He estimates that there would initially be a decrease
in the load and that it would take about 30 generations for it to
reach its initial level.
(c) XR diseases
(i) Short-term changes
The time required for the doubling of incidence of an XR disease
is intermediate between that for AD and AR diseases. Carter (1972)
estimates it to be about five generations.
(ii) Lon^term_ changes
Again using the same parameters as above and substituting in the
formulae of Morton (1971) it would take 3n. generations for the gene
frequency to get halfway to the new equilibrium value. The new
12.
n.
equilibrium frequency would be about times the initial frequency,
(d) MF diseases
For diseases which are partly genetic the calculations are more
arbitrary and often empirical. For example, for pyloric stenosis
which was previously fatal but can now be treated. Carter (1972)
found that three percent of new patients were born of treated parents.
This would give a three percent increase in the incidence per generation
and the current incidence would be doubled in 28 generations. For
other partly genetic diseases the rate of increase in incidence would
depend on their initial incidence,the effectiveness of the treatment,
the previous level of fitness and the Incidence of the condition in
children of affected parents.
2. Selection of mate
AR diseases
As explained in section(2)this practice will only be applicable
to AR diseases.
(i) fhort-term changes
Morton (1971) points out that the complete avoidance of marriages
between heterozygotes, could reduce the frequency of deaths from
sickle-cell anaemia in many African populations from some 100,000 per
year to essentially zero. Fraser (1973) has studied the effect of
complete avoidance of marriages between individuals heterozygous for
deleterious AR alleles on the frequency of heterozygotes and the
frequency of the deleterious allele. The effect would depend upon
whether heterozygotes have a superior fitness. If so, the frequency
of the recessive allele would increase until after many generations
half the population would be heterozygous. He calculates that if
13.
cystic fibrosis is at present maintained by a heterozygote advantage
of 2.6 percent it would take 30 generations to double the hetero¬
zygote frequency whereas if only mutation pressure tended to increase
the gene frequency it would take 2500 generations to double the
frequency of heterozygotes.
(ii) Long-term changes
The effects of partial selection of mates on the frequencies of
AR genes have been evaluated by Barker (1966) and Mayo (197Qa). If
affected individuals did not reproduce and a proportion (less than one)
of heterozygotes were to seek a homozygous normal mate the incidence
of affected individuals would slowly rise from a minimum in the first
generation to the old level at equilibrium. The gene frequency would
only be slightly increased in one generation even with heterozygote
advantage and it would then rise slowly to a new higher equilibrium
frequency.
Mayo (1970a)has also shown that there is little effect on gene
frequencies at linked polymorphic loci in the short term and there is
only an effect in the long term if there is tight linkage, or if there
is no initial linkage and genotypic equilibrium.
(B) Eugenic practices
4. Family limitation by carriers and
5. Family limitation by carriers at risk
The possible effects of family limitation, either by all hetero¬





Complete family limitation by carriers of alleles which may give
rise to AD diseases would reduce the incidence of such diseases to
twice the mutation rate in one generation (Fraser (1973)). This minimum
incidence is unlikely ever to be achieved in practice because complete
ascertainment of individuals carrying the gene will rarely be possible.
This is partly due to variation in penetrance of the gene and age of
onset of the disease. The maximum proportionate reduction in incidence




Fraser (1973) has also discussed the effects of family limitation
by heterozygous carriers in AR diseases. If all couples where both
partners are heterozygous were to have no children the disease would
be almost completely eliminated from the population in the next
generation. If all carriers were to refrain from reproduction what¬
ever the genotype of their marriage partner the deleterious allele
would be eliminated in one generation. Fraser argues that since
every individual carries several deleterious alleles in the heterozygous
state, any generalised extension of the scheme to many loci would
preclude reproduction altogether. However it might be applied to
certain diseases serially or to a proportion of carriers in each
generation.
Retrospective detection
For most diseases heterozygous couples are not detected until
they have had an affected child. The reduction in incidence of the
disease which would result if these couples subsequently had no
children has been discussed by Fraser (1972b). He has tabulated the
proportionate reduction in incidence for different means and variances
of family size. This proportion is 0.23 for the family size distrib¬
ution of the British 1961 Oensus. This is quite a substantial reduction
which takes place in one generation. It would be much less if affected
children were not diagnosed before subsequent children were born or if
mean family size in the population was reduced. Fraser (1973)
considers that the effect of this practice on the frequency of the
deleterious allele would be negligable even in the long term. This
is because few of the affected individuals whose birth is prevented
would have reproduced anyway and the heterozygotes whose birth is
prevented will only be a very small percentage of the total number,
(ii) Long-term changes
Barker (1966) has examined the change in equilibrium incidence of
an AR disease and the corresponding change in gene frequency when there
is partial exclusion of heterozygote marriages and a reduced family
size in such marriages as do occur. When only the latter occurs there
will be a decrease in both disease incidence and gene frequency. If
there is a combination of both practices the disease incidence will
always decrease but the gene frequency may either increase or decrease
depending on the relative proportions of the two practices. Barker
thus concludes that the optimum eugenic procedure would entail
minimisation of family size in heterozygote marriages,
Kidwell and Hagy (1971) studied the effects of complete family
limitation in sibships with AR diseases, including sibs of affected
Individuals. This has only a small effect at equilibrium on both




Fraser (1972b) has discussed the effect of family limitation by
affected males and carrier females on the incidence of XR diseases.
He discusses the case where heterozygous females have no more children
after the birth of an affected child and shows that the proportionate
reduction in disease incidence would be smaller than for AR diseases
as a larger proportion of cases are due to new mutation. If the
disease is lethal then the proportionate reduction in incidence in
the next generation would be about 15 percent for the family size
distribution of British 1961 Census. If there was a uniform family
size of two the reduction in incidence would only be about nine percent.
(ii) Long-term changes
If the disease does not preclude reproduction in affected males the
disease incidence would be reduced if these males were to have a reduced
family size. Fraser (1973) has calculated that if affected males
originally had a reproductive fitness of 0.2 there would be a 20 percent
reduction in the incidence of the disease at equilibrium if these males
did not reproduce. A further reduction would occur if there was





In diseases with multifactorial inheritance the recurrence risk
is usually low. It is not possible at present to identify high risk
couples before the birth of an affected child. Staiith (1970) estimates
that the proportion of cases prevented by restricting family size
after the birth of an affected child might be from 0.5 percent to a
maximum of five percent. The actual proportion would depend on the
incidence in the general population, the family size distribution
and the recurrence risk in sibs of affected individuals.
7. Artificial insemination for spouses of carrier males and
8. Artificial insemination for spouses of carrier males at risk
FJraser (1973) has briefly discussed the possible effects of AI
on the frequencies of deleterious alleles. AI would be equivalent to
reducing the fitness of individuals with the deleterious gene and could
have long term beneficial effects on the gene pool.
Qysgenic or Eugenic Practices
3. Selective abortion with reproductive compensation
9. Selective abortion without reproductive compensation
There are an increasing number of genetic diseases where it is
possible to detect the fetal phenotype in utero and then offer an
abortion if the fetus is found to be affected. Several workers
have discussed the effects of such a practice on the incidence of
genetic diseases and on gene frequencies.
The direction of the gene frequency change would depend upon
whether or not there was reproductive compensation. If there was,
additional unaffected carriers of the deleterious allele might be born.
Haldane (1924) uses the term family selection to describe the situation
where the number of survivors in each family is unchanged and offspring
eliminated by natural selection are replaced by viable full sibs. This
situation would occur in human populations if there was selective abortion
with reproductive compensation. King (1965) has calculated that family
selection would reduce the rate of selection by one third of that when
there is no reproductive compensation for lethal recessive alleles and
by one half for non-lethal recessive and dominant alleles.
(a) AD diseases
(i) Short-term changes
The effects of selective abortion in AD diseases have been discussed
by Fraser (1973) and Motulsky et al (1971). The effects of selective
abortion of affected fetuses on disease incidence and gene frequency
would be virtually the same as for family limitation by carriers of
the allele. Even if additional offspring were born to compensate for
those fetuses aborted none of them would carry the deleterious allele.
The reduction in incidence of the disease would be greatest for diseases
where carriers of the deleterious allele have a high fitness.
Fraser (1973) has estimated the number of abortions of all fetuses
with the deleterious allele, required, to reduce the frequency of an
autosomal deleterious allele to the level inposed by mutation in one
generation. If all couples continued reproduction until two unaffected
offspring were born the number would be approximately 4qn.where n is
19.
the population size and is the gene frequency. Since £ is very
small for dominant conditions Fraser regards this as a reasonable
price to pay, especially since this would be a once and for all
program, in that the gene frequency would remain very low for thousands





Motulsky et_ al_ (1971) have also considered the reduction in
incidence of AR diseases as a result of selective abortion. If all
couples at risk wore detected prospectively then the disease could
be teaporarily eliminated in one generation. They consider a screening
program based on premarital screening of females, followed by screening
of male partners, intrauterine diagnosis and abortion, with reproductive
compensation until two normal children are born. For several common
AR diseases such a program would be economically feasible but for
rarer diseases the number of tests required to prevent the birth of
one affected child would become very large. The effects of this
screening program on the frequency of the deleterious allele would be
small in the short term, for the same reasons already discussed for
family limitation by heterozygous couples (page 15 ); namely that
affected individuals usually have low fitness and transmission of the
deleterious allele is mainly through marriages involving one heterozygous
parent.
Mayo (1970a) reached the same conclusion from calculations of gene
20.
frequency changes if heterozygous couples practice selective abortion
of all affected fetuses with reproductive condensation. Even with
heterozygous advantage the gene frequency change would be very small.
As in the case of AD diseases, with prospective detection of hetero-
zygotes, it would require 4qn abortions to reduce the frequency of
an AR deleterious allele to its mutational level in one generation.
Motulsky et al (1971) do not consider that selective abortion provides
a solution to the problem of eradicating genes causing AR diseases,
because is generally much higher and many of the fetuses who would
have to be aborted would be heterozygotes and therefore not be affected.
Retrospective detection
Stealler changes in gene frequency and disease incidence would
occur if couples were not ascertained until after the birth of an
affected child. In the absence of reproductive compensation the
changes in incidence discussed by Praser (1972b) (page 15) would also
apply when there was selective abortion rather than family limitation.
Motulsky et_al (1971) have estimated that if every mother with a
previous child affected by an AR disease was to have selective abortion
during subsequent pregnancies, until two clinically normal children
were born, there could be a reduction of 12 percent to 34 percent in
incidence of the condition in one generation. The actual reduction
in incidence would depend upon how much reproductive compensation these
couples previously practiced. The lower figure refers to the case
where all couples previously had two children irrespective of their
phenotype and the higher figure to the case where they all continued
reproduction until two normal children were born. In practice the
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percentage reduction would be intermediate between these extremes,
(ii) Long-term changes
Prospective detection
The long term effects of prospective detection of heterozygous
couples and selective abortion with reproductive compensation are
discussed by Fraser (1973) and Uotulsky et_ al_ (1971). If the hetero-
zygote originally had an advantage over the normal homozygote but as
a result of improved environmental conditions this advantage is
eliminated then the combined effect of selective abortion and loss of
heterozygote advantage would be to cause a slight reduction in gene
frequency. If however heterozygote advantage was maintained there
would be a slight increase in the gene frequency because of the birth
of additional heterozygotes. Eraser considers that the former
possibility is more likely.
Retrospective detection
Hagy and Kidwell (1972) have studied the equilibrium frequencies
of individuals of different genotypes if there is selective abortion
of all affected fetuses conceived after the first affected child with
complete reproductive compensation. They have shown that the equil¬
ibrium frequency of the deleterious allele would increase for fitnesses
of heterozygotes ranging from a 5 percent advantage to a 5 percent
disadvantage over the normal homozygote. However the increase would
be very small except when there was heterozygous advantage and it





Possible changes in the incidence of XR diseases if heterozygous
females were to practise selective abortion of certain fetuses have
been considered by several workers. If heterozygous females were
only ascertained after the birth of an affected child and all affected
fetuses subsequently conceived were selectively aborted the decrease
in the incidence in the next generation would be equal to that if these
couples had no more children (Fraser (1972b)) i.e. about 15 percent,
(ii) Long1-term changes
The long term effects of selective abortion in XR diseases have
also been considered by Fraser (1972a) and the results are also
discussed by Motulsky et al (1971). Fraser considers a uniform
family size and three strategies of selective abortion* (A) prospective
diagnosis of heterozygosity in the mother where reproduction ceases
after the birth of a fixed number of normal children and (B) retro¬
spective diagnosis of heterozygosity in the mother where reproduction
ceases after the birth of a fixed number of children and (C) when it
ceases after the birth of a fixed number of normal children. For
each of these strategies he considers the effect of (1) abortion of
all male fetuses, (2) abortion of affected male fetuses only and
(3) abortion of affected male and carrier female fetuses.
Fraser considers firstly a uniform family size of two. In this
case, if the disease is lethal, all but three of the nine possible
combinations of strategy would result in a decrease in the equilibrium
incidence of affected males to a minimum of one third of the initial
value if heterozygous females are detected prospectively (A). If
there was retrospective selective abortion of all males until two
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children were born (Bl), the equilibrium incidence of affected males
would be unchanged but if there was retrospective selective abortion
of all or affected males until two normal children were born (CI, C2)
the incidence of affected males would actually increase but Fraser
(1072a) calculates that there would be no substantial increase for
at least 20 generations.
All strategies considered, apart from those where heterozygous
females are aborted (3), would result in an increase in the frequency
of these females at equilibrium to a maximum of 2.3 times the initial
frequency when there is abortion of all male fetuses until two normal
children are born (CI).
If family size is greater the same would be true, except that
selective abortion of affected males until the desired number of
normal children were born (C2) would result in a decrease, instead of
an increase in the equilibrium incidence of affected males.
Although, as Fraser states, in most of the cases he considers
there is a reduction in the incidence of affected males, the strategies
which are now in use (i.e. retrospective selective abortion of all
male fetuses (Bl and CL)), would result in no decrease in the equilibrium
incidence of affected males and in case (CI) there would actually be
an Increase. The increase in the frequency of heterozygous females
would be especially great in these two cases and thus there would be
an increasing demand for selective abortion. However, these are
only equilibrium values and short term changes in incidence would be





Selective abortion is rarely possible for multifactorial diseases
such as the congenital abnormalities but it may be possible to detect
affected fetuses in utero in the future (e.g. anencephaly, Brock and
Sutcliffe (1972)). If couples who already had an affected child
were to have subsequent pregnancies monitored and all affected fetuses
were selectively aborted the incidence of these malformations could
be reduced by the same amount as for family limitation by these couples
i.e. up to about five percent.
PRACTICAL STUDIES
The studies described above are all purely theoretical and the
frequency changes discussed would only occur if many individuals were
to adopt the practices. Investigation of the actual reproductive
performances of affected individuals and their relatives can give some
insight into the changes which might occur in practice. This problem
has been considered by several workers. They have mostly been concerned
with the actual reproductive performances of affected individuals and
of their parents. A few have considered other relatives of affected
individuals.
1. Affected Individuals
Since most treatments have been introduced only recently few treated
individuals have as yet reached reproductive age. Several studies have,
however, been made of actual reproductive rates of individuals with
those genetic diseases which do not preclude reproduction.
Cotter (1067) has discussed the reproductive pertornances of
individuals in a large pedigree for the AD disease ch/ondrodystrophy
dating back to 1333. By coopering the early with the later gener¬
ations he has estimated that the fitness* of ch/ondrodystrophic dwarfs
was initially close to unity but now they have a reduced fitness
primarily because of withdrawal from the breeding papulation. Cotter
suggests that this may be the result of social attitudes to the genetic
disease
Reed and Neel (1999) made estimates of the fitnesses of individuals
in families with Huntington^ chorea froa a survey of all cases in
Michigan. They estimated the relative fitness of individuals hetero¬
zygous for the Huntingtonfe chorea gene to be 0.3 compared to the
general population and to be 1.01 compared to their homozygous normal
sibs. This suggests that it is not the presence of the gene which
reduces the fitness. The reduced fitness of both affected individuals
and their normal sibs my result from a fear of developing the disease
(in the latter) or of transmitting it to their children.
Theffe two studies indicate that increasing the life span of
affected individuals might not in itself result in their having more
offspring if they still suffered much disability. However, the more
normal the life affected individuals were able to live the more off¬
spring they would be likely to have. For example if affected indiv¬
iduals no longer had to be institutionalised there might be an increase
in the number of offspring they would have. Erlonacycr-Kimling and
Paradowski (1938) suggest that the decrease in length of hospitalisation
may be one factor which has caused a change in the number of offspring
of schizophrenics. By comparing two groups of patients admitted to
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New York hospitals in 1934-6 and 1951-6 they have shown that the
reproductive rate is increasing and even surpassing that of the
general population.
2. Parents of affected individuals
Many studies have been made of the reproductive rates of couples
who have had an affected child. These indicate that several factors
influence the parents* reproductive rate. These are the burden, the
recurrence risk and parental understanding.
(i) Effect of burden
Hare et_ al_ (1966) followed up 120 families into which a child
with a major central nervous system (CNS) malformation had been
born. At interviews one month and six months after the birth of
the child, about a half and a third, respectively of the mothers were
reluctant to have more children. Ho (1971) followed up families with
a child with Down's syndrome 2-4 years after the birth of the child.
Parents whose affected child was dead more often had further children
than those whose child was alive. Boon (1972) found that the
birth of a child with Fallot's tetralogy was not a great deterrent
against having further children. There was however a tendency for
the parents to postpone having further children until the condition
of the affected child had improvedc^d. <x gi-ao-W tb acxap^
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These results suggest that if the disease produces severe dis¬
ability and there is little or no therapy available (e.g. Down's
syndrome or CNS malformations), parents are reluctant to have further
children unless the affected child dies early. The parents in Ho*s
study felt that they had to devote themselves to the care of the
affected child and actual fear of having another affected child was
dominant in only a few cases. On the other hand if affected individuals
are less severely disabled, or effective therapy is available, as for
Fallot's tetralogy they are more likely to have further children,
(ii) Effect of recurrence risk
Of the families with CNS malformations (Hare et al 1966) only
40 percent had been told of the risk of recurrence. The authors of
the other studies do not give the exact proportions of parents, who
had been told about the risks.
There is evidence that if parents are advised of the risk of
future children being affected, this also influences their tendency
to have more children. Carter et_ al_ (1971) report the results of a
follow-up of 455 couples seen at a genetic clinic who wished for advice
on the risks of recurrence of serious disorders in their children.
They tried as far as possible to distinguish couples deterred by the
risk, from those who did not want further children for other reasons.
They found that when the recurrence risk was high (greater than 10
percent) two-thirds of the couples were deterred by the risk from
planning further children but when the risks were low (less than 10
percent) only about a quarter were deterred by the risk. A closer
study of the high risk group showed that the decision to take the risk
usually depended on whether a further affected child would have a
serious long term handicap. They found that the majority of instances
where the parents were not deterred involved conditions where any
further child if affected was likely to die young, where a treatment
was available, or where the condition was relatively mild.
Similar results were obtained by Emery et_ al_ (1973) in a follow
up study of 104 families referred for genetic counselling. Of those
at high risk 82 percent were deterred from having further pregnancies
and of those at low risk 23 percent were deterred. In four of the
ten high risk couples not deterred this was because they had no
living children and the disease usually resulted in death in early
infancy. Of the ten low risk couples deterred three had completed
their family, two were divorced and one had a severely handicapped
child.
Emery et al^ (1972) also carried out a follow-up study of women
with one or more relatives with Duchenne muscular dystrophy. They
found that 88 percent of women at high risk of having an affected son
or carrier daughter did not want any more children and of those at
low risk 50 percent did not want further children. Although it is
not known how many of the couples had already completed their family
the large proportion not wanting further children particularly in
the low risk group is probably because Duchenne muscular dystrophy
is a severely disabilitating disease with no therapy available at present.
Leonard et al (1972) studied the attitudes to further reproduction
of parents of children affected with cystic fibrosis, phenylketonuria,
Down's syndrome and a non genetic disease rheumatoid arthritis. They
found that 20 percent of parents of children with the latter two diseases
were against having further children even though the risks of further
children being affected were very low. This was presumably because
of the burden of bringing up a severely handicapped child. 70 percent
of parents of children with cystic fibrosis were against having further
children. Here in addition to the burden there is a 25 percent risk
that a future child would be affected. In the case of parents of
children with phenylketonuria where the risk is the same as above but
effective therapy is available only 14 percent were against having
further children.
(iii) Effect of parental understanding
Any influence on the parents* reproductive rate of a risk of a
future child being affected would depend on the parents* understanding
of the genetic implications of the disease. Carter et_ al^ (1971) and
Emery et al (1972, 1973) found that in general couples had understood
the risks they had been given. However Leonard et_ al_ (1972) found
that 19 out of CI families completely failed to understand the infor¬
mation provided and eight understood it only imperfectly. This may
be due to the fact that the families studied by Carter were derived
from a higher socio-economic level and had all asked for counselling,
whereas the families studied by Leonard were from lower socio-economic
classes and were less well educated and were sometimes hostile at
interview. In Leonard*s study however he found no significant relation¬
ship between genetic knowledge and reproductive outcome. Having more
children seemed more related to maternal age and religion and this may
be largely due to the fact that 28 of the 76 families were Roman Catholic.
(iv) Extent of adoption of new practices
Garter (1971), Emery et^al (1972, 1973) and Leonard et al (1972)
also discussed the practices adopted by the couples subsequent to
counselling. The families studied by Carter (1971) were all seen
initially between 1952-61 and were followed up three to ten years
later. All the couples who were undeterred went on to have children
some of whom were affected and some normal. Of 169 couples who were
deterred six were divorced and three separated and two made use of
artificial insemination by donor but this was not discussed unless the
couple asked for it. 35 of these couples had unplanned pregnancies
eight having a termination, another six being refused a termination.
Emery et al_ (1973) followed up couples seen between 1965-69.
56 couples did not want further children but five had unwanted preg¬
nancies all undergoing therapeutic abortions. One of the women who
was undeterred had an abortion of a male fetus. The families
discussed by Emery et «1 (1972) with Duchenne muscular dystrophy were
also seen from 1965-69. Of the 41 couples who did not want further
children only two had unwanted pregnancies and these were aborted.
Of the nine couples undeterred two had amniocentesis, one fetus
subsequently being aborted when it was found to be male.
The couples studied by Leonard et_ al (1972) were seen between
1969-70. Those with children with cystic fibrosis (CF), phenyl¬
ketonuria (PKU) and Down's syndrome (DS) were asked their attitudes
to sterilisation, to abortion of any pregnancy and to amniocentesis
and selective abortion if this were to become available. 51 percent
CF, 30 percent DS and 14percent PKU couples were in favour of sterilisation.
Obly 18 percent CF, 13 percent DS and 14 percent PKU couples were in
favour of abortion of any pregnancy but unfavourable attitudes to
abortion became favourable in the context of antenatal diagnosis,
36 percent CF, 53 percent DS and 29 percent PKU being in favour of
selective abortion. This was despite the fact that 38 percent of
the couples were Roman Catholic.
Although the nuabers of patients involved is small these figures
do suggest some possible trends. For example there may be an Increase
in the tendency to divorce if coiq>les know there is a risk of their
having an affected child. Carter states that in view of the age of
the couples one percent of them would be expected to be divorced and
therefore five out of 455 currently divorced is not excessive. However
at least four out of 169 deterred couples is nearly two and a half times
what would be expected.
A greater proportion of couples in Carter's study had unplanned
pregnancies than in Emery's which could indicate an increase in use
of effective contraceptive measures by the couples but it might just
reflect the longer time period over which the couples were followed up.
Only half the couples in Carter's study wanted an unplanned
pregnancy to be terminated. Hie difficulty experienced by some of
Carter's patients in getting1 a pregnancy terminated on the grounds of
a genetic risk to the fetus, no longer applies, since the passing of
the 1967 Abortion Act in the U.K. All the couples discussed by
Emery j|t &1 (1972, 1973) who had unplanned pregnancies wanted them
terminated, indicating an increased acceptance of abortion. The
increased acceptance of abortion when a fetus can be positively ident¬
ified as being affected or normal can be clearly seen from the study
of Leonard et al (1972). It would have been interesting to see what
proportion of couples preferred selective abortion to family limitation
and what proportion preferred family limitation.
(v) Reproductive compensation
It has been suggested that couples having abortions or whose
children died in infancy might have additional pregnancies so that
their mean family size would be no different from that of other
couples. If this did in fact occur it would indicate that couples
practising selective abortion would not have a reduced number of living
offspring but additional unaffected children would be born to compensate
32.
for those aborted.
Newcombe (1065) studied the reproductive performances of mothers
following stillbirths, infant death from erythroblastosis, hemorr¬
hagic disease and asphyxia and following the birth of a child with
Down's syndrome who did not die. When these mothers were compared
with another group with similar ages and parities there was no
evidence for reproductive compensation except for asphyxia and Down's
syndrome. In the former case it was thought to be due to an assoc¬
iation of asphyxia and high fertility in a sub-population in the study.
Heed (1971) has reviewed several studies for evidence of repro¬
ductive compensation with particular reference to Rhesus hemolytic
disease. He found little support for the idea that it is a general
phenomenon. However, although the results presented in the papers
he reviews do not give strong evidence in favour of reproductive
compensation, they do suggest a small effect.
Only two of the studies reviewed by Reed (1071) were concerned
with women who had had an abortion, rather than a stillbirth or a
child who had died in infancy. In one of these, James (1963) found
a significantly greater number of pregnancies in women prone to
abortion than in other women. Reed (1971) suggests that this may
have been due to the existence of a class of women having increased
tendency towards abortions and an Increased number of pregnancies.
However it could indicate that if there was selective abortion of
certain fetuses, a©productive compensation would occur,
3. Other Relatives of Affected Individuals
In addition to the parents of the affected individual the reproductive
rates of other relatives may be affected by the presence of an affected
individual in the family.
Tips and Lynch (1963) found a reduction in pregnancy rate both
in the parents and in paternal and maternal aunts after the birth of
an affected child. It is not possible from their results to calculate
the reduction in reproductive rate of aunts only, as the results for
aunts and parents were combined in their paper.
Jteed and Neel (1959) compared the fertility of sibs of individuals
with Huntington's chorea with individuals in the general population and
they found the relative fertility of non-choreic sibs to be about 0.77.
Most of these individuals had an affected parent and it is likely to
be the presence of an affected parent, rather than an affected sib,
which affects their reproductive rate. This is because many of the
individuals affected at the time of the study would not have been
affected at the time they and their sibs reproduced.
These two studies therefore indicate that the presence in a
family of an affected individual influences the reproductive rate of
a number of different relatives. However Cotter (1967) could find
no evidence for a difference in fitness between sibs of individuals
with chondrodystrophy and the general population in the pedigree he
investigated.
Erlenmeyer-Kimling and Paradowski (1966) found no difference in
fitness amongst the sibs of schizophrenics compared with the general
population in 1934-1936 but in 1954-56 their fitness was 1.4 times
that of the general population indicating a newly emerging sibling
advantage. It seems therefore that there may be an effect on
reproductive fitness in relatives in some diseases but not in all.
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CONCLUSIONS
The theoretical studies indicate that there would be changes in
the incidence of genetic diseases and in the frequencies of deleterious
alleles, as a result of the introduction of practices such as improved
treatments, selection of mates, family limitation, artificial insemin¬
ation and selective abortion. At present few couples obtain genetic
alialUonS toodvlrf^Co-floS
advice and those—who do«o may be unwilling to adopt new techniques,
such as selective abortion, until their safety and reliability can be
proved. With the improvement of these techniques, extension of genetic
counselling services and improvement in methods of detection of indiv¬
iduals at risk, the gene frequency changes may become larger. The
results of the follow-up studies indicate that most couples at high
risk of having an affected child are deterred from having further
children, although there was an indication that as treatments become
available fewer couples would be deterred from having further children.
These results are all integrated with those of the thesis later
and discussed in a general discussion section.
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(4) TOE DISEASES AND THEIR FREQUENCY CHANGES TO BE DISCUSSED
In this section the modes of inheritance and the categories of
age of onset of the diseases to be considered, will first be described.
The current forces affecting the incidences of these diseases and the
frequencies of the corresponding alleles will then be discussed.
Lastly there will be a description of the scope of the present study
and the assumptions and conventions used throughout.
(A) Diseases Considered
(i) Modes of Inheritance
Genetic diseases of four main modes of inheritance have been
considered.
1. Autosomal recessive (AR) e.g. cystic fibrosis
2. Autosomal dominant (AD)
t-
(a) with conplete penetrance e.g. achonc^pplasia
(b) with incomplete penetrance e.g. osteogenesis imperfecta
3. X-linked recessive (XR) e.g. haemophilia
4. Multifactorial (MF) e.g. spina bifida. (These are diseases whose
manifestation may depend upon the joint effects of many genes and
of the environment).
(ii) Age of Onset
Three different categories of age of onset have been discussed.
Individuals are only considered to be at a selective disadvantage after
onset of the disease.
(a) Ctaset is at birth or before the birth of any subsequent children
to the parents of the affected individual.
(b) Onset takes place after the parents of the affected individual
have completed their family but before the individual himself
starts his family.
(c) Onset is after the affected individual has completed his family.
(B) Current State
At any particular time the frequency of a gene in the population
is the result of a balance between forces tending to increase its
frequency and other forces tending to decrease its frequency. In
a large random mating population, in the absence of intervention by
man, most deleterious alleles are maintained at low frequencies. This
is because of strong negative forces tending to decrease their frequency
and relatively weak positive forces tending to increase their frequency.
If these existing forces remain constant for a long time, an equil¬
ibrium situation will arise in which the gene frequency will remain
constant from generation to generation. If the forces do not remain
constant there will be a resulting trend in gene frequency either
upwards or downwards. Recently introduced practices such as those
discussed in sections (2) and (3) introduce new forces which may
change the frequency of deleterious alleles.
In practice the existing forces affecting frequencies of deleter¬
ious alleles will have several components e.g. mutation and natural
selection. The sizes of these forces and the resulting current
trends in gene frequency are very difficult to measure especially in
human populations. In this thesis no attempt has been made to measure
possible changes in frequency due to these existing forces. Interest
is centred on new farces and their possible effects on disease incidence
and gene frequency.
37.
All the changes calculated are those which would result from
the new forces over and above any change due to natural selection
against affected Individuals. This makes it possible to measure the
relative effects of the new forces. If there is initial equilibrium
the effect of natural selection will be balanced by the effect of
other forces such as mutation and so the overall change in frequency
would be equal to that due to the new force. In the absence of
initial equilibrium the change due to the new force must be added on
to those due to natural selection and to mutation etc. to obtain the
overall change.
(C) Scope of the Study
The workers whose studies are described in the literature review
have mainly been concerned in estimating new equilibrium values of
the gene frequency which will only be attained after several or many
generations. Long term gene frequency changes resulting in new
equilibrium values would be less important than short term ones.
The reaching of a new equilibrium value would depend on medical
practices remaining constant over many generations. This is unlikely
with rapid developments in the fields of treatment and detection of
individuals at risk.
They have also been mainly concerned with the effects of single
practices acting in isolation. Although these effects are of theore¬
tical interest, it is far more probable that several practices would
operate simultaneously and the resulting changes in gene frequency
would depend upon the effects of several practices.
For these reasons, in this thesis, effort has been concentrated
on estimating single generation changes in disease incidence and gene
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frequency both by practices operating: alone and in combination.
The study is aimed at estimating:
1) The relative importance of different practices in causing
changes in disease incidence and gene frequency.
2) The relative importance of the practices which are potentially
dysgenic and those which are potentially eugenic.
(D) Assumptions and Conventions
For all classes of disease considered, unifactorial and multi¬
factorial, the change in disease incidence is taken to be the differ¬
ence between that in the offspring generation at birth and that in
the parental generation at birth. The change (A^) which results
from natural selection alone is subtracted from the change (A ) which
2
results from a particular practice together with natural selection to
obtain the net change (A -A ) due to the practice.
m X
It is possible to measure actual gene frequency changes only
*
for unifactorial (AR, AD, XR) diseases, as in the case of MF diseases
individual genes and their frequencies are not known. The gene
frequency in the offspring generation at birth does not necessarily
reflect changes in the genotype distribution among the offspring.
If mating is non-random as in mate selection, or if selective
abortion with reproductive compensation is practised, the genotype
frequencies of offspring may be changed but the gene frequencies may
not. Then if fewer affected individuals and more unaffected carriers
were born the offspring would pass on more deleterious genes to the
next generation when there would be an increase in gene frequency.
In order to consider the change as if it were in the current generation
(as for the rest of the practices), the gene frequency change is
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Figure 4.1 Diagram to ahow how the changes in disease
Incidence and gene frequency are measured
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measured throughout as the difference between the frequency in the
parents at reproduction and the frequency in their offspring at
reproduction. The change due to existing forces, is subtracted as
before.
A diagramatic representation of how the changes in disease
incidence and gene frequency have been measured and where the practices
studied act is shown in Figure 4.1.
For unifactorial diseases it is assumed that the parents have
Hardy-Weinberg genotype frequencies at birth. Affected homozygotes
in AD diseases and affected females in XR diseases are ignored as
their frequencies are very smallif cdoa\s Uw Fd-.xa.ss,
For multifactorial diseases a different net of conventions and
assumptions is used. It is assumed that there is an underlying
continuous and normally distributed liability to the disease with
zero mean and unit variance as shown in Figure 4.2. The proportion
of individuals exceeding the threshold of liability is affected, this
proportion being denoted by P. The mean liability of any group of
individuals is expressed as the number of standard deviations from
the mean of the parental generation. From the heritability of
2
liability <h") to the disease and the liability of individuals who
reproduce it is possible to calculate the mean liability and hence
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Figure 4.2 Diagram to Illustrate the conventions and
assumptions used for multifactorial diseases.
For definition of parameters see Table S.l.
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(5) DERIVATION OF CHANGES IN DISEASE INCIDENCE AND GENE FREQUENCY
Changes in disease incidence and gene frequency have been
calculated for diseases of four modes of inheritance at different onset
ages and for all the practices, described in section (2), which are
applicable for a particular mode of inheritance. As the methods of
calculation of the changes are very similar throughout, only a few
examples are given in detail in this section. The variables and
symbols used are summarised in Table 5.1 and the conplete set of
results is tabulated in Tables 5.2 - 5,11.
As was discussed in section (4D) it is necessary to estimate the
effect of natural selection alone, in order to obtain the net effect
of a particular practice. Therefore in section (5A) the effect of
natural selection is calculated for diseases of each mode of inherit¬
ance. In section (5B) the net effects of three of the new practices
are calculated. Firstly the joint effect of the new practice and
natural selection is obtained. The effect of natural selection alone
is then subtracted from this to obtain the net effect of the practice.
(A) Effect of natural selection
%
For simplicity it is assumed that there is a constant natural
selection force against affected individuals. Possible effects of
positive selection forces resulting from factors such as heterozygote
advantage have not been considered in this section.
Heterozygote advantage may be an important factor in the incidence
of some diseases in certain populations e.g. sickle-cell anaemia in
African populations (Allison, 1964). It has also been suggested
that heterozygote advantage occurs in Tay-Sachs disease in Jews
TABLE 5.1
Variables and symbols used
Variable Symbol
All modes of inheritance
Proportion of individuals who adopt a practice c^
Proportion of couples who adopt a practice c^




Proportionate change in fertility of
individuals of genotype jl i
Frequency of normal allele p
Frequency of deleterious allele q
Proportion of the offspring of couples at risk
who are born after the first affected child r
Proportion of the offspring of couples at risk p
who are normal sibs of affected individuals s
Coefficient of selection against individuals
of genotype i^ i
Change in s^ s*
Proportion of individuals of genotype i_
ascertained i
Penetrance of A gene in Aa individuals y
Multifactorial diseases
Mean liability of affected individuals a
Mean liability of individuals (couples)
exceeding a given liability x' (x*') x
Proportion of individuals who adopt a practice c^
Proportionate change in fertility f^
Heritability of liability to the disease h2
Mean liability of normal individuals n
Mean liability of individuals (couples)




Proportion of all affected individuals who are p
born after the first affected child in the family rm
Proportion of individuals who are normal sibs of p
affected Individuals sm
Disease incidence in the parental generation P
Proportion of individuals (couples) exceeding a
given liability x* (x") x
Relative loss of fitness of affected
individuals f
Change in
Proportion of individuals ascertained w^
The abscissa at the threshold x
The ordinate at x z
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(Myrianthopoulos and Aronson, 1966) and in cystic fibrosis in
Caucasians (Danks et al_, 1965). Mayo (1970b), however, finds the
evidence for greater fertility of heterozygotes in cystic fibrosis
and Tay-Sachs disease inadequate.
Formulae for changes in incidence and in gene frequency for
diseases where there is heterozygote advantage can be calculated in
a similar manner to those for diseases where there is no heterozygote
advantage. The formulae are given in appendix (3). They are more
coup lex as the changes are dependent both upon the initial gene
frequency and on the coefficients of selection against normal and
affected homozygotes. Using figures from Falconer (1960) possible
changes for sickle cell anaemia in African populations have been
calculated and thca* are plotted in Figures A3.1 and A3.2. Differences
between these results and those for diseases where there is no hetero¬
zygote advantage are discussed in section (6).
1) AR diseases
Consider an AR disease with individuals of genotype aa affected.
In the parental generation at birth the genotypes have the following
frequencies and fitnesses
Genotype AA Aa aa
2 2
Frequency p 2pq q
Fitness 1 1 1-s
aa
If selection operates between birth and reproduction of the
parental generation the couples at risk of having affected offspring
have frequencies and fitnesses as follows:-
42.
Mating1 type Frequency Fitness Proportions of offspring
AA Aa aa
,22 , 1 1 1Aa x Aa 4p q 1 — - —
3 11
Aa x aa 4pq (1-s ) 0 — —
aa 2 2
4 .2
aa x aa q (1-s ) 0 0 1
aa
(i) Disease incidence The approximate incidence of affected
12 2 13 4
individuals in the offspring is -7. 4p V + 4pq (1-s ) + q (1-s4 2 aa aa
= «2 U-2qSaa'
The change in disease incidence between parental and offspring
generations due to natural selection is therefore approximately
2 2 3
q" (l-2qs ) - q = -2q s
aa aa
(ii) Gene frequency The gene frequency change is measured between
the parental generation at reproduction and the offspring generation
at reproduction. The approximate frequency of a in the parental
1 2.2
generation at reproduction is — (2pq) + q" (1-s ) = q - s q"
2 aa aa
As a result of selection against affected individuals the frequency
2
of a is reduced by approximately s q (l~2qs ) by the time the— aa aa
offspring reproduce. Therefore the approximate change in gene
2
frequency due to natural selection is -s q
aa
2a) AD diseases with complete penetrance
Consider an AD disease with individuals of genotype Aa affected.








(i) Disease incidence Following the same method as above couples
at risk of having affected offspring have frequency and fitness as
followsj-
Mating type Frequency Fitness Proportions of offspring
Aa aa
*3 „ \ 1 1Aa x aa ip q <1-8A_) — —
The approximate incidence of affected individuals in the offspring is
4p3q (1-s ) = 2p3q (1-s )
2 A- A-
Taking p = 1 the change in disease incidence due to natural selection is
approximately 2q(l-s )-2q = -2qs .
A~* A—
<ii) Gene frequency The approximate frequency of A in the parental
generation at reproduction is —, 2pq (1-8, ) = q(l-s )2 A— A~
As a result of selection against affected individuals one half of
whose genes are A, the frequency of A is reduced by approximately b
1 3
s . 2p q <l-s ) by the time the offspring reproduce. Therefore
A"* «£ Jr\mm
the approximate change in gene frequency due to natural selection is
-V «tt-A->
2b) AD diseases with incomplete penetrance
For AD diseases with incooplete penetrance the calculations are
exactly the same as for (2a) except that only a proportion % of
individuals of genotype Aa are affected and at a selective disadvantage.
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Therefore the overall fitness of Aa individuals is (1-ys ).
A-
(i) Disease incidence Following the same method as above the
approximate incidence of affected individuals in the offspring is
3 y
4p q (1-ys ).~ (since half the offspring of heterozygotes are hetero-
A- 2
zygous and a proportion are affected). The approximate change in
disease incidence due to natural selection is therefore
2
2qy <l-ysA_) - 2pqy = -2qy
(ii) Gene frequency The approximate frequency of A in the parental
generation at reproduction is —. 2pq (1-ys ) = q(l-ys ). As a
2 A— A—
result of selection against affected individuals the frequency of _A
is reduced by approximately ~ s .2qy (1-ys ) by the time the offspring
2 A— A—
reproduce. Therefore the approximate change in gene frequency due to
natural selection is -qys (1-ys )
3) XR diseases
Consider an XR disease with males of genotype aY affected. In
the
the parental generation at birth/genotypes have the following frequencies
and fitnesses:-
Females Males
Genotype AA Aa AY aY
2
Frequency p 2pq p q
Fitness 1 l l i_s
a
Couples at risk of having affected offspring have frequencies and
fitnesses as follows:-
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Mating- type Frequency Fitness Proportions of offspring-
Females Males
AA Aa AY aY
.V o 2 , 11 11Aa X AY 2p q 1 ~ - - -
Aa x aY 2pq2 l-a 0 | \ f
(i) Disease incidence Hie approximate disease incidence amongst
X 2 X 2 •
male offspring is —. 2p q + 2pq" (1-s ) = q(l~qs )
2 ^ a a
Hie change in incidence due to natural selection is therefore
2 2
approximately q-qs - q = -q s
a a
(ii) Gene freguenc^ Two thirds of the genes at an X-linked locus
are carried by females and one third by males. Since half the genes
of heterozygous females and all the genes of affected males are a
the approximate frequency of a in the parental generation is
2 X X X
■— [—■• 2pq] + — [q(l-s )] = q(l-"~s ). As a result of selection
J <2 3 2L *5 0.
against affected males who contribute one third of all the genes at
the locus the frequency of a is reduced by approximately ~ s q (1-qs )~ 3 a a
by the time the offspring reproduce. Therefore the approximate change
in gene frequency due to natural selection is qs .
3 &
4) MF diseases
Consider an MF disease with individuals having a normal distribution
of liability to the disease as in Figure 4.2. In the parental .gener¬





Mean liability n a
Fitness 1 *~8f
The mean liability of the offspring is the product of the
heritability and the mean liability of their parents. If selection
operates between the birth and reproduction of the parental generation
the mean liability of the offspring is h [n(l-P) + aP(l-sf)].
_z z 2
Substituting n = —— and a = — the mean liability becomes -zh sf.
Since the parental generation is taken to have a mean liability of
zero at birth this expression is the difference between parental and
offspring generations in mean liability at birth. The difference in
disease incidence is approximately z times the difference in mean
liability, since z is the height of the curve at the threshold point.
2 2 2 2 2
Thus the approximate change in disease incidence is -z~h s^ = a~P~h s^.
(B) Effects of practices
The effects of three of the new practices are calculated in this
section for diseases of each mode of inheritance. These exanples
illustrate the methods used for all the practices considered. The
first example deals with the effects of improved treatment as this is
the simplest method. The second example deals with the measurement
of the effects of prospective family limitation by carriers illustrating
the method of calculation when there is a change in the fitness of
individuals other than those who are affected. In the third example
the most complex method of calculation, that for prospective selective
abortion with reproductive compensation is described. This gives the
47.
method used when the fitness of couples rather than that of individuals
is considered. Here there is also a change in the genotype distribution
of the offspring. For each of these practices the changes in disease
incidence and gene frequency for early onset AR, AD (complete penetrance)
and XR diseases and changes in disease incidence for early onset MF
diseases are calculated. Changes resulting from other practices
and for AD diseases of incomplete penetrance are calculated in Appendix 1.
1) AR diseases
Improved treatment (1)
Suppose an improved treatment for the disease has the effect of
reducing selection against aa Individuals by an amount s • . The disease
aa
incidence and gene frequency changes are calculated by the same method
as in section (A) replacing s by (s - s* ).
aa aa aa
(i) Disease incidence The change in disease incidence between
3
parental and offspring generations is approximately -2q (s - s* ).
aa aa
Subtracting the effect of natural selection alone, the net change due
3
to the practice is approximately 2q s *
aa
(ii) Gene frequency Similarly the difference in gene frequency
between the parental and offspring generations is approximately
2
-(s - s' )q . Subtracting the effect of natural selection alone
aa aa
2the net change due to the practice is approximately s* q"
48.
Family limitation_by carriers (4)
- prospective
Suppose a proportion w of heterozygous carriers is ascertained
before they have had any children (i.e. prospectively) and of these
a proportion c^ subsequently reduce their intended family size by a
proportion f• . Putting these terms together the fitness of carriersAa
is (1 - w, c f• ). Assuming that fitnesses are multiplicative the
Aa i Aa
2
fitness of heterozygous (Aa x Aa) couples is (1 - w. c f' ) .Aa i Aa
(i) Disease incidence Since most affected individuals are the
offspring of couples where both partners are heterozygous the approx¬
imate reduction in disease incidence is calculated by only considering
couples of this type. These cotqples have frequency and fitness as
followss-
Mating type Frequency Fitness Proportions of offspring
AA Aa aa





Aa x Aa 4p q
The difference in disease incidence between the offspring and parental
1 2 2 2 2
generations is then approximately —. 4p q (1-w. c f' ) - q4 Aa i Aa
= -q"w. c f• (2-w c f • )Aa i Aa Aa i Aa
Subtracting the effect of natural selection alone the approximate net
2
change due to the practice is -q w. c.f' (2-w. c f• )
Aa i Aa Aa i Aa
(ii) Gene frequency The approximate frequency of in the parental
2
generation is q-s q . Since half the genes of heterozygotes are a
the reduction in gene frequency due to family limitation is approximately
~ (2pq w c f• ) ' q w. c f»2 Aa i Aa Aa i Aa
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Hie reduction in gene frequency due to selection against affected
2 o
individuals born is approximately s^q" (1-w^c^fTherefore
subtracting the effect of natural selection alone the net change in
gene frequency due to the practice is approximately
2 2 2,
~q w, c f' - a q (1-w. of• ) + s q = -q w. cf•* Aa i Aa aa AaiAa aa Aa i Aa
Selective abortion with reproductive compensation (3)
- prospective
Suppose a proportion w of couples where both partners are heterozygous
a
is ascertained prospectively and a proportion c of these practise
SB
selective abortion of affected fetuses with reproductive compensation.







(i) Disease incidence The approximate incidence of affected indiv-
X 2 2 2
iduals in the offspring is —. 4p' q~ (l~w c ) = q* (l~w c )4 am > s a
Following the same reasoning ae in (4) above the net change due
2 2 3
to the practice is approximately q (1-w c ) - q" + 2q s
ra ra aa
2
a -q w c
mm
(ii) C?ene frequency The approximate frequency of a in the parental
2
;generation is q - s q .
aa
The reduction in gene frequency due to selection against affected
Frequency
Practising selective .2 2
abortion * q V.
Not practising selective . 2 2,, .
. & 1p q (1-w c )abortion mm
50.
2
individuals born is approximately s q (1-w c )
aa m m
The reduction in gene frequency due to selective abortion of affected
12 2 °
individuals is approximately 4p~q w c = q w c4 mm mm
To compensate for individuals aborted there are an additional
2
q w c offspring born. Two-thirds of these are heterozygotes half
m m
of whose genes are a. Therefore the approximate increase in gene
2 1 2
frequency as a result of reproductive compensation is —. —. q~w c
3 2 mm
1 2
= —' q w c
3 mm
Following the same reasoning as in (4) above the net change due to the
2 . 2 12 2
practice is approximately -s q <l-w c)~qwc + — q w c +qs
aa mm m in 3 mm aa
2 , 2*
= q w c (s -q~)
mm aa 3
2a) AP diseases with complete penetrance
Improved treatment (1)
Suppose an improved treatment for the disease reduces selection
against affected individuals by an amount s' . The changes in disease
A—
incidence and gene frequency can be calculated by the same method as
used in section (A) substituting (s -s* ) for s
A- A- A-
(i) Disease incidence The change in disease incidence between
parental and offspring generations is -2q (s -s• ). Subtracting
A- A-
the effect of natural selection alone the net change due to the practice
is 2qs•A—
(ii) Gene frequency Similarly the approximate change in gene
frequency between parental and offspring generations is
i <i-A.+ s;->
51.
Subtracting the effect of natural selection alone the approximate net
change in frequency due to the practice is
qs' (1+s '-2s )
A-- A— A-
If s is large and s' is small this net change is negative.
A- A—
This implies that there is a greater reduction in gene frequency after
the introduction of an improved treatment, when the change is measured
between the parental generation at reproduction and the offspring
generation at reproduction. This is the result of the fact that with
an improved treatment the gene frequency in the parental generation
is higher than with no such treatment. This difference is trivial
for AH diseases but not for AD diseases. Without improved treatment
the frequency is q(l~s ) and with improved treatment it is
A—
q(l-s +s* ). Although the result obtained above is mathematicallyA- A-
correct it is of more practical interest to compare the proportionate
changes in the frequency of A between parental and offspring generations.
Without improved treatment the proportionate change is
•~s qCl-s.)/ q(l-s. ) = -s. . With improved treatment the proport-
A- PrY A- A-
ionate change is (-s +s' ). Therefore the net effect of irqproved
fl""
treatment is to diminish the proportionate reduction in gene frequency
by an amount s• .
A -
Family limitation by carriers (4)
- prospective
In the case of AD diseases with complete penetrance heterozygous
carriers of the deleterious allele are all affected. Suppose a
proportion w. of these individuals is ascertained prospectively andA—
of these a proportion reduce the number of offspring they would have
52.
had subsequently by a proportion f' . Affected individuals originally
n"*
have a fitness of (1-s ) and this is reduced by a proportion
A-
w c.f • . Couples at risk of having affected offspring have frequency
A- i A-
and fitness as followss-





Aa x aa 4p q (1-s ) (1-w of* )A— A- i A-
(1) Disease incidence The approximate incidence of affected indiv-
1 3
iduals in the offspring is —. Ip q (1-s )(l-w c f • )
« A"" A* 1 A**
4 ^o-V)<i-«A.o1q.)
Hie difference in disease incidence between parental and offspring
generations is then approximately 2q(l-s )(l-w c f • ) - 2pq
A- A- i A-
Subtracting the effect of natural selection alone the net change
due to the practice is approximately -2qw of• (1-s. )A- i A- A—
(ii) Gene frequency The approximate frequency of A in the parental
generation at reproduction is q(l-s, )
A-
The reduction in gene frequency due to family limitation is approximately
2' 2pq VVi-<l-A-> = q,A-Vk-<1"A->
The reduction in gene frequency due to selection against affected indiv¬
iduals born is approximately ^ s .2q(l-s )(l-w c t* )2 A- A- A- i A-
= qs (1-s )(l-w c f• )
A— A— A- i A—
Subtracting the effect of natural selection alone the net change in gene
frequency due to the practice is approximately
-'VVa-(1"SA-) " q8A-<1~V)a-Vl'A-) + qV<1-A-) = -qV°lfA-a-SA
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Selective? abortion with reproductive con^gensattor (3)
- prospective
Suppose a proportion of couples where one partner is affected
is ascertained prospectively and a proportion c^ of these practise
selection abortion of affected fetuses with reproductive compensation.






(i) Disease incidence The approximate incidence of affected indiv¬
iduals in the offspring is 4p3q (1-w o )(l-s ) = 2q (l-w c >(l-s, )<2 01 81 A"* 18 HI A""*
Following the sane reasoning as in (4) above the approximate net change
in disease incidence due to the practice is 2q (l-w c )(l-s > -2pq + 2qs
81 E9 A"* A-
= -2qw c (l-s )ra a A-
(ii) Gene frequency The approximate frequency of A in the parental
generation is q(l-s ). The reduction in gene frequency due to
n"*
selection against affected individuals born is approximately
s , 2q(l~w c )(l-s ) s q8. (l-w c )(l-s. )2 A- mm A- A- mm A-
The reduction in gene frequency due to selective abortion of affected
11 3
individuals is approximately —. ip qw c (l-s. > = q w c (l-s. )2 2 ^ a m A- ram A-
Ihere is no change in gene frequency as a result of the birth of
additional offspring to compensate for those affected because none of
them carry the A gene.
Frequency Fitness
Practising selective . 3 .
.
.. 4p qw c (l-s. )abortion mm A-
ErST1*1"* "1*oti" a-v>
Therefore the net change in gene frequency due to the practice
is approximately
-qs (1-w c )(1-b ) - q w c (l-s ) + qs <l-s. ) = -q w c (l-s )
A- mm A- mm A- A- A- mm A-
3) XR diseases
Improved treatment (1)
Suppose an improved treatment has the effect of reducing selection
against aY males by an amount s'. The disease incidence and gene
— a
frequency changes can be calculated by the same method as used in
section (A), substituting (s -s*) for s .
3 R 11
(i) Disease incidence The change in disease incidence between
2
parental and offspring generations is -q (s -s1). Subtracting the
a a
effect of natural selection alone the net change due to the practice
2
is approximately q s'
a
(ii) Gene frequency The approximate change in gene frequency between
parental and offspring generations is -^q (a -s*).
3 a a
Subtracting the effect of natural selection alone the approximate net
change in gene frequency due to the practice is -^q s*.3 ft
For XR diseases as for AD diseases there is an increased gene
frequency in the parental generation when there is improved treatment
and this increase is not trivial. Therefore it is more valid to
compare the proportionate changes in the frequency of a. Without
improved treatment the proportionate change in gene frequency is
s q(l-7 ) - -s (3-s )3 a 3 a a/ a
55
With improved treatment the proportionate change is
-5"
The net effect of improved treatment is therefore to reduce the
proportionate reduction in gene frequency by an amount
-(Bft-8a.) + '» _ 2a* / (3-s )(3-s +s»)(3-s +s») (3-s ) a/ a a aft ft ft
Family limitation by carriers (4)
- prospective
Suppose a proportion of carrier females is ascertained pros¬
pectively and of these a proportion subsequently reduce their
intended family size by a proportion 1' . Since most carrier females
AS
are married to normal males the approximate changes in disease incldenoe
and gene frequency are calculated by only considering couples of this
type. These couples have frequency and fitness as shown:-
Mating type Frequency Fitness Proportions of offspring
Females Males
Aa x AY 2p2q °«*I )Aft X Aft
<i> Incidence The approximate Incidence of affected indiv-
1 2
iduals amongst male offspring is —. 2p"q (1-w. c f' ) = q(l-w. c.f' )2 Aa l as aa i Aa
subtracting the incidence in the parental generation and the effect of
natural selection alone the approximate net change in disease incidence
due to the practice is -qw. of'
Aa 1 Aa
(ii) Gene frequency The approximate frequency of a in the parental
generation at reproduction is q(l-~s )
•i ft
The approximate change in gene frequency due to family limitation by
2 1 2
carrier females is -— f-> 2pq w of' ] = -— qw. of'3 2 Aa i Aa 3 Aa i Aa
AA Aa AY aY
1 1 1 1
2 2 2 2
56
The change in gene frequency due to selection against affected
individuals born is approximately -^s q (1-w c f' )
o ft Aft 1 Aft
Therefore subtracting the effect of natural selection alone the
approximate net change in gene frequency due to the practice is
-fqw of - iqs (1-w Of') + ^qs = -^qw c f * (2-s )3 AaiAa 3a AaiAa 3a 3 Aa i M a
Selective abortion with reproductive compensation (3)
- prospective
Suppose a proportion w of couples where the female is a carrier
m
is ascertained prospectively and a proportion c of these practise
m
selective abortion of certain fetuses with reproductive condensation.
The fetuses aborted may be:-
a) all males
b) affected males only
c) affected males and carrier females
Couples where the female is a carrier have frequencies as follows
Frequency Proportions of offspring
Females Males
AA Aa AY aY
Not practising selective 2 . i ~ 7T "T
. I. 2p qCl-w c ) 22 22abortion mm
Practising selective 2 ,.11 „
abortion 2p " V. <a) 2 2 0 0
<»> I }
Cc) 1 0 10
(i) Disease incidence In cases (a), (b) and (c) all affected
individuals are aborted and so the change in disease incidence is the
same in all of them. The approximate incidence of affected individuals
1 2
amongst male offspring is —. 2p q (1-w c ) = q(1-w c )2 mm mm
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Subtracting the incidence in the parental generation and the
effect of natural selection alone the net change in disease incidence due to
selective abortion is approximately -qw c
m m
(ii) Gene frequency The approximate frequency of a in the parental
generation at reproduction is q(l-^s ).
o a
In (a), (b) and (c) there is the same reduction in gene frequency due
to selection against affected individuals born and to selective abortion.
The reduction due to selection against affected individuals born is
approximately ^qs (1-w c ).3 a mm
XX 2






lb compensate for 2p qw c males aborted there are an additional
m m
2
2p qw c females born. One half of these are carriers, half of their
m m
genes being a. Therefore the approximate change in gene frequency
2 1 X P
due to the birth of additional carrier females is — f—. —. 2p 'qw c ]
3 2 2 ram
. 1
= ^wmcmo m
Subtracting the effect of natural selection alone the net change
in gene frequency due to selective abortion of all males is approximately
-rqs (1-w c ) - rqw c + rqw c + -qs = rqw c s
3 a mm Jmm 3 in m 3 a 3 m m a
(b) affected males
The number of fetuses aborted is only half that in (a) and there
2 9
are only an additional—p qw c females born. By the same method as3 mm
in (a) the approximate change in gene frequency due to the birth of
additional carrier females is ^qw c9 mm
53.
The net change In gene frequency due to selective abortion of affected
■ales Is therefore approximately -Ajs (1-w c > - ~qw c + ^qw c + ^qsJ & IB a 3 m is y mm 3 c
1 , 2
= rqw c (s -—)
3 ■ ■ a 3
<°) affected aales and carrier females
1 2
In addition to affected males aborted there are 2p qw c
* ® ©
carrier females aborted.
the reduction In gene frequency due to abortion of carrier females Is
. . , 2.11 .2 . . 1
approximately - [-. 2p qw^J 35 ^»wBCm
Hie net change in gene frequency due to selective abortion of affected
■ales and carrier feoales is therefore approxiaately
-4qa <l-w c ) - ~qw c - ~qw c + ^qa * -^qw c (2-s )3 a am 3 ■ a 3am 3 a Sara a
4) MP diseases
Improved^ treatment (1)
Suppose an lnproved treatment has the effect of reducing selection
against affected individuals by an amount s*. The change in disease
incidence can be calculated as in section (A) replacing af by (s^-mp.
The change in disease incidence between parental and offspring gener¬
ations is approximately ~aP^h*(s -a!).
X X
Subtracting the effect of natural selection alone the net change due
to the practice is approximately a2p2h2s*
Family limitation by 'carriers* (4)
- prospective
Suppose it is possible to detect prospectively, individuals whose
» t
liability exceeds a certain value x say where x (the abscissa at
59.
the threshold). For example,for the disease diabetes mellitus
individuals with a high blood sugar level may be ascertained. Suppose
a proportion is ascertained and of these a proportion c^ subsequently
reduce their intended family size by a proportion f^. In the parental





















(1-wcf) (1-w c f «)<l-s )
x i x x i x f
Following the method in section (A) the mean liability of the offspring
2
can be shown to be h [w c f' (aPs -a P ) - aPs.]. The difference in
x i x f x x f
disease Incidence between offspring and parental generations is
approximately z(=aP) times this difference in mean liability. sub¬
tracting the effect of natural selection alone the net change due
to the practice is approximately
-aP h w of' (a P -aPs.)
X i X XX f
Selective abortlon_with reproductive compensation (3)
- prospective
Suppose it is possible to detect prospectively couples where the
t»
mean liability of the two individuals exceeds a certain value x say.
Suppose P is the proportion of couples exceeding this liability
X
and that a proportion w of them is ascertained and a proportion c
x a<
60.
of the so practise selective abortion with reproductive compensation.
As calculated in section (A) if the fitness of affected individuals
is (1-s^) and selection operates between the birth and reproduction
of the parental generation the mean liability at reproduction is
[n(l-P) + aP "(1-s )]. This is therefore the mean liability of all
coiqples and is approximately -zsf expressed as a deviation from the
mean of the parents at birth. The distribution of liability of
couples, after the removal of some individuals from the breeding'
miij Ka,<^cx>-deJL as
population by selection, -±a-approximately normal with variance one
half that of individuals. Therefore the mean liability of couples
11
whose liability exceeds x , expressed in terms of the number of
standard deviations of liability of individuals is,/2 a - zs^
x f
(where is the mean liability of these couples expressed in terms
of the standard deviation of liability of couples). Similarly the
• t
mean liability of couples whose liability does not exceed x is
42-n - zs .
x f
This is summarised below:
• i • t
Liability not greater than x Liability greater than x
No selective abortion Selective No selective
abortion abortion
Frequency (1-P ) w c P (l-w c )p
x x m x x m x
Mean liability i2 n -zs J 2 a -zs^ 2 a -zs„
X f X f X f
The mean liability of the offspring of couples not practising
selective abortion is
h2 (1-PX) ( ,2 nx-zsf) + (l-wxcm) PY ( 2 ax - zsf)
(1-P ) + (l-w c ) P 1
x x m x J
substituting n = -~2£ and a = the mean liability becomes
x l-p x p
X X
61.
r-SE8f ♦ wxCm (2*fI>x ~ ^ sx)j
mmmrnmm flh i snis.sw»sdL».iMa«Mw«»ewgJU»is3LM»«wM»'iiHi —mmS^
1 - w o P
X » X
The proportion of the offspring1 of these couples who are affected is
2 !—
approximately P + gh"r-gs^ + wxcB (gaf
1 - w o P
x a x
The offspring of these couples make up a proportion <1 - w e P )
X SI X
of all offspring. Couples practising selective abortion have no
affected offspring therefore the change in disease incidence between
offspring and parental generations is approximately
P(l-w c P > * sth2f-ss. + w c (a». P - j~2 z )] - P
xax f x a fx x
Subtracting the effect of natural nolection alone the approxiaate
net change in disease incidence due to the practice becomes
-w c PP [l + ah^-aPs. ♦ J~2 a )]
x a x t x
TABLE5.2

































































































































































































Possible net changes in disease incidence and gene
frequency in X-linked recessive (XH) diseases (with












3s V(3-s )(3-s +s.)*
a a a a









3 m o a
b) affected males -qw c
m m
-qw c (s --)






~rqw c (2-s )
3mm a
- retrospective
a) all males -qw c P
m m r
~~qw cPs
3 m m r a
b) affected males -qw c P
m m r
1 , 2 ^
—qw c P (s -—)







-~qw c P (2-s )
3 m m r a
(B) Eugenic practices
4. Family limitation




- prospective -qw. c f'Aa i Aa 4"*A.VA.<2-.)
- retrospective -qw of* P
Aa i Aa r qnaVLV2-8.'
* *
Proportionate change (see page 54)
TABLE 5.5 (contd.)










3 s Aa i Aa
qP w of* (2-S )














a) all males -qw c
m m
4qw c (1-s )
3mm a
b) affected males -qw c
m m







Jkjw C (2-s )
3mm a
- retrospective




3 m m r a a
b) affected males -qw c P





ra ra r ~lqWmCn,P-(2-So)3 ra m r a
TABLE 5.6
Possible net changes in disease incidence in multi¬
factorial diseases with early onset ((a) and (b)).




,a P h s]f
2. Selection of mate -




-w c PP [l+ah (42a -aPs )]
x m x x f
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Possible net changes in disease incidence and gene
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TABLE 5,11
Possible net changes in disease Incidence in multi¬
factorial (MF) diseases with late onset (c).
Practice Net change in disease incidence
(A) Dysgenic practices
1. Improved treatment 0
2. Selection of mate -
3. Selective abortion with
reproductive compensation
- prospective -w c PP (l+i2h2aa )
x m x x
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X X X X X
5. Family limitation
by carriers at risk
- prospective
r- 2-|2aPh w c f»a P
x m m x x
- retrospective -w c f*P P
x m m rm
6. Family limitation by sibs
of affected individuals
-w c f*P P(l+ih4a2)
x x x sra 2
7. Artificial insemination for
spouses of carrier males
8. Artificial insemination for
spouses of carrier males -
at risk
9. Selective abortion without
reproductive compensation
- prospective -w c PP (l+[2h2aa )
x m x x
- retrospective -w c PP*
x m rm
(6) DISCUSSION OF RESULTS OBTAINED
In section (5) and In appendix (1) a large number of formulae
are obtained for the changes in disease incidence and gene frequency
resulting from various practices. Hie actual sizes of the changes
depend on the values of parameters, such as gene frequency, which are
independent of the practice being studied and on the values of para¬
meters actually measuring the practice. They are also dependent upon
the age at which the disease has its onset. In order to illustrate
the effects of the different practices some examples of possible changes
are plotted in Figures 6.1 - 6.15. These are the net changes in disease
incidence and gene frequency for AR (without heterozygote advantage),
AD, XR and MF diseases of early onset for given values of the parameters.
The net changes in disease incidence are expressed as percentages
2
of the initial incidence (i.e. £ for AR diseases, 2qy for AD diseases,
£ for XR diseases and P for MF diseases). In the majority of cases
the net changes in gene frequency are expressed as percentages of the
initial frequency £. For AD and XR diseases the net proportionate
changes in gene frequency (multiplied by 100) resulting from inproved
treatments (see pages 51 and 54) are plotted in Figures 6.2, 6.11 and
6.13. In Figure 6.9 the net change in frequency of an AR gene is
2
expressed as a percentage of £ . This is because most of the changes
2
in frequency of an AR gene are proportional to £ . With two exceptions
therefore the values plotted in Figure 6.9 are valid for all values of
£. The measurement along the abscissa depends on the particular
practice being considered. For improved treatment it is the change
in the fitness of affected individuals. For family limitation by
certain Individuals or couples the measurement is the product of the
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proportion of individuals (couples) ascertained, the proportion of
these adopting the practice and the proportionate change in fertility
of those adopting the practice. It is therefore a measure of the
proportionate change in fertility of all individuals or couples of
the genotypes considered. For selection of mate, AI and selective
abortion the measurement along the abscissa is the product of the
proportion of individuals (couples) ascertained and the proportion of
these who adopt the practice.
In Figures 6.1-6.7 changes for one particular practice for diseases
of different modes of inheritance are given. The effect of a practice
may be very different for two diseases with different modes of inherit¬
ance. The effects of all relevant practices for diseases of one mode
of inheritance are plotted in Figures 6.8-6.15. These latter graphs
illustrate the relative importance of the different practices in
causing changes for diseases of each mode of inheritance studied. They
can also be used to estimate the effects of several practices operating
simultaneously.
64.
Parameters independent of the practice considered
In this section the values used for each of the parameters are
discussed, firstly for unifactorial diseases and then for multifactorial
(MF) diseases.
Unifactorial diseases
i) Gene frequency (fl)
For AD diseases all the changes (expressed as described, page 62)
are independent of the initial gene frequency. This is also true for
XR diseases with one exception but not for AR diseases. In the cases
where the changes are dependent on £ it is necessary to substitute a
value for £ in the formulae. For AR diseases the value of £ used is
0.02. This is the approximate frequency of the gene for cystic
fibrosis in Britain. This disease has a relatively high frequency
when compared with other AR diseases and for many AR diseases the
changes would be smaller than those calculated for this value of <j.
For XR diseases the value of £ is 0.0001 as for haemophilia in Britain
(Cavalli-Sforza & Bodmer (1971)). In the figures the curves where
these values of £ are used are marked with an asterisk (•). This
shows that in these cases the changes plotted are evaluated for these
specified frequencies.
ii) Penetrance (£)
For AD diseases with Incomplete penetrance the value of £ used
is 0.5. With this value for £ the changes are expected to be inter¬
mediate between those for AD diseases with complete penetrance and
those for AR diseases.
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iii) Ctoefficient_of_ select ion (s^
The reproductive fitness of individuals with early onset genetic
diseases is in general very low. Many of these diseases result in
death in early childhood. Taking s equal to unity reduces many of
the changes to zero. In order to include the effects of as many
practices as possible in the figures, the value used for s^ is 0.9.
iv) Proportion of offspring of couples at risk born after thejfirst
The proportion of offspring born after the first affected child
in the family is dependent both on the probability that any child is
affected and on the family size distribution in the population.
Fraser (1973) has derived formulae to measure the resultant reduction
in fertility, if couples have no more children after the birth of a
child affected with an AR disease. This reduction in fertility is
the same as the proportion of offspring born after the first affected
child. Eraser's results can be extended to AD and XR diseases.
Consider first an AR disease
Couples at risk of having an affected child are mainly those where
both partners are heterozygous, as explained earlier. Otoe quarter of
their offspring are affected.
Families of size jb can be divided into two groups:
a) a proportion (^~)B has s_ normal children and no affected
children
3 8
b) a proportion l-(^) has at least one affected child
The mean number of affected children per couple is s/4
3 s
The mean number of first cases per couple is l-(^)
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Therefore for families of size £ the proportion of affected offspring:
who are born after the first affected child (i.e. not first cases) is
£
4
Summing: over all family sizes, if F is the frequency of families of
size £ in the population, the proportion of affected offspring: born
after the first affected child is P where
r
If [f - l + <V]




Since the chance that any child is affected is the same, whether
they are born before or after the first affected child, Py is also the
proportion of all offspring1 born after the first affected child.
This result can be extended to diseases with other modes of
inheritance. In general if £ is the probability of having an affected
child
all Fs ^PS~1 + (1~p)S^
Pr
•h F.p"
For AD diseases a proportion y/2 of the offspring of couples at risk
(Aa x aa) is affected. Therefore p = 1/2 for diseases with complete
penetrance and p = y/2 for diseases with incomplete penetrance.
For XR diseases a quarter of the offspring of couples at risk (Aa x AY)
are affected therefore p = 1/4. Substituting in these formulae values
for F calculated from the British 1961 census (appendix 2) the values
fi
of P are as follows
r
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AR diseases, AD diseases where y = 0.5 and XR diseases,
P = 0.23
T
AD diseases with complete penetrance, P =0.38
r
These values for P are used in Figures 6.1-6.13.
r
v) Proportion of the offspring of couples at risk who are normal sibs
of affected individuals
The proportion of the offspring who are normal sibs of affected
individuals depends upon the family size distribution and on the
proportion of offspring who are affected. Suppose couples at risk
have a total of s offspring, r of whom are affected. If £ is the
probability that any child is affected the proportion of their off¬
spring who are normal sibs of affected individuals is
f, (") Pr (i-p)s"r mlr=l r a
Summing over all family sizes the proportion of offspring of couples
at risk who are normal sibs of affected individuals is
p = x t!(■) ppa-p>"r
s s=l s r=l r s
Where F is the frequency of families of size £ in the population.
For AR and XR diseases p = 1/4
For AD diseases with complete penetrance p = 1/2
For AD diseases with incomplete penetrance p = y/2
The values of used in Figures 6.1-6.13 were obtained by
substituting for F the same values as in (iv) above.
s
For AR and XR diseases and AD diseases where y = 0.5, P = 0.1S
s
For AD diseases with complete penetrance, Pg = 0.20.
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Multifactorial diseases
i) Initial incidence and heritability
Formulae for possible changes in incidence of an MF disease are
given in Tables 5.6 and 5.11. There is no common factor by which
each of these formulae can be multiplied, to obtain proportionate
changes in disease incidence which are applicable to MF diseases in
general. The changes are dependent not only on the initial disease
incidence but also on the heritability. Two examples are presented
in Figures 6.14 and 6.15. In Figure 6.14 changes in disease incidence
are plotted for a disease with an initial incidence of 7.7 per thousand
and heritability 0.6 (e.g. spina bifida and anencephaly in South Wales,
Carter ejt al (1968)). In Figure 6.15 the changes refer to a disease
with an Incidence of 1.2 per thousand and heritability 0.76 (e.g. cleft
lip with or without cleft palate in Utah, Woolf (1971)).
ii) Coefficient of selection sf
For ease of calculation the fitness of affected individuals is
taken to be zero (s^=l) since it has only a slight effect on the
changes in disease incidence.
iii) Proportion of affected individuals born after the first affected
For unifactorial diseases it is possible to define a class of
couples who are the parents of the majority of affected individuals
(e.g. Aa x Aa couples in AR diseases). Since these couples all have
the same probability of having an affected child it is possible, using
this probability, to calculate the proportion of offspring of these
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couples born after the first affected child. For MF diseases.
however, the probability of having an affected child follows a
continuous distribution and it is not possible to divide couples into
discrete classes of those at risk and those not at risk of having an
affected child. Because of the variable risk that any child is
affected it is not possible to calculate a value for as for uni-
factorial diseases. Instead, the proportion of all affected
individuals who are further cases in affected sibships (P ), has
rm
been estimated for the diseases used as examples from the data given
by Carter et al (1968) and WOolf (1971). In the study of Carter et al
approximately five percent of index cases of spina bifida or anence-
phaly had an older sib affected with either disease. The authors
estimate that ascertainment was 96 percent complete and so P is
rm
taken to be approximately 0.05.
Woolf (1971) studied 496 propositi with cleft lip with or without
cleft palate. From the figures given in his paper it can be calculated
that approximately 5.8 percent of the propositi had an older brother
or sister affected with the same condition. For this disease therefore
P can be taken to be approximately 0.058.
rm
iv) Proportion_of individuals who_are normal sibs of affected individuals (Pg )
Approximate values for this parameter have been calculated from the
data of Carter et al (1968) and Woolf (1971). The index patients in
Carters study had a mean of 1.71 normal sibs. The value of P is
am
therefore approximately 1.71 times the disease incidence. This gives
P = (1.71 x 7.7)/1000 = 13.17/1000. In Woolfs study family size
sm
was greater than in Carter's. In this case the mean number of normal sibs
was approximately 3. This gives P = (3 x 1.2)/1000 = 3.6/1000.SHI
Symbol
Key to Figures 6.1-6.15 and 7.1-7.6
Meaning
AR Autosomal recessive
AD Autosomal domlrant with complete penetrance
AD+ Autosomal dominant with penetrance 0.5
XR X-linked recessive
1 Improved treatment
2 Selection of mate
3 Selective abortion with reproductive compensation
4 Family limitation by carriers
5 Family limitation by carriers at risk
6 Family limitation by sibs of affected individuals
7 Artificial insemination for spouses of
carrier males
8 Artificial insemination for spouses of
carrier males at risk
9 Selective abortion without reproductive
compensation
a Selective abortion of all males
b Selective abortion of affected males






Evaluated for a specified frequency
Net proportionate change in gene frequency (xlOO)
The effect of a practice for diseases of different
modes of inheritance
In this section the practices discussed in section (2) are
considered in turn. The practices have effects on disease incidence
and gene frequency which are dependent on the mode of inheritance of
the disease. The different effects are shown in Figures 6.1-6.7.
(A) Dysgenic practices
1, Improved treatment
Possible effects of the introduction of treatments on disease
incidence are shown in Figure 6.1. For all diseases there is an
Increase in incidence which is especially large for AD diseases as
all the individuals whose fitness is improved are at risk of having
an affected child. For AR and XR diseases the net increases are
proportional to the initial gene frequency. In AR diseases where
there is heterozygote advantage e.g. sickle cell anaemia in Africa
the possible increase may be relatively large (Figure A3.1). In
other AR and XR diseases where the gene frequencies are smaller the
possible net increases in disease incidence are very small. This is
because for recessive diseases individuals are only at risk of having
an affected child in the unlikely event of their marrying a carrier
of the allele. For XR diseases even if the fitness of affected
individuals was increased to unity, the increase in disease incidence
would only be of the order of 0.01 percent. This Increase is too
small to be shown accurately in Figure 6.1.
The corresponding changes in gene frequency are shown in Figure 6.2.
In contrast to the increase in disease incidence the increase in
Flaw 6.1 Tho ifftot on dlM«M lneldwM of tba
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Figure 8.2 The effect on gene frequency of the









frequency of deleterious XR alleles is relatively large. This is
because one third of all the deleterious alleles are carried by
affected individuals being passed on to carrier female offspring.
For AR diseases the change in gene frequency is greater if there is
heterozygote advantage (e.g. Figure A3.2) but in most AR diseases
the change is small as only a proportion g, of all deleterious alleles
are carried by affected individuals* For AD diseases the net
proportionate change in gene frequency is the same as the change in
disease incidence.
2. Selection of mate
If heterozygous carriers of AR genes seek a homozygous normal
partner there is a relatively large percentage decrease in disease
incidence equal to that which occurs if the same proportion of carriers
have no offspring (Figure 6.3). The percentage increase in gene
frequency is slightly greater than that which occurs if there is an
increase in fitness of affected individuals. The change is due solely
to the decrease in the number of affected individuals born and the
consequent reduction in the number of genes eliminated by selection.
As discussed earlier, genes carried by affected individuals are only
a very small proportion of the total and hence the gene frequency
change is small.
3. Selective abortion with reproductive compensation
- prospective
The effect of selective abortion of the offspring of couples at
risk of having an affected child is to produce a decrease in the disease
incidence (Figure 6.3). For AR and XR diseases the net decrease is
directly proportional to the proportion of couples adopting the
Figure 6.3 The effect on disease incidence of carrier










Figure 6.4 The effect on gene frequency of selective
abortion with reproductive ooopensstion.
Proportion of couples adopting practice
practice and In theory If all couples were to adopt the practice the
disease could be coegiletely eliminated* Far AD diseases however the
net decrease is much smaller as if affected individuals have low
fitness they will not have many offspring who might be selectively
aborted*
The net increase in gene frequency (Figure 6.4) is relatively
large fear XR diseases being greatest when all male fetuses are aborted,
as if there ia reproductive cogensat ion, this is equivalent to
replacing all affected males by carrier females. The increase is
a quarter of this if only affected males are aborted. If affected
males and carrier females are aborted there is a relatively large
decrease in the frequency. For AR diseases the percentage increase
in gene frequency is very small as the additional heterozyqotos born
are only a small proportion of the total, most being the offspring of
one heterozygous and one homozygous normal parent. For AD diseases
with complete penetrance there is always a decrease in gene frequency
because none of the additional offspring born carry the deleterious
allele.
- retrospective
The percentage changes in disease incidence and gene frequency are
smaller if couples are not ascertained until they have had an affected
child. The changes are equal to P^ times those which occur when
ascertainment is prospective for AR and XR diseases and for AD diseases
with complete penetrance. For the present British family size
distribution P is quite small being approximately 0.23 for AR and XR
T
diseases and approximately 0.38 for AD diseases with complete penetrance
(see page 67). If family size were to become smaller P^ would be
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reduced and hence the net changes would become even smaller. For
example modifying the British family size distribution so that of all
couples having one or more children one quarter have one child, one
half have two children and one quarter have three children the
corresponding values of P are 0.15 and 0.28.T
For AD diseases with incomplete penetrance the theoretical changes
calculated for retrospective detection may be greater than those for
prospective detection. This is because the assumption is made that
when detection is prospective only offspring of affected carriers are
aborted, whereas when it is retrospective the offspring of a proportion
of all carriers who have had an affected child are aborted. If
affected individuals have low fitness the number of offspring of
affected individuals may be smaller than the number of offspring
born after an affected sib. For diseases where y = 0.5 retrospective
detection has a theoretically greater effect on disease incidence and
gene frequency if affected individuals have fitness less than 0.3.
B) Eugenic practices
4. Family limitation by carriers
The net changes in disease incidence resulting from family
limitation by a proportion of all heterozygous carriers of the deleterious
allele are shown in Figure 6.3. If there is a proportionate reduction
in fertility of all carriers the net decrease in incidence of AD and XR
diseases is the same as if an equal proportion practise selective
abortion. The decrease in incidence of AE diseases is slightly
greater as for a given proportion of all heterozygous carriers ascer¬
tained, a greater proportion of all heterozygous couples is ascertained.
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The net decrease in gene frequency (Figure 6.5) is largest for
Alt and Xlt diseases where heterozygous carriers normally do not have
a reduced fitness but is small for AD diseases.
5. Family limitation by carriers at risk
- prospective
For AD and XR diseases the net changes in disease incidence and
gene frequency are the same as above. Family limitation by hetero¬
zygous couples in AR diseases produces a decrease in disease incidence
directly proportional to the proportionate reduction in fertility of
heterozygous couples (Figure 6.3). The gene frequency change
(Figure 6.5) is much smaller as most heterozygous carriers are married
to a homozygous normal individual but for diseases with heterozygote
advantage the change may be greater (Figure A3.2).
- retrospective
The changes in disease incidence and gene frequency differ from
those when there is prospective ascertainment as described for selective
abortion.
6. Family limitation by sibs of affected individuals
If sibs of individuals affected by AR, XR and AD diseases where
there is incomplete penetrance have a reduced number of offspring
there is a net decrease in disease incidence and in gene frequency
in the next generation. The changes depend on the proportion of the
offspring of couples at risk who are unaffected sibs of affected
individuals (Pg). Pg in turn depends on the family size distribution.
For the British family size distribution of the 1961 census P = 0.18
s
for AR and XR diseases and AD diseases where y = 0.5 (see page 67).
If family size is smaller P is reduced though not to the same extent
Figure 6.5 Hie effect on gene frequency of family
limitation by carriers.
Netchangeingenefrequ ncy(p rcent)
as P . This is because the size of P is determined by the number
r r
of offspring born after an affected child whereas P depends upon
the number of children born before and after an affected child. For
the example discussed under retrospective selective abortion (page 73)
P^ becomes 0.15 for AH and XR diseases and AD diseases where y = 0.5.
For AR diseases the net decreases in disease incidence and gene
frequency are very small as most heterozygotes do not have affected
sibs but are the offspring of one heterozygous and one homozygous
normal parent. For AD diseases (where y = 0.5) and XR diseases the
changes in disease incidence and gene frequency are larger. This
is because all heterozygous carriers, not arising by new mutation or
who are the offspring of normal females and affected males (in XR
diseases), are the offspring of couples at risk and therefore might
have affected sibs.
7. Artificial insemination for spouses of carrier males
Possible changes in disease incidence resulting from artificial
insemination are shown in Figure 6.3. There is a net decrease in
disease incidence which for AR diseases is the same as that when there
is selective abortion. For AD diseases however the decrease is only
one half that when there is selective abortion as AI is only applicable
to half the couples at risk. In XR diseases AI has a negligable
effect on the disease incidence as affected males are not at risk of
having affected offspring unless carried to a carrier female.
The net decrease in gene frequency is relatively large for AR
diseases but much smaller for AD diseases where carrier males have
low fitness (Figure 6.6). For XR diseases there is a decrease in
the gene frequency intermediate between that for AD and AR diseases





caused by a reduction in births of carrier females.
8. Artificial insemination for spouses of carrier males at risk
- prospective
For AD diseases the net changes in disease incidence and gene
frequency are the same as above since all carrier males are at risk.
For XH diseases very few affected males are at risk so the effects
are negligable. For AR diseases the decrease in disease incidence
is the same as above but the decrease in gene frequency is smaller
because most carrier males are married to a homozygous normal female.
- retrospective
The changes in disease incidence and gene frequency differ from
those when there is prospective ascertainment as described for
selective abortion.
9. Selective abortion without reproductive compensation
- prospective
There is a net decrease in disease incidence equal to that which
occurs if there is reproductive compensation. The net decreases in
gene frequency (Figure 6.7) are greatest for XR diseases in the case
where there is selective abortion of both affected males and carrier
females. If all or only affected males are aborted the change is
about one tenth of this. For AD diseases with complete penetrance
the changes are smaller if affected individuals have low fitness. In
the case of AR diseases the gene frequency change is small because
most of the deleterious alleles are borne by unaffected carriers.
- retrospective
The changes in disease incidence and gene frequency differ from
those when there is prospective ascertainment as described for selective
Figure 6.7 The effect on gene frequency of selective
abortion without reproductive compensation.
Netchangeingfrequency(p rce t) I CD CJ1
abortion with reproductive condensation.
Diseases where affected individuals have greater fitness or the age
of onset is greater
If affected individuals have fitness greater than in the above
exanples the net increases in disease incidence and gene frequency
are smaller and the net decreases larger. The same is true for
diseases with onset after the reproductive period if the parameters
have the same value. However, as discussed earlier the changes are
likely to be smaller in practice because fewer carriers would be
ascertained.
The only practice considered which causes an increase in the
disease incidence in the next generation is the introduction of
improved treatments. This Increase is small except for AD diseases
and AR diseases where there is heterozygote advantage. All the
other practices produce a decrease in the disease incidence. These
decreases are small for AD diseases if carriers of the allele have
low fitness, but potentially large for AR and XR diseases.
Increases in the gene frequency result from the introduction of
inproved treatments and also from selective abortion with reproductive
compensation. For AD diseases the increase in gene frequency
resulting from improved treatments is large but that resulting from
selective abortion is small if carriers have low fitness. Relatively
large increases in the frequency of XR genes result from both
practices because additional carrier females are born but for AR
diseases where there is no heterozygote advantage the Increases are
small because most deleterious alleles are transmitted to the next
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generation by couples where only one partner is heterozygous.
Selective abortion without reproductive compensation, AI and
family limitation by carriers all produce a net decrease in gene
frequency which is largest for AR and XR diseases when a proportion
of all heterozygous carriers reduce their family size.
If ascertainment is not until couples have had an affected child
all the changes are smaller.
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The effect of different practices for diseases of
one node of inheritance
1. Autosomal recessive diseases
The changes In disease Incidence and gene frequency are plotted
In Figures 6.8 and 6.9 respectively. It can be seen that the only
practice which produces a net increase in disease incidence i.e.
improved treatment, also produces the largest net increase in the
gene frequency in one generation. Of the other practices which all
produce a decrease in disease incidence, selection of mate and
selective abortion with reproductive compensation are the only two
which produce a net increase in gene frequency.
If a proportion of all heterozygous carriers either limit their
family size or select a homozygous normal marriage partner there is
a maximum decrease in disease incidence in one generation but the
increase in gene frequency produced by selection of marriage partner
/
gives a potential for increase in disease incidence in future gener¬
ations. By contrast the reduction in gene frequency as a result of
family limitation is considerably greater than any of the other
changes and could produce a long term reduction in disease incidence.
It is however likely,that only a small proportion of all carriers
would restrict their family size. With family limitation by a
proportion of carriers at risk the decrease in disease Incidence is
nearly as great as for family limitation by the same proportion of all
carriers. The decrease in gene frequency, however, is much smaller
when only carriers at riBk are concerned, but the decrease is as large
in size as any of the possible increases due to other practices. The
difference between the effect on gene frequency of family limitation
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by all carriers and by those at risk may be smaller when there is
heterozygote advantage (see Figure A3.2).
Prospective detection of carrier couples with AI or selective
abortion also results in the same decrease in disease incidence as
above with small changes in the gene frequency. If ascertainment
is retrospective both disease incidence and gene frequency changes
are small.
The graphs can also be used to see what changes might result from
combinations * of practices for diseases where there is no heterozygote
advantage. For example, an increase in gene frequency resulting from
an increase in reproductive fitness of affected individuals could be
offset by a reduction in fertility of carriers. If there is a
proportionate reduction in fertility of all carriers this reduction
need only be about two percent of the change in reproductive fitness
to prevent an increase in gene frequency. If only carriers at risk
reduce their family size the proportionate reduction in fertility must
be at least half the change in reproductive fitness. Similarly an
increase in gene frequency if a proportion of all carriers were to
select a homozygous normal mate could be offset by a voluntary
reduction, of two percent of this proportion, in the fertility of
all carriers. Retrospective detection of carrier couples with
subsequent family limitation could offset an increase in the fitness
of affected individuals of up to about 0.33.
After ascertainment coiq>les at risk might either practise selective
abortion of affected fetuses or reduce their family size. It can be
seen that the gene frequency would not increase if the proportionate
reduction in fertility was at least 20 percent of the proportion of
♦
For most combinations the joint effect is the sum of the individual
effects. This is not the case when improved treatment is one of the
practices (see appendix 4).
Figure 6.8 Hie effect of various practices on the
incidence of an autosomal recessive disease.
Abscissas-
Change in fitness of affected individuals (1)
Proportionate reduction in fertility (4, 5, 6)
Proportion adopting practice (2, 3, 7, 8, 9)
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Figure 6.9 The effect of various practices on the
frequency of an autosomal recessive gene.
Abscissa:~
Change in fitness of affected individuals (1)
Proportionate reduction in fertility (4, 5, 6)
Proportion adopting practice (2, 3, 7, 8, 9)
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couples practising selective abortion with reproductive compensation.
The effects of a large number of combinations of practices can
be considered. If affected individuals have fitness of 0.1 as in
this example the potential increases in gene frequency are smaller
than the potential decreases. If the fitness was greater the
increases would be even smaller and the decreases larger. For values
of the fitness of more than 0.33 selective abortion with reproductive
compensation would produce a decrease rather than an increase in gene
frequency but for most diseases the fitness of affected individuals
is very much lower than this.
Similarly the effect of combinations of practices can be estimated
for sickle cell anaemia in Africa, where there is heterozygote
advantage, from Figure A3.2. Compared with diseases where there is
no heterozygote advantage a greater reduction in fertility would be
required to offset the effect of improved treatment but a smaller
reduction would be sufficient to offset the effect of mate selection.
2. Autosomal dominant diseases
The results for diseases of complete and inconplete penetrance
are discussed together in this section, since the conclusions are
very similar. Net changes in disease incidence for diseases where
there is complete penetrance are shown in Figure 6.10. For diseases
with a penetrance of 0.5 the changes in incidence are about half those
for diseases with coiqplete penetrance, except for retrospective
ascertainment, as discussed earlier. The possible increase in incidence
due to improved treatment is much larger than the possible decreases
which result from all the other practices. This is because if the
fitness of affected individuals is only 0.1 they have few offspring
anyway and the net effect of their practising: family limitation or
selective abortion is small.
Figure 6.11 shows the net changes in gene frequency for diseases
with complete penetrance. The change resulting from an increase
in the fitness of affected individuals is again very much greater
than the others. For diseases where the penetrance is 0.5, though
not when there is complete penetrance, selective abortion with
reproductive compensation may cause an increase in the gene frequency.
There is an increase if affected individuals have a fitness of less
than one third and a decrease otherwise. All the other practices
considered produce a net decrease in gene frequency. These changes,
like those in disease incidence are very small, rising to a maximum
of only one percent for diseases with complete penetrance where there
is selective abortion or family limitation by carriers. For diseases
with incomplete penetrance the maximum decrease of about seven percent
occurs when there is retrospective family limitation.
The effects of practices acting in combination can best be seen
from a consideration of the changes in disease incidence because all
the changes are expressed as percentages of the same factor (23).
It can be seen from Figure 6.10 that the effect of increasing the
fitness of affected individuals by 0.4 (from 0.1 to 0.5) by means of
an improved treatment is to cause a net increase in disease incidence
of 40 percent. This potential increase in disease incidance can
only be offset if some of the treated individuals adopt one of the
practices considered. The dotted lines show the net changes in
disease incidence, resulting from other practices, if the fitness of
affected individuals is 0.5, as it is after the introduction of the
Figure 6.10 The effect of various practices on the
incidence of an autosonal dominant disease
with complete penetrance.
Abscissa:-
Change in fitness of affected individuals (1)
Proportionate reduction in fertility (4t S)
Proportion adopting practice (3, 7, 8f 9)
[solid lines, s^ = 0.9; dotted lines, s^ = 0.5]
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Figure 6,11 The effect of various practices on the
frequency of an autosomal dominant gene
with complete penetrance.
Abscissa:-
Change in fitness of affected individuals (1)
Proportionate reduction in fertility (4, 5)
Proportion adopting practice <3, 7, 8, 9)
Netchangeingfrequency(perc nt)
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treatment. If the fitness of affected individuals was increased
from 0.1 to 0.5 there would be an increase in the disease incidence
in the next generation unless there was either a voluntary reduction
in the fertility of all affected individuals by 80 percent or 80
percent of all affected individuals practised selective abortion of
affected fetuses. If a proportion of spouses of affected males
practised AI the net increase in disease incidence could be reduced
to a minimum of 15 percent.
For AD diseases with a penetrance of 0.5 the same increase in the
fitness of affected individuals would produce a net increase in
disease incidence of about 20 percent. This could be offset if 80
percent of all affected individuals were to have no offspring1 or
practised selective abortion of affected fetuses. If spouses of
affected males practised AI this could reduce the net increase in
disease incidence to a minimum of 7,5 percent.
In the same way, changes in disease incidence for other values
of the fitness of affected individuals can be calculated. The effect
of an increase of x in the fitness of affected individuals can only
be offset if there is a voluntary reduction of x divided by the new
fitness in the fertility of all affected individuals. Alternatively
if this proportion (x divided by the new fitness) of affected
individuals practised selective abortion of affected fetuses there
would be no increase in the disease incidence. The effect of AI is
to partially reduce the net increase in disease Incidence.
3. X-linked recessive diseases
The percentage changes in the incidence of an XR disease are shown
in Figure 6.12. The effect of improved treatments for affected
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individuals is to produce a negligable increase in tho disease
incidence. Possible decreases in disease incidence are much greater
however. If a proportion of carrier females were to have no offspring
or to practise selective abortion of affected fetuses there would be
an equal proportionate reduction in disease incidence.
In contrast to the change in disease incidence, the change in
gene frequency after the introduction of improved treatments (Figure
6.13) is not negligable. The maximum proportionate Increase if
affected individuals have normal fitness is over 0.4. Of the other
practices only selective abortion of all or affected males would
produce an increase in gene frequency. The others would produce a
decrease. A maximum net decrease in gene frequency of about 36 percent
would result if carrier females had no offspring or practised selective
abortion of both affected male and carrier female offspring. Decreases
due to other practices are ell less than 10 percent.
Changes caused by practices acting in combination* can also be
derived from these graphs. If carrier females are ascertained at the
same stage (prospectively or retrospectively) and decide either to
have no offspring or to practise selective abortion of all or of
affected males with reproductive compensation there is the same decrease
in disease incidence no matter what are the relative proportions of
females adopting the two practices. However with selective abortion
of all males there is an increase in gene frequency unless the
proportion having no offspring is more than 30 percent of that
practising selective abortion. If only affected males are aborted
the corresponding value is 21 percent.
»
For most combinations the Joint effect is the sum of the individual
effects. This is not the case when improved treatment is one of the
practices (see appendix 4).
Figure 6.12 The effect of various practices on the
incidence of an x~linked recessive disease.
Abscissas-
Proportionate reduction in fertility (4, 5, 6)
Proportion adopting practice (3, 9).
Netchangeindise sincide c(percentq)
Figure 6.13 The effect of various practices on the
frequency of an x-1inked recessive gene.
Abscissa:-
Change in fitness of affected individuals (1)
Proportionate reduction in fertility (4, 5, 6)
Proportion adopting practice (3, 7, 9)
Netchangeingenfrequency(p rc t)
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If a proportion of couples practise selective abortion some with
reproductive compensation and some without reproductive compensation
the net change in the gene frequency depends upon their relative
proportions. With selective abortion of all or of affected males
there is an increase in gene frequency unless the proportion practising
reproductive compensation is less than 10 percent or 43 percent
respectively of the proportion not practising reproductive compensation.
In Figure 6.13 the net change in gene frequency for improved
treatments is given in addition to the net proportionate change.
Consideration of the size of the former change shows that the effect
of increasing the fitness of affected Individuals by a certain amount
can only be offset by a proportionate reduction of at least one half
of this in the fertility of carrier females.
4. Miltifactorial diseases
Possible changes in disease incidence for spina bifida and anen-
cephaly (SBA) and for cleft lip with or without cleft palate (CLP) in
the populations studied by Carter et al (1068) and Woolf (1071) are
plotted in Figures 6.14 and 6.15 respectively. From the figures it
can be seen that the introduction of improved treatments could increase
the disease incidence by a maximum of about three percent for SBA and
one percent for CLP. The other practices would all produce a net
decrease in disease incidence. If couples were ascertained retro¬
spectively and practised selective abortion or reduced their family
size the disease incidence could be reduced by a maximum of about five
percent. If sibs of affected individuals reduced their family size
the reduction would only be of the order of one to two percent.
Larger changes in disease incidence would only become possible if
individuals at high liability could be detected before they had any
children (i.e. prospectively). The examples given in the figures
are for the cases where individuals or coiq>les in the upper 'five
percent* and upper 'one percent* of the distribution of liability
are ascertained.
As for AD diseases, in order to investigate the combined effect
of improved treatments and the other practices, it is necessary to
consider the effects of the other practices when the fitness of
affected Individuals is at its new higher level. This is because
some of the individuals who may adopt the practice are affected.
The dotted lines in Figures 6.14 and 6.15 show the changes in disease
incidence if affected individuals have a fitness ofm% as opposed
to zero, for the case when there is family limitation by a proportion
of all carriers. For all other practices producing a net decrease
in disease incidence however, the change in incidence when affected
individuals have normal fitness would be less than 0.5 percent
greater than when their fitness is zero.
If the fitness of affected individuals was increased the resulting
increase in disease incidence, in the next generation, could be offset
if there was a voluntary reduction in fertility of couples after they
had had an affected child. The minimum reduction in fertility needed
would be 75 percent of the increase in fitness for SBA. For CLP the
corresponding value is 20 percent.
Prospective detection of individuals at high liability with
subsequent family limitation or selective abortion could also offset
the effect of increased fitness of affected individuals. For example,
for either SBA or CLP, a 20 percent reduction in the fertility of
Figure 6.14 The effect of various practices on the
incidence of a multifactorial disease with
prevalence 0.0077 and heritability 0.6
e.g. spina bifida and anencephaly.
Abscissas-
Changes in fitness of affected individuals (1)
Proportionate reduction in fertility (4, 5, 3)
Proportion adopting practice (3, 9)
[solid lines, 8=1; dotted lines, sf = 0]
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1 individuals in the upper five percent in the distribution of
liability




Figure 6.IS The effect of various practices on the
incidence of a multifactorial disease with
prevalence 0.0012 and heritability 0.76
e.g. cleft lip with or without cleft palate.
Abscissa:-
Change in fitness of affected individuals (1)
Proportionate reduction in fertility (4, 5, 6)
Proportion adopting practice (3, 9)
[solid lines, sf = lj dotted lines, sf = 0]
^individuals in the upper five percent in the distribution of
liability
^individuals in the upper one percent in the distribution of
liability
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individuals in the upper 'one percent* of the distribution of liability
could offset an increase in disease incidence resulting from an
increase in the fitness of affected individuals to unity.
It must be emphasised that these results for SBA and CLP refer
only to the populations studied by Carter et al (1968) and Woolf (1971).
In other populations where the incidences of these diseases are
different the proportionate changes in incidence may not be the same.
In addition the changes which occur, if detection is retrospective or
if relatives of affected individuals adopt one of the practices, are
dependent on the family size distribution of the population. In
general the changes in disease incidence are greater the greater is the
initial incidence and the heritability though the latter has a negligable
effect on the size of possible changes when couples are ascertained
retrospectively.
Summary
For AR diseases where there is no heterozygote advantage possible
net in increases in disease incidence are very small and decreases
relatively large. The maximum increase is about four percent with
improved treatment of affected individuals and the maximum decrease
is 100 percent for family limitation by carriers or selection of mate.
These maximum changes are however, most unlikely to be achieved in
practice. With two exceptions all the net changes in gene frequency
2
are very small and are directly proportional to £ . In these two
exceptions (namely family limitation by a proportion of all hetero¬
zygous carriers and Al for the spouses of a proportion of all hetero¬
zygous males), the net change in gene frequency is directly proportional
to £. It can be calculated that a reduction of only two percent in
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the fertility of carriers would be sufficient to offset an increase
in gene frequency resulting: from either an increase in the fitness
of affected individuals to unity or the selection of a homozygous
marriage partner by all heterozygotes. The changes calculated in
appendix (3) suggest that for diseases where there is heterozygote
advantage the main differences from the above are that improved
treatment could produce larger increases in disease incidence and
gene frequency and family limitation by heterozygous carriers could
produce a greater decrease in gene frequency. In addition, to offset
an increase in the fitness of affected individuals a greater reduction
in the fertility of carriers would be required.
In the case of AD diseases, net changes in disease incidence and
gene frequency due to improved treatments are very much larger than
changes due to other practices. Ihis is because in many disorders
affected individuals have few offspring and so any further reduction
of their fertility does not have very much additional effect. The
possible increase in disease incidence as a result of improved
treatments can only be offset if some of these Individuals voluntarily
have no offspring or practise selective abortion of affected fetuses.
However if the treatment is very effective and affected individuals
can lead a more or less normal life they might be less likely to adopt
one of these practices.
As for AR diseases so in XR diseases possible increases in disease
incidence are very small and decreases very great. The maximum increase
in disease incidence in one generation is only of the order of 0.01
percent as very fern affected males have affected offspring. By contrast
the decrease, if carrier females reduce their family size or practise
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selective abortion, reaches a theoretical maximum of 100 percent.
Although increases in disease incidence are negligible increases
in gene frequency are not. An increase in the fitness of affected
individuals or the selective abortion of all male offspring
of carrier females with reproductive compensation could Increase the
gene frequency by up to about 30 percent. Decreases in frequency
of the same size could result from family limitation or selective
abortion of both affected male and carrier female fetuses. The over¬
all change in gene frequency would therefore depend on the proportions
of carrier females practising family limitation and selective abortion.
The changes in incidence of MF diseases depend on both the initial
Incidence and the heritability of the disease concerned. Iup roved
treatments for affected individuals would have very little effect on
the disease incidence because few affected individuals are offspring
of an affected parent. If at the same time as an improved treatment
was introduced a large enough proportion of couples who had had an
affected child reduced their family size or practised selective abortion
of affected fetuses there might be no overall increase in disease
incidence. If it was possible to detect prospectively, individuals
whose liability exceeded a certain value, the disease incidence might
be reduced considerably.
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(7) EXAMPLES TO ILLUSTRATE THE APPLICATION OF THE RESULTS
In order to illustrate the application of the results derived in
the previous sections changes in disease incidence and gene frequency
are calculated here for three diseases. The diseases considered are
sickle cell anaemia, porphyria varlegata and haemophilia with AR,
AD and XR modes of inheritance respectively.
1. Sickle cell anaemia
Sickle cell anaemia has a high incidence in Blacks in the USA
The incidence is approximately 25 in 10,000 and so the gene frequency
is 0.05. This high incidence is the result of the fact that these
Blacks are descendants of individuals who lived in areas of Africa
where malaria was prevalent and there is good evidence that hetero-
zygotes for the sickle cell gene have an increased resistance to malaria.
This disease has received much publicity recently in the USA where
programs devised to reduce its incidence have been proposed (Culliton,
1972a,b). The formulae derived above can be used to estimate the
changes in Incidence of the condition which might thus be achieved.
The results are plotted in Figure 7.1.
of
In the absence/any heterozygote advantage in the USA and with low
fitness of affected individuals there will be a continuous elimination
of deleterious alleles from the gene pool and a natural reduction in
the Incidence of the disease over time. In the figures the base lines
are taken as lines corresponding to the present incidence of 25 in
10,000 and gene frequency of 0.05 and in order to obtain the new
incidence and gene frequency this natural reduction must be added on
to the changes due to the factors considered below.
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i) Disease Incidence
In the past affected individuals did not reproduce but now with
the development of treatments, the fitness of affected individuals
can be increased to about 0.33 (Cavalli-Sforza and Bodmer, 1971).
The resulting1 net change in disease incidence can be calculated by
substituting in formula A(l) in Table 5.2. The net change in
incidence is 2q3s« = 2(0.05)30.33 = 0.825 x 10~4.
aa
3 2
The percentage change inincidence is (2q s• /q ) x 100 = 3.3.
aa
Mass screening programs to detect carriers of the sickle cell
.gene have been initiated particularly amongst school children (Culliton,
1972b). If these individuals were subsequently to seek a marriage
partner Mho was not also a carrier of the gene or if they were to
limit their family size irrespective of the genotype of their marriage
partner there could be quite a large reduction in the incidence of
the disease. From Table 5.2 the net change in disease incidence as
2
a result of family limitation by carriers is -q w. c f• (2-w of' ).Aa i Aa Aa i Aa
If there was a five percent reduction in the fertility of all carriers
2
the reduction in disease incidence would be (0.05) (0.05) (2-0.05) =
-4
2.44 x 10 . The percentage reduction in incidence is
100(0.05) (2-0.05) s 9.75.
Even if only those carriers whose marriage partner was also hetero¬
zygous were to limit their family size it can be calculated that there
would still be a percentage reduction in the incidence of the condition
equal to the percentage reduction in fertility of all heterozygous
couples. This same reduction in incidence of the condition could be
achieved if instead of limiting their family size this percentage of
cotqsles was to practise selective abortion of affected fetuses.
Figure 7.1 Possible net changes in the incidence of
sickle cell anaemia brought about by various
practices, (I) as a percentage of the
initial incidence, (11) actual change
(xl0,000), (relative to current practices).
Abscissa:-
Change in fitness of affected individuals (1)
Proportionate reduction in fertility (4, 5, 6)
Proportion adopting practice (2, 3, 7, 8, 0)
Proportion of cobles where one partner is
Black and the other is white (1M)
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Selective abortion for this condition is not possible at the moment
but it seems likely to be possible in the near future (Hollenberg
et al 1971). If family limitation or selective abortion were only
initiated by couples after the birth of an affected child (i.e.
retrospectively) the change in disease incidence would be smaller.
From Table 9.2 the net reduction in disease incidence as a result
2
of retrospective selective abortion is q wmcmpr• Taking the same
value for P^ as used in section (6), if 20 percent of all affected
fetuses conceived after the first affected individual in the family
are selectively aborted the net change in disease Incidence would be
approximately -(0.09)2 (0.2) (0.23) = -1.15 x 10~4.
Similarly, changes in disease incidence resulting from other
practices can be calculated from the formulae in Table 9.2. Although
the disease has a high incidence amongst Blacks in the USA its
incidence amongst Whites is small and intermarriage of Blacks and
llltites could reduce its incidence quite substantially. However, it
can be calculated from data given by Glick (1970) that at present
only one to two percent of marriages of Black individuals are between
couples where one partner is Black and the other is White. This
would reduce the disease incidence only slightly as shown in Figure 7.1.
ii) Gene frequency
In addition to causing changes in the incidence of the condition
the practices discussed above would cause changes in the gene frequency
which would not always be in the same direction as the changes in disease
incidence. There may therefore be a potential for an increase in the
incidence of the disease in subsequent generations.
The changes in gene frequency are plotted in Figure 7.2. From
Figure 7.2 Possible net changes in the frequency of
the sickle cell gene brought about by various
practices, (I) as a percentage of the
initial frequency, (II) actual change,
(relative to current practices).
Abscissa
Change in fitness of affected individuals (1)
Proportionate reduction in fertility (4, 6, 6)




Table 5.2 the change in gene frequency as a result of the introduction
2
of improved treatments is q s' . The effect of increasing the fitness
aa
to 0.33 would be to produce a net increase in gene frequency of
2
(0.05) (0.33) = 0.0008. The percentage net change in gene frequency
is lOOqs* = 1.65.
aa
Family limitation by heterozygotes, heterozygous couples or sibs
of affected individuals would produce a decrease in both the disease
incidence and the gene frequency. It can be calculated that with the
above increase in fitness of affected individuals there would be no
resultant increase in gene frequency if there was a voluntary decrease
in fertility of all carriers by 1.7 percent or of heterozygous couples
by 25 percent. Either of these practices could therefore counter¬
balance the effect of an increase in the fitness of affected individuals.
Selective abortion of affected fetuses would have no effect on
gene frequency unless there was reproductive compensation. However
even in this case there would only be a small increase in frequency.
The selection of a homozygous normal mate by carriers would produce
a comparatively larger increase in gene frequency. Suppose 80 percent
of carriers were to select a homozygous normal mate. The increase in
2 2
gene frequency is given by q s wA c_, (2-w. cj = (0.05) (0.8) (1.2)
aa Aa i Aa i
= 0.0024 (for s =0). A five percent reduction in the fertility of
all carriers could however counterbalance this increase. The change
in gene frequency for such a reduction in fertility is given by
-q w, of* = -(0.05)(0.05) = -0.0025.Aa i Aa
It seems therefore that in theory at least current forces could
reduce the incidence of sickle cell anaemia at least in the first
generation even with an increase in the fitness of affected individuals.
Mate selection or selective abortion with reproductive compensation,
by resulting: in the birth of additional heterozygous offspring, would
give a potential for an increase in incidence in future generations.
This increase could however be counterbalanced if only a small
proportion of carriers were to reduce their family size. The size
of the changes would depend on the porportions of couples adopting
the various practices. with the introduction of better methods for
the treatment of affected individuals heterozygous carriers might be
less likely to reduce family size or to practise selective abortion and
there might be a gradual increase in the Incidence of the disease.
2. Porphyria variegata
Another disease with a high incidence in certain populations and
with an autosomal dominant mode of inheritance is porphyria variegata.
The disease has a prevalence of about 26 in 10,000 in the Vftite
population of South Africa (W.H.O. 1968) and this can be taken to be
the approximate incidence of the condition if affected individuals
have fitness close to unity. The corresponding gene frequency is
0.00125.
The gene is thought to have reached a high frequency because of
the high fertility and low mortality of a very small number of Dutch
and French settlers who went to South Africa 300 years ago. By chance
one of the early settlers carried the gene for porphyria variegata.
It is only in the last 50 years since the introduction of barbiturate
and sulphonamide drugs that the disease has been potentially fatal.
Administration of these drugs to carriers of the gene can result in
paralysis and even death. In many carriers of the gene the
symptoms of the disease are so mild as not to come to the physicians
attention. Because of the danger of these drugs to carriers of the
gene it has been proposed that in areas like South Africa where there
is a high prevalence of porphyria all the population at risk should
be screened. Screening methods are very simple involving tests on
urine and faeces and could result in tracing 99 percent of those who
have inherited the abnormal gene, many of whom may be asymptomatic
(W.H.O. 1908).
If this procedure was to be adopted individuals carrying the
gene could be counselled and the genetics of the condition explained
to them. Changes in the incidence of the disease and in the gene
frequency which might arise as a result of family limitation or any
other of the practices discussed previously can be calculated using
the formulae in Table 5.3. The results obtained, taking the fitness
of affected individuals to be initially unity, are plotted in Figures
7.3 and 7.4 with the base lines corresponding to an Incidence of 25 in
10,000. In order to obtain the actual new incidence any changes, due
to factors not considered, must be added on to those discussed below,
(i) Disease Incidence
Suppose carriers of the gene were detected before they had any
children and they decided to limit their family size so that there
was an overall reduction in the fertility of all carriers of 20 percent.
From formula B(4) in Table 5.3 the net change in incidence of carriers
born would be -2q wA c f' (1-sa ) = -2 (0.00125X0.2) = -5 x 10~4.A~ 1 A- A—
The percentage change in incidence would be -lOOw c.f • (1-s ) =? -20.
Figure 7.3 Possible net changes in the incidence of
porphyria varlegata brought about by various
practices, (1) as a percentage of the
initial incidences, (11) actual change
(xlO,000), (relative to current practices).
Abscissat-
Proportionate reduction in fertility (4, 8)
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Similarly for any percentage reduction in the fertility of all
carriers there would be an equal percentage reduction in incidence
of carriers born. There would be the same percentage reduction
in incidence if this proportion of carriers practised selective
abortion of all carrier fetuses. However antenatal diagnosis is
not yet possible for this condition. If carriers of the gene were
only detected through an affected child the change in disease incidence
would be ~2q w c f* P (1-s. ). Taking P = 0.38 as in section (6),A- i A— r A— r
a 20 percent reduction in the fertility of all carriers after they
have had an affected child would produce a net change in disease
-4
incidence of approximately -2(0.00125)(0.2)(0.3S) = -1.9 x 10
The percentage decrease in incidence would be lOOw. c f• P (1-s. )
A- i A- r A-
= 100(0,2)(0.33) = 7.6. Changes in disease incidence which would
result from AI are also shown in Figure 7.3 and Inspection of the
formulae in Table 5.3 shows that these changes would be half of those
occuring when there was family limitation by a proportion of all
carriers. However AI is an even more remote possibility than
selective abortion.
(ii) Gene frequency
For porphyria variegata all the factors discussed above would
reduce the gene frequency as well as the disease incidence. The
changes in gene frequency can be calculated by substituting in the
formulae in Table 5.3. Since s is equal to zero for this disease
A—
the percentage changes in gene frequency are the same as those in
disease incidence. Therefore if individuals with the deleterious
gene were to limit their family size or if selective abortion or AI
were possible there would be a decrease in incidence of the disease
Figure 7.4 Possible net changes in the frequency of the
porphyria variegata gene brought about by
various practices, (I) as a percentage of
the Initial frequency, (11) actual change,
(relative to current practices),
Absclssa:-
Proportionate reduction in fertility (4, 5)
Proportion adopting practice (3, 7, 3, 9)
Netchangeingefrequency
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which could be maintained for more than one generation.
The changes in disease incidence and gene frequency calculated
above would only occur if carriers of the gene adopted the practices.
They would be more likely to co-operate in a preventative scheme if
they found the disease a handicap to themselves. If carriers did
adopt these practices to any great extent the incidence of the
condition might be reduced quite considerably.
3. Haemophilia A
As an example of a well known sex-linked recessive disorder
consider haemophilia A. This has an incidence of about 1 in 10,000
in England (Stevenson and Kerr, 1907). In the past, few affected
males reproduced, but the last few years have seen the development
of improved methods of treatment so that they are enabled to lead
an increasingly more normal life. Improved methods for the detection
of carrier females have also been developed, one test being able to
identify 90 percent of carriers (Zimmerman et al_ 1971).
The formulae derived above can be used to calculate possible
changes in the incidence of the disease and in the gene frequency.
The changes, calculated assuming the disease is initially lethal,
are plotted in Figures 7.5 and 7.6. The baselines are lines
corresponding to the present incidence of 1 in 10,000 and gene
frequency 0.0001.
(i) Disease incidence
Possible changes in disease incidence can be calculated from the
formulae in Table 5.5. Suppose that as a result of prospective
Figure 7.5 Possible net changes in the incidence of
haemophilia brought about by various
practices, (I) as a percentage of the initial,
(II) actual change (xl0,000), (relative to
current practices).
Abscissa:-
Proportionate reduction in fertility (4, 5, 6)
Proportion adopting- practice (3, 9)





ascertainment of carrier females there was a 20 percent voluntary
reduction In the fertility of carriers. The change in disease
-4
incidence would be -qw. c f' s -(0.0001)(0■2) r -0.2 x 10 . The
Aa i Aa
percentage change in disease incidence would be -lOOw.c f* = -100 (0.2)Aft 1 Aft
= -20. Selective abortion of all male, affected male, or affected
male and carrier female fetuses by 20 percent of carrier females would
produce the same decrease in incidence of haemophilia. At present
only selective abortion of all male fetuses is possible but in the
future it may become possible to detect affected males and carrier
females in utero.
If carrier females were only detected after the birth of an
affected son and there was subsequent family limitation or selective
abortion smaller decreases in incidence would occur. The changes
would be P^ times those for prospective detection. Taking - 0.23
as in section (0) the change in disease incidence if there is a 20
percent reduction in the fertility of carriers after they have had an
—4 —4
affected child is -(0.23)(0.2) x 10 = -0.046 x 10 .
(ii) Gene frequency
Possible gene frequency changes are plotted in Figure 7.6. In
the past affected males rarely reproduced but now as a result of
treatments their fitness is estimated to be 0.6 to 0.9 (Cavalli-Sforza
and Bodraer, 1971). The net proportionate increase in gene frequency
(see page 54) can be calculated from formula A(l) in Table 5.5.
Sippose the fitness is increased to 0.7. The net proportionate change
in incidence is 3 s • / (3-s )(3-s +s') = 3 (0.7)/2(2.7) = 0.39.
a a a a
There would also be an increase in the frequency of the deleterious
gene with selective abortion of all or affected males and reproductive
Figure 7.6 Possible net changes in the frequency of the
haemophilia gene brought about by various
practices, (I) as a percent of the initial
frequency (II) actual changes, (relative to
current practices).
Abscissai-
Change in fitness of affected individuals (1)
Proportionate reduction in fertility (4, 5, 6)
Proportion adopting practice (3, 9)








compensation. Suppose 10 percent of carrier females were to
selectively abort all male fetuses. The increase in gene frequency
is given by formula A(3a) in Table 5.3. The increase is
in w c s = (0.33)(0.0001)(0.1) = 0.000003 for prospective detection.
3 m a a
If affected males only, were selectively aborted the increase in gene
frequency would be ~q w c (s --^0 = (0.33 )(0.0001) (0.1) (0.33) = o.000001
m ra J
These increases in gene frequency would only occur if there was repro¬
ductive compensation. In the absence of reproductive compensation
there would be no change in gene frequency.
There would also be a decrease in gene frequency if carrier females
were to voluntarily reduce their family size. Suppose there was a
decrease in fertility of carrier females of 10 percent. From formula
B(4) in Table 5.5 the decrease in frequency would be
iq w c f* (2-s ) = - (0.0001)(0.1) = 0.000003.
3 Aa i Aa a 3
It seems therefore that current forces could reduce the incidence
of haemophilia in the first generation but unless they were continued
into subsequent generations the frequency of the gene and hence the
disease incidence, might rise. For an increase in the fitness of
effected individuals to 0.7 the increase in gene frequency could only
be offset by a voluntary reduction of 40 percent in the fertility of
carrier females. Similarly selective abortion of all or affected male
fetuses with reproductive compensation would produce a relatively large
increase in gene frequency. However it is likely that if affected
males had a better prognosis fewer carrier females would want to go
through the trauma of intrauterine diagnosis.
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(8) THE EXTENT OF THE CHANGES IN PRACTICE
In section (6) the possible changes in disease incidence and
gene frequency were discussed. They were shown to be dependent
both on the particular practice and on the mode of inheritance of the
disease. In order to examine to what extent such changes might
actually occur it is necessary to consider three other factors.
These are
1. The feasibility of a practice i.e. the extent to which the practice
is likely to be possible.
2. The proportion of individuals, for whom a particular practice is
relevant, who are actually ascertained.
3. The proportion of ascertained individuals who adopt a particular
practice.
The last of these was discussed in section (3), the other two
will be discussed in this section.
1. Feasibility of a practice
The feasibility of any practice is dependent upon advances in
medical research. All the practices considered involve one or more
of the following:
a) The detection and treatment of affected individuals
b) The detection of carriers of the deleterious gene
c) The detection of the sex and/or genotype of the fetus,
a) Detection_and treatment of affected individuals
If affected individuals are ascertained early enough in the
progression of the disease then it is possible in at least some cases
to partially cure the condition. For example in some Inborn errors
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of metabolism symptoms are already present in early infancy and if
treatment is to achieve the maximum benefit it must be started as
soon after birth as possible. Unfortunately the diagnosis is
often delayed and various screening tests are therefore being devel¬
oped which can be applied to all newborn infants. For example in
galactosaemia and phenylketonuria serious brain damage can be
prevented by early diagnosis and the placing of the affected child
on a special diet.
The method of treatment used depends on the particular nature of
the disease. Dietary treatment is the most common. Other possible
treatments many of which are only in the experimental stage are enzyme
injection, organ transplantation and attenqpts to modify the excretion
of metabolites. So far all genetically determined diseases for which
therapy is available are those in which a primary enzyme deficiency
has been noted. These are all inherited by autosomal recessive or
X-linked recessive mechanisms and therapy for autosomal dominant
diseases is not yet available. Raine (1072) lists 131 metabolic
diseases of unifactorial inheritance and classifies possible treatments
as i) of established value, ii) proposed with promising preliminary
results and iii) purely experimental. In 34 of the conditions (32 AR,
2 XR), the treatment is regarded as established, in 8 (all AR), as
proposed and in 42 (36 AR, 6 XR) as experimental,
b) Detection of carriers of the deleterious_gene
Although most recessively inherited inborn errors of metabolism
are quite rare the frequency of heterozygotes is substantially higher.
In some recessive diseases where the primary protein lesion is known
qualitative and quantitative measurements of enzyme level in vivo or
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In vitro by means of tissue culture can be used to distinguish
heterozygotes. When the primary protein lesion is unknown hetero-
zygote detection is more difficult and sometimes only successful if
a metabolite is found which will serve as a marker. Of the 131
metabolic diseases listed by Raine (1972) there are 26 conditions
(24 AR, 2 XR), where the heterozygote may be detected by enzyme assay
and 16 (12 AR, 4 XR), where either loading tests to stress the metabolic
pathway under consideration or other studies are required. It seems
probable that with the identification of the primary protein lesion
in more conditions and improvements in methods of enzyme assay and
tissue culture, heterozygote detection should be possible for many
more diseases.
c) Detection of sex and/or genotype of the fetus
For some diseases it is possible to identify an affected fetus
in utero by examination of the amniotic fluid composition, staining
characteristics of the cells in the fluid, or the specific enzyme
activity of the cells before or after culture. If the disease can
be recognised early enough it may be possible to offer selective
abortion. Even if the diagnosis is not possible until too late in
pregnancy to offer an abortion it may still be useful in that treatment
can be initiated at the earliest possible stage. In X-linked disorders
the ascertainment of fetal sex is often a substitute for prenatal
detection. This may be done by sex chromatin counts, karyotype
analysis, or searching for fluorescent Y chromosomes.
At present there are few diseases where an affected fetus can be
detected in utero but the potential for antenatal diagnosis is
considerable. In principle any Mendelian disorder in which the
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biochemical lesion is known or which is associated with a distinct
marker substance should be detectable in utero provided the genetic
defect is expressed at an early stage. Brock (1972) lists more than
130 diseases in which the primary enzyme or protein defect has been
identified with reasonable certainty. These diseases are those in
which future prospects for antenatal diagnosis are brightest. All
of them are recessively inherited apart from a few haemoglobinopathies.
Milunsky et al (1970) list 44 inborn errors of metabolism where they
believe prenatal diagnosis to be within the scope of current investig¬
ations. Raine (1972) lists 9 conditions (8 ARf 1 XR), where ante¬
natal diagnosis has been successful in some cases and a further 14
conditions (13 AR, 1 XR), in which the deficient enzyme has been
shown to be present in normal amniotic cells. If the fetus was
affected therefore the enzyme deficiency might be demonstrable.
There are a large number of genetic diseases where there is
currently little prospect of antenatal diagnosis. This group includes
disorders of obscure origin such as Duchenne muscular dystrophy and
Huntington's chorea and those of known origin such as von Gierke's
disease, phenylketonuria and beta-thalassaemia where the defect is
not expressed in known tissue cells. In certain diseases where the
basic biochemical lesion is unknown antenatal diagnosis may be possible
if the locus of the gene which causes the disease is linked to another,
the genotype at which can be detected antenatally, e.g. the locus for
myotonic dystrophy is closely linked to that determining the secretor
status.
Not only can affected individuals be detected in utero but in
some X-linked conditions e.g. G.6.P.D. deficiency, X-linked chronic
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granulomatous disease, Lesch-Nyhan syndrome, Fabrys disease and
Hunters syndrome prenatal detection of female carriers Is possible
by tissue culture of fibroblasts.
Fetuses manifesting certain common congenital malformations such
as anencephaly and spina-bifIda, or rare unifactorial Mendelian diseases
associated with a well defined morphological abnormality, can be
identified by fetoscopy. In certain congenital abnormalities
biochemical changes in amniotic fluid may be demonstrable and possibly
even diagnostic, as in the case of alpha-feto-protein in anencephaly
and spina-bifida (Brock and Sutcliffe, 1972).
Summary
From the above discussion it can be seen that although the
practices are at present only possible for a limited number of diseases
it is likely that they will be available for considerably more diseases
in the near future. Prospects for the extension of the practices to
other diseases seem most favourable for recessive diseases. Once a
basic biochemical lesion has been identified this opens up the
possibility for the development of therapy and also for antenatal
diagnosis and heterozygote detection. There are likely therefore to
be some diseases for which both eugenic and dysgenic practices are
possible and others for which none are possible rather than some where
only dysgenic practices are possible. This would reduce the likeli¬
hood of any increase in disease incidence or gene frequency.
For autosomal dominant diseases however the development of therapy
for affected individuals seems a more remote possibility than for
recessive diseases. The same is true for the detection of affected
individuals in utero unless the fetus has a well defined morphological
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abnormality or the probable genotype of the fetus can be determined
from the genotype at a linked locus.
2. The proportion of individuals ascertained
In an attempt to obtain an estimate of the proportion of
individuals ascertained by current medical practices, a study was
made of families attending genetic clinics in Edinburgh and Manchester
between 1965 and 1972. Data on families seen up to 1970 was published
earlier (Smith et al 1971). As mentioned in the earlier paper the
kinds and frequencies of the diseases studied reflect the work and
interests of the Human Genetics department of Edinburgh University
so that this is a study of ascertained families rather than a population
study. However despite this limitation some interesting findings
emerge which are probably relevant to genetic disease in general.
About 53 percent of the families were referred specifically for
genetic counselling, the majority of the others being referred for
diagnosis or research (Figure 8.1). The proportion referred by
consultant was 67 percent, 22 percent were referred by general
practitioner and a few by disease groups or through other family
members. A tabulation by mode of inheritance of the numbers at risk
«
and the number of preventible cases is given in Table 8.1. In 146
of these families the disease was judged to be not serious or not
genetic and no further persons in these families were considered to
be at risk.
Often only one individual (the first contact) in these families
was actually seen and counselled if this was applicable. In order to
Affected children born since 1960 to parents who were at high risk
a priori.























































































































































obtain information about Individuals currently referred to the genetic
clinic, an analysis of data on first contacts was first carried out.
The same calculations were then carried out using data on all indiv¬
iduals in the families who were judged to be at high risk ( ^10 percent)
of becoming affected or of having an affected child. A comparison
of the results of these two sets of calculations should indicate where
there might be scope for ascertaining more individuals at risk in
the future,
a) First Contacts
i) Individuals at high risk of becoming affected
Amongst first contacts only about one percent were at high risk
of becoming affected. These were almost all in families with AD
diseases but even in these families only five percent of first contacts
were at risk. The great majority of first contacts were either
affected (usually individuals referred for diagnosis or research) or
not at risk (usually parents referred for counselling after the birth
of an affected child).
ii) Individuals at high risk of having an affected child
A much greater proportion of first contacts were at high risk of
having an affected child. The proportion was about 33 percent but
of these two thirds were referred only after the birth of a child who
was affected or at high risk of becoming affected in the future
(Figure 8.2). This was reflected in the fact that 70 percent were
married with ehildren. Approximately 33 percent were aged 20-30 and
40 percent were aged 30-40 and this suggests that many may have
completed their family.
Figure 8.2 Stage of ascertainment, marital status and
age group of first contacts and of all
individuals at high risk of having an affected
child.
FIRST CONTACTS AT HIGH RISK OF HAVING
AN AFFECTEO CHILD
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b) All individuals In the families
i) Individuals at high risk of becoming: affected
In addition to the first contacts there were 433 other individuals
in these families who were athigh risk of becoming affected. These
were mainly in families with AD diseases where there was an average
of two such persons per family.
ii) Individuals at high risk of having an affected child
There were 927 individuals in these families, other than first
contacts, estimated to be at high risk of having an affected child.
There was an average of about 2.5 such individuals in families with
AD and XR diseases but less than 0.2 in families with AR and MF
diseases. Of all individuals at high risk of having an affected
child only about 37 percent had already given birth to a child who
was affected or at high risk of becoming affected and about 54 percent
were unmarried (Figure 8.2).
Comparison of results on first contacts and all Individuals at high risk
It seems that with current methods of ascertainment the practices
discussed would have little effect on disease incidence and gene
frequency. At present few individuals at risk of developing genetic
diseases are detected most individuals being referred to the clinic
only after the onset of definite symptoms of the disease when any
therapy might be less effective. Most individuals at high risk of
having an affected child are only referred after the birth of one or
more such children. This would reduce the effect on the gene pool of
their adopting one of the practices subsequent to counselling. Many
may have already completed their family and would not adopt any of the
practices for this reason.
If an effort was made to contact other family members there could
be greater changes in disease incidence and gene frequency at least in
AD and XR diseases. In families with these diseases first contacts
have many relatives at high risk of becoming affected or of having
affected children. Relatives at risk of becoming affected are mainly
in families with late onset AD diseases where the introduction of any
therapy, while being of advantage to the individual himself would only
have an effect on the gene pool if onset was before the individual had
had offspring. Of individuals at high risk of having an affected
child 63 percent had not yet had an affected child and 54 percent were
unmarried. If such Individuals were counselled and they subsequently
decided to reduce their family size there could be a larger reduction
in disease incidence. Any affected children they did have could be
diagnosed early and offered therapy if it was available.
In families with AR and MF diseases there were comparatively few
individuals at risk. In most of these families both mother and the
affected child (if alive) were seen at the clinic and there were no
other family members at high risk of becoming affected or of having
an affected child. Therefore in these families contacting relatives
would reveal few Individuals at risk who might adopt one of the practices.
Screening individuals in families with AR diseases could reveal hetero-
zygotes who might subsequently reduce their family size but the effect
on the gene pool would be small as these would be a small proportion of
all heterozygotes. Tb detect, prospectively, individuals at high risk
of having children with AR diseases, screening would have to be extended
beyond the families of affected individuals.
In addition to the effect of detection of more couples at risk
prospectively there might also be greater changes in the incidence of
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diseases of all modes of inheritance if more couples were detected
before they had had more than one affected child. For example there
were 95 cotples who had had at least one child affected with an AR
l
disease. Of these children 24 had been born since 1960 to couples
who were at high risk a priori. These births might have been
prevented if the couples had been informed of their risks as soon as
the first affected child was diagnosed.
These results indicate that with current methods of ascertainment
the effect of any of the practices would be minimal. Greater changes
could occur if more individuals were detected after the birth of a
first affected child rather than later when their family might be
complete. In AD and XR diseases there is also considerable scope
for detecting individuals at risk prospectively by contacting relatives
of individuals referred.
In the Human Genetics department at Edinburgh University a Register
for the Ascertainment and Prevention of Inherited Disease (RAPID) has
been developed. The RAPID system is being used for the follow-up of
individuals who have been counselled and also for contacting and
counselling others at risk in the family. In addition, in an effort
to contact even more Individuals at risk, families have been ascertained
through hospital and health department records and disablement registers.
If this was extended to other areas and individuals ascertained adopted
the practices much greater changes in disease incidence and gene
frequency might occur.
(9) EQUILIBRIUM FREQUENCIES OF GENETIC DISEASES
In the proceeding sections only single generation changes in
disease incidence and gene frequency were considered. This was
because these will be sore important in practice than long' terra
changes. It is however relatively easy to calculate equilibrium
frequencies of these diseases for any of the practices discussed
earlier. The equilibriua frequencies, resulting from the adoption
of one or more of the practices, can be calculated In terras of the
reproductive fitnesses of individuals with the deleterious gene.
The derivation of formulae for calculating equilibrium frequencies
of X-linked recessive diseases was described in an earlier study
(Holloway and smith (1973)), In this section formulae for the
equilibriua frequencies of diseases with an autosomal recessive,
autosomal dominant and X-linked recessive mode of inheritance will
be derived. The formulae will then be used to derive possible
equilibriua frequencies for sickle-cell anaemia (AR), porphyria
varlegata (AD) and haemophilia (XR).
FORMULAE WHEN FITNESS VALUES ARE KNOWN
1) AR diseases
Considea* three genotypes AA, Aa and aa as before with initial
2 2
frequencies £ , 2pq and & respectively. Let the frequencies of Aa
and aa in any generation be denoted by C and A . It is assumed
« R
that affected individuals have fitness of zero. This has been
approximately true for most AR diseases at least until recently and
as shown earlier the frequency of affected individuals is much more
influenced by the reproductive practices of heterozygotes than those
of affected individuals. The three possible mating types together
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with their frequencies and fitnesses and the genotype distributions
of the offspring are given below.
Mating type Frequency Fitness Proportions of offspring
AA Aa aa
AA x AA (1-CD)2 110 0R
Aa a AA 2Cr(1-Cr) "iff 0
„ 2 1 1 1Aa x Aa C F„ — ~ ~~
R 2 4 2 4
F and F aire the relative fitnesses of (Aa x AA) and (Aa x Aa)
JL
couples respectively compared to (AA x AA) couples. For a completely
recessive gene with no heterozygote advantage they are both equal to
one unless any of the above practices (such as family limitation) is
adopted.
Affected individuals are either the offspring of (Aa x Aa) couples
or result from a mutation in a gamete which subsequently unites with one
carrying the a allele. The frequency of the latter event is approxim¬
ately equal to the product of the frequency of carriers and the
mutation rate jx. (Affected individuals could also result from
mutations in both gametes of the uniting pair but this event is so rare
that it can be ignored). Therefore at equilibrium
\ = 1*2 V + ^CR "-1
Carriers arise from a mutation in either gamete of the uniting pair or
are the offspring of carriers, one half of whose offspring are also carriers.
1 12
Therefore at equilibrium C = 2\i + —F . 2C (1-Cn) + —F C_R 2 1 R H 2 2 R
c„ = * ♦ F, CCR - CR2, ♦ i*2CR2 9.2
\ J
The equilibrium frequencies of affected and carrier individuals
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can thus be found in terms of the mutation rate by substituting appro¬
priate values of F and F into equations 9.1 and 9.2. For exas$>le1 2
consider the situation where none of the (Aa x Aa) Couples has any
children so that F = 0 and (Aa x AA) couples have a normal family
6
size so that F^ = 1.
Then from equation 9.2 C = 2ji, C = x, 2jxIt R
Substituting in equation 9.1 gives A = |* •-! 2pR
2) AD diseases
Consider two genotypes Aa and aa with initial frequencies 2pq
2
and . Individuals of genotype AA are ignored as previously. Let
the frequency of Aa individuals in any generation be A . The mating
types together with their frequencies and fitnesses and the genotype
distributions of the offspring are given below. It is assumed that
Aa individuals are rare and marriages involving two affected partners
are ignored.
toting type Frequency Fitness Proportions of offspring
AA Aa aa
Aa x aa '"VW F3 0 I I
aa x aa (1~AD)2 100 1
Affected individuals arise from a new mutation in either gamete
or are the offspring of affected individuals, one half of whom are
also affected.
Therefore at equilibrium A^ = 2jx + 2A^ (1-Ap) F^ which approximates to
A = 2u + A F 9.3
D r D 3
Given the value of F the equilibrium frequency of affected individuals





The genotypes are for females, AA and _Aa with initial frequencies
2
£ and 2pq and for males AY and aY with initial frequencies £ and £.
Affected females are ignored as previously. Let the frequencies of
Aa and aY individuals in any generation be and respectively.
It is assumed that affected males and carrier females are sufficiently
rare to make the numbers of marriages between thera negligable. There-
fore the mating types are as follows J-
Mating type Frequency Fitness Proportions of offspring
Femelies Males
AA Aa AY aY
AA x AY (1-C )(1—A )
X X
1 1 0 1 0
AA x aY A (1-C )
X X P4 0 1 1 0








Affected males either arise from a new mutation or are the
offspring of carrier females, half of whose sons are affected. There¬
fore at equilibrium A = p + ~ F C (1-A ) which approximates to
X 2 5 X X
A = p + ~ F C 0.4.
x 2 5 x
Similarly, carrier females can arise by new mutation, from affected
males (all daughters are carriers), or from carrier mothers (half
their daughters are carriers). Therefore at equilibrium
C = 2p + F A (1—C ) + ~ F C (l—a ) which approximates toX t X X 2 5 X X
C = 2p + F A + FC ...0.5.
X 4 X 2 5 x
The equilibrium frequencies of affected males and of carrier females
can be found by substituting values of F^ and Fg in these equations.
For example if F = 0 and F = 1, as for a lethal condition where there
4 O
is no family limitation by carrier females, then A = u, + 7: C and'
x r 2 x
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C = 2a + — C . This gives C = 4u and A = 3u.
x 2 x x ^ x
CALCULATION OF THE FITNESS VALUES
From the above It can be seen that when the fitness values are
known the equilibrium frequencies of affected individuals can be
calculated. In practice, however, the values of F , F etc. are
not known simply but depend both on the reproductive fitness of
affected individuals and on the proportions of couples adopting the
various practices. If individuals at risk of having an affected
child are detected prospectively and have no children their fitness
is zero. If they terminate their family retrospectively i.e. after
the birth of an affected child their fitness if P (see page 65 ).
r
Any who partially restrict their family after detection have a fitness
less than unity and those who go on to have a normal family size have
a fitness of unity.
If there is selective abortion, AI, or partner selection by hetero¬
zygous carriers (in AR diseases), then in addition to possible changes
in the net reproductive fitness there are changes in the proportions
of offspring of different genotypes who are born. This must be taken
into account in the calculation of the fitness values. Suppose x
is the ratio of the number of individuals of genotype iji bom after
the adoption of any one of the practices to the number born before the
practice is adopted. Then for AR diseases
F = ~~(x +xA) 9.6
1 2 AA Aa
Fo = <x.. + 2x. +x > 9-72 4 AA Aa aa
For example if one half of (Aa x Aa) couples have no children the
fitness of these couples (F ) is one half. The values of x , x
2 AA Aa
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and x are also one half and substituting: these values in equation
aa
9.7 gives F = 7 (7 + 1 + ~) = - as ejected.2 4 2 Z Z
If (Aa x Aa) couples were to practice selective abortion of all aa
fetuses without reproductive compensation then xA = x. =1 andAA Aa
x =0 thus F = ~ (1 + 2 + 0) —.
aa 2 4 4
If there was selective abortion with full reproductive compensation
so that a normal family size was produced then F = 1. Additional
AA and Aa individuals would be born in the ratio 1:2. To calculate
the values of x and x consider families of size 4. with no
AA Aa
selective abortion there will be an average of 1 AA individual, 2 Aa
individuals and 1 aa individual. With selective abortion and repro¬
ductive compensation there will be an average of 1.33 AA individuals,
2.67 Aa individuals and no aa individuals. Therefore
x.. = = 1.33 and x = = 1.33, x =7=0AA 1 Aa 2 aa 1
giving F9 = 7 [1.33 + 2.67 + 0] = 1 as expected.
Similar expressions can be obtained for F . F. and F„. For AD3 4 5
diseases
F„ = 7 (xA + x ) 9.83 2 Aa aa
For XR diseases the overall fitness values are the averages of those
for male and female offspring. Therefore F = 7; (x +x.„) ..... 9.94 2 Aa AY
F5 = I <XAA + XM * XAY + X.Y)] = 4 (XAA + V + XAY + \Y> "
GENERAL FORMULAE FOR EQUILIBRIUM FREQUENCIES
Equations 9.1 to 9.5 can now be combined with equations 9.6 to
9.10 to obtain a single set of formulae for the equilibrium frequencies




Let the subscript 1^ refer to the symbols for the ith group of
(AA x Aa) couples who make vq> a proportion of all such couples.
Similarly let the subscript refer to the symbols for the ^th group
of (Aa x Aa) couples who make up a proportion P of such couples.
J
Let z and z be the proportions of offspring born to the respective
1 J
couples before detection. In particular if (Aa x Aa) couples are
detected after the birth of an affected child then z, = (1-P ).
j r
Combining' equations 9.1 and 9.7 we obtain:-
ar = + 4 cr2 Pd ti!d * W"V 9al
Combining equations 9.2, 9.6 and 9.7 we obtain:-
cR + (cn-cP L pi f*i + W"V
+
2 U Pd C*d + """J' V,1 9'12
2) AD diseases
For AD diseases if we combine equations 9.3 and 9.8 we obtain
aD = 2,1 + SD la P1 [zi + a"2i> "A.J 9'13
'Vhere the subscript i^ refers to the ith .group of Aa individuals who
make up a proportion P^ of all Aa individuals and is the proportion
of offspring born before detection.
3) XR diseases
Let the subscript i^ refer to the symbols for the ith group of
carrier females who make up a proportion P^ of all such females and
the subscript J_ refer to the symbols for affected males. The equili¬
brium frequencies of affected males and of carrier females can then
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EQUILIBRIUM FREQUENCIES OF COMMON DISEASES
To illustrate the use of these formulae consider as examples the
three diseases discussed in section (7). These are sickle cell
anaemia, porphyria variegata end haemophilia with AR, AD and XR modes
of inheritance respectively.
1) Sickle-cell anaemia
Equations 9.11 and 9.12 can be used to calculate possible equili¬
brium frequencies of this disease for various reproductive policies
of heterozygous carriers, assuming that affected individuals have a
fitness of zero. Suppose that couples are screened before having
any children and that as a result 50 percent of (Aa x AA) couples and
50 percent of (Aa x Aa) couples are ascertained. Of the (Aa x AA)
couples ascertained suppose nine tenths go on to have a normal family
size and one tenth have no children and that all the couples not
ascertained have normal family size. Of the (Aa x Aa) couples suppose
For-
thatAan additional 30 percent^are detoctod after having an affected
QS-a. da-tex-V «.<!.
chlldAand that after detection, whether this is prospective or retro¬
spective, one quarter have a normal family size, one quarter have no
children, one quarter practise selective abortion of affected fetuses
without reproductive compensation and the remaining quarter practise
selective abortion with reproductive compensation. The 20 percent
of couples still undetected are assumed to have a normal family size.
Table 9.1
Proportions of oouples by stag* of detection and reproductive






















Hi is is summarised in Table 9.1. From equation 9.11
AR = fCR + 5 CR 5=1 PJ [*J + (1"V *aa
1=1 pj ['j + a"V *9*^
a 0.2(1) + 0.125 (0+1) + 0.125 (0+0) + 0.125 (0+0) + 0.125 (0+0)
+ 0.075 (0.77+0.23(1)) + 0.075 (0.77+0.23(0)) + 0.075 (0.77+0.23(0))
+ 0.075 (0.77+0.23(0)) = 0.573
AR = "°R + 4 °R2 • °-573
\ = "CR + °'143CR2
Similarly from aquation 9.12 C = 2|i + 0.95 <C -C 2) + Jc 2 (0.905)H R H 2 R
-5 . .2
For |x = 10 this gives C = 40jx and A - 270(xR R
Thus the equilibrium frequency of sickle cell anaemia under these
2
purely hypothetical conditions would be 270[x .
2) Porphyria varlegata
Possible equilibrium frequencies of this disease can be calculated
from equation 9.13. Suppose that 80 percent of carriers of the gene
are detected prospectively and of these one half have a normal family
size and one half either have no children or practise selective
abortion of affected fetuses. The actual proportions having no
children and practising selective abortion are immaterial since which
ever practice is adopted no affected offspring are born. The 20
percent of carriers remaining undetected are assumed to have a normal
family size. This is summarised in Table 9.2.
From equation 9.13 A„ = 2u + A„ T. P. [z, + (1-z ) xD r D li i i i Aa1J
Substituting in this equation gives Aq = 2jx + A^ [0.2 + 0.4 (0+1)
+ 0.4 (0+1(0))]
0.4 Ad = 2fx Ad = 5(A
Table 9,2
Proportion* of Affected individuals by stage of detection and
reproductive policy as used in the example for porphyria
variegata (see page 118).
Reproductive policy Sta^ of detection
Undetected Prospective Retrospective
Normal family size 0.2 0.4 0
No offspring or 0 0>4 0
selective abortion
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Under these hypothetical condition® therefore the equilibrium frequ¬
ency of the disease is 5ja.
3) haemophilia
By substitutin ; in equations 9.1 1 and 9.18 possible equilibrium
frequencies of haemophilia an be obtained. For example consider the
following hypothetical situation. Amongst affected males suppose
that 30 per cent do not survive to reproduce, a further 30 per cent
have no offsprin and 40 per cent have a normal family size. Of
carrier females suppose 20 per cent are undetected and have a normal
family size and that another 20 per cent are detected prospectively
Por- V.ojj^-13 CX<\ tUU OWi
andA30 per cent retrospectively. After detection suppose that one
quarter have a normal family size, one quarter have no children and
one half practise selective abortion of all male fetuses, half of
these without reproductive compensation and half with reproductive
compensation so having a normal family size. This is summarised
in Table 9.3.
From equation 9.11 Ax = H ~ [z^ + (1-z^ x^ ]
OO ^
£_1 P [« + xAy 3 « 0.2(1) + 0.08 [0+1(1)3 + 0.08 [0+1(0)3
+ 0.08 [0+1(0)3 + 0.08 [0+1(0)3 * 0.18 [0.77+0.23(1)] + 0.18 [0.77+0]
+ 0.15 [0.77+0] + 0.13 [0.77+0]
a 0.2 + 0.05 + 0.15 (1+3(0.77)) = 0.7468
Equation 9.14 therefore becomes A = u + 0.3733 C .
x x
Similarly equation 9,15 becomes C = 2u + 0.4 A + ~ C
X x 2 x
Solving equations 9.14 and 9.15 gives C « 6.81p. A = 3.55}i i.e. theX x
equilibrium frequency of haemophilia under these hypothetical conditions
would be about 3.55p.
Table 9.3
Proportions of affected males and carrier females by stage of
detection and reproductive policy as used in the example for
























Hie formulae derived above can be used to calculate possible
equilibrium frequencies for any unifactorial genetic disease, where
affected individuals are rare and have a low fitness. In order to
use these formulae it is necessary to know both the proportions of
individuals adopting the various practices and their reproductive
fitnesses. For any practice the reproductive fitness of individuals
with the deleterious (gene can be calculated (see pa.ye 114). It is
however difficult to obtain reliable estimates of the proportions of
individuals of a particular genotype who are detected and the proport¬
ions adopting particular practices. Even if these values were known
for one generation it is most unlikely that they would remain constant
in successive generations. The equilibrium frequencies calculated
will therefore be of theoretical interest only.
The theoretical equilibrium frequencies calculated for sickle
cell anaemia, porphyria variegata and haemophilia are considerably
smaller than the initial frequencies. These new frequencies are
independent of the Initial frequencies of the diseases and are thus
applicable to any disease with the same mode of inheritance and same
values of the fitness parameters. However these examples were chosen
simply to illustrate the use of the formulae and in practice the
proportions of individuals detected and adopting any of the practices
are likely to be much smaller than in the examples. The corresponding




In this thesis an attempt has been made to measure possible
changes In the Incidence of genetic diseases and in the frequencies
of the corresponding deleterious alleles which might arise as the
result of ourrent and future medical practices. In an effort to
summarise the large number of results and the range of disease
conditions to which they may apply, qualitative scores have been
assigned to show the possible effects of the practices. These are
given in Tables 10.1 and 10.2. The feasibility of the practices,
for diseases of different modes of Inheritance, have been assessed
largely on the basis of the discussion in section 8.1 and the results
are given in Table 10.3. The extent to which any of the practices
might be used, if available, is discussed later.
Considering together the possible effects (Table 10.1) and
feasibility of application (Table 10.3) indicates that the overall
effect of the various practices studied is likely to be a general
decrease rather than an increase, in the incidence of genetic diseases
in the next generation. The only practice (improved treatment) which
could cause increases in incidence could only produce a relatively
small increase in incidence of XT? and MF diseases and AR diseases
where there is no heterozygote advanta<?e. Larger increases could
occur in AH diseases with heterozygote advantage or in AD diseases
but in the latter case therapy is rarely available. Similarly
considering together Tables 10.2 and 10.3 shows that for AR or AD
diseases possible decreases in gene frequency are greater than possible
increases for the practices available at present. In these cases
therefore there is likely to be a longer term decrease in disease
TABLE 10.1
Summary of possible changes in disease incidence for diseases
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TABLE 10.2
Summary of possible changes in gene frequency for diseases
of early onset where affected individuals have low fitness
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Net proportionate change in
gene frequency
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TABLE 10.3
An assessment of the feasibility of applying the various practices
at present or in the future
Feasibility of practice
PRACTICE AR AD XR MF


















++ +++ ++ +
++ +++ ++ +
+++ +++ +++





































by sibs of affected
individuals
7. AI for spouses of
carrier males
8. AI for spouses prospective
of carrier s












incidence. In XR diseases however there is a possibility of a longer
term increase in disease incidence as a result of improved therapy
or selective abortion with reproductive compensation.
Usage of practices
The adoption of any particular practice would depend upon the
individual disease and the availability of other practices. For
exaople if effective therapy was introduced for a disease couples at
risk of having an effected child might be less likely to limit their
or
family size -of- abort affected fetuses giving- a possible increase in
incidence in future generations. However treated individuals might
voluntarily decide to have no offspring and some treatments might
simply increase the life span of affected individuals but leave them
biologically infertile. Warwick (1968) showed that the median age
of death of Individuals with cystic fibrosis was 3 months before
treatment was available, but now, in one clinic where there is inten¬
sive prophylactic treatment, it is 21 years. However only about
2-3 percent of affected males are fertile (Taussig et al (1972)) and
though women have reproduced the risk of pregnancy to maternal and
fetal health may be great (Grand et al 1966).
If heterozygotes could be detected it seems likely that they
would only reduoe their family size if they had a high risk of having
affected children. In AD and XR diseases all heterozygotes would
fall into this category but in AR diseases only heterozygotes married
to another heterozygote would be at risk. If heterozygotes for
deleterious AR genes were detected before marriage they might prefer
to avoid having affected children by selecting a marriage partner
who is not also heterozygous. In the U.S.A. efforts have been made
123.
to screen Blacks for sickle-cell trait while still at school
(Culliton, 1972b) and this might result in more selection of marriage
partner than if screening was not done until individuals were older
when many might be already engaged or married.
Couples at risk might not be detected until they had had an
affected child. The results discussed in the literature review
suggest that in this case couples would be less likely to initiate a
further pregnancy if their affected child was likely to live for
some time or require much care and attention.
For diseases in which selective abortion is possible some couples
might prefer to use it rather than reduce their family size. The
results discussed in the literature review suggest an increasing
acceptance of abortion particularly when a fetus can be positively
identified as being affected. In Tay-Sachs disease and Pompe's
disease couples at risk can be Identified by screening and doctors
can tell if any fetus has the disease early enough to perform an
abortion. AI is another possibility but it is uncertain how many
couples would use it as it has not yet been widely offered.
General considerations
The implementation of any of these practices on a large scale
might introduce several new problems both practical, e.g. an increased
demand for resources and ethical e.g. rights of individuals to
reproduce. Some of these are discussed below,
a) Demand for resources
Any increase in the numbers of individuals using these practices
would be accompanied by an increased demand for material resources
and for trained personnel. For example there might be an increased
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demand for special diets or drugs for affected individuals. In
phenylketonuria, maple syrup urine disease and galactosaemia affected
individuals require highly purified diets with specially regulated
quantities of certain metabolites. Individuals with cystic fibrosis
require long term administration of antibiotics and agents to liquefy
viscid bronchial secretions.
If individuals were screened for carrier status or to detect a
disease in its early stages additional laboratory facilities would
be required for testing samples. There would also be a need for
personnel to counsel individuals ascertained about possible risks of
becoming affected or of having affected children. If selective
abortion was possible as in Tay-Sachs disease there would also be an
increased demand for resources for antenatal diagnosis.
In cases where large amounts of data were collected it might be
considered essential to computerise the information so that it could
be used effectively. Any such scheme would require skilled staff
at least initially,
b) Cost
For some diseases where therapy became available the cost of
treatment might be so great that it would not be possible to treat
many individuals. For example in phenylketonuria the special diet
can be relaxed by the age of 6 years but in maple syrup urine disease
there is no indication that dietary restriction can ever be relaxed
and the treatment is thus very expensive. The effective treatment
of Fabry's disease requires purified enzyme which is costly to produce.
The cost of screening might also render it uneconomical. In
the U.S.A. Tay-Sachs disease occurs in 1 in 6000 Jewish births. It is
feasible to screen the *at risk' papulation to detect couples where
husband and wife are both carriers and monitor pregnancies of these
couples. However the inoidence of Pompe's disease is only 1 in 100,000
live births (Sotoa and Boggs (1970)) and although heterozygote detection
and antenatal diagnosis are possible widespread screening would
probably not be feasible. The cost of prevention of the birth of
an affected individual would have to be weighed against the cost of
caring for the individual if he was born.
c) Misuse of information
Any information obtained about a person's genotype might be used
to his detriment unless steps were taken to limit access to it. For
example it might prove difficult to reassure the public that even
though carriers might be at risk of having- an affected child they
themselves are quite normal. Culliton (1972a) reports that as a
result of screening for the sickle oell trait in U.S.A. Blacks some
carriers are allegedly having trouble obtaining life and health
insurance and are being discriminated against with respect to jobs.
The same might occur if individuals at risk of developing late onset
dominant conditions such as Huntington's chorea were identified.
d) Unforeseen consequences
Some consequences of the introduction of these practices might
only become apparent at a later date. For example treated individuals,
though not at risk of having offspring with the same disease might still
have abnormal offspring. It is well known that women with phenylket¬
onuria are more likely than other women to have offspring with mental
retardation or structural abnormalities. This is thought to be due
to intrauterine exposure to abnormal concentrations of phenylalanine*.
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metabolites (Howell and Stevenson, 1971). There is a high risk that
fetuses of diabetic mothers will die in late pregnanay unless they
are delivered prematurely. It is possible that similar phenomena
might be found in other diseases.
If AI was used to any great extent it would probably be difficult
to screen donors for deleterious alleles. Women using this donor
sperm might then have abnormal offspring and bring the scheme into
disrepute.
Some alleles which produce disease in horaozygates might have
beneficial effects in the heterozygous state as yet unknown. A
reduction in the frequency of such alleles might have a detrimental
effect in certain populations. For example in cystic fibrosis the
gene frequency is too high to be maintained solely by mutation. It
has been suggested that in diseases where the gene frequency is high,
heterozygotes might have enhanced resistance to disease, otherwise
improved viability or enhanced fertility (Mayo, 1970b).
e) Ethical problems
Several ethical problems arise in trying to decide what are the
best Interests of society in general, of particular couples and of
affected individuals and unborn fetuses. These have been discussed
quite extensively for example at the Fogarty International Symposium
(1971). It is clear that there are several different views as to
what is morally acceptable which will be hard to reconcile in practice.
If an effective treatment was introduced for a disease which was
previously fatal in infancy few would argue that such a treatment should
be withheld because of a possible increase in gene frequency in future
generations. However the situation would be somewhat different if the
treatment involved the individual in much suffering. Since the
H^dro csLp UaUc,
development of the ventriculoatrial shunt many babies with spina
bifida have been treated. However in many cases the quality of
survival is less satisfactory than hoped for and many children have
to undergo repeated hospital admissions. Many, including parents
would prefer that such babies be allowed to die peacefully in infanoy
if they would still suffer from major handicaps.
If selective abortion was possible in a disease where affected
Individuals underwent much suffering it might be considered in the
best interests of the fetus, hi® parents and society in general to
abort affected fetuses. However in some diseases such as Downs
syndrome it is difficult to say if the affected Individual really
does suffer himself even though a great burden is inflicted on the
parents and on society in bringing up the child. Similarly if
unaffected carriers could be identified in utero it might be considered
in the best interests of society that they should be aborted in order
to reduce the frequency of the deleterious allele even though the child
would be completely normal. In either of these two latter cases the
decision whether to carry out an abortion would be more difficult.
Other problems would arise if large scale screening progress were
introduced in certain areas for the detection of preclinical cases of
a disease or of heterozygous carriers. The identification of such
Individuals might point to other family members outwith the area who
were at high risk of becoming affected or of having an affected child.
The identified individual might however wish that his status be kept
secret and there would be a conflict between his rights and those of
his relatives. If individuals at high risk of having an affected child
were detected it might be in the best interests of society for their,
not to reproduce. However is the right of society to prevent the
birth of affected children greater than the right of particular couples
to have their own children? Hie general conclusion of the Fogarty
Symposium was that society's interests are secondary to those of the
individual.
At present, with little use of the practice®, these problems are
not faced by many people. However they are likely to become more
important in the future and individuals faced with them will need some
guidance as to how to act in different situations.
Conclusions and recommendations
The results of this study suggest that the joint effect of the
practices discussed is likely to be a decrease in the incidence of
genetic disease in the next generation. Possible exceptions might
be AD diseases if therapy was to become available and AR diseases
where there was a persistence of hetorozygoto advantage.
In the longer term the change in disease incidence would probably
depend upon whether effective therapy was available for affected
individuals. The papers discussed in the literature review suggest
that couples are more reluctant to adopt one of the other practices if
effective therapy is available or if affected individuals usually die
very young. Effective therapy would have little long term effect on
the incidence of AR diseases but could cause a relatively large increase
in incidence of AD and XR diseases unless treated individuals voluntarily
had fewer offspring.
At present none of the practices are very important in causing
changes in disease incidence because they are not feasible for many
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diseases and few individuals are counselled regarding their risks.
The initiative for counselling is usually left to the individual
himself who often only seeks counselling after having an affected
child. If the child's diagnosis is late the couple may not be
detected until their family is complete.
In order to alleviate distress in particular families and to
reduce the incidence of genetic diseases in general there is a need
fori-
i) Education - the lay-public and in particular general practitioners
should be given more information about genetic diseases so that if a
disease occurred in a family they would be more aware of possible
implications for other family members. fills might be partially
achieved if genetics was more widely taught in schools so that more
individuals would understand the hereditary nature of certain diseases.
ii) Screening - In order to detect more Individuals at risk prospectively
screening of the general population would be required at least in AR
diseases. It mi«Jit only be economically feasible to do this in
conditions where it is relatively cheap and easy to detect heterozygotes.
Or in populations where certain diseases are very common. In other,
rarer, diseases heterozygote detection might not be feasible except
for relatives of affected individuals or in consanguineous marriages.
iii) Extension of counselling services and follow-up - With an increase
In the number of individuals ascertained there is an increased need
for facilities so that they can be given genetic counselling. There
is also a need for follow-up of these Individuals and, in AD and XR
diseases, of their relatives, to detect those at high risk.
iv) Legislation - In the future new laws might be necessary to protect
the rights of certain individuals; in particular to ensure that any
information gathered is not misused. Discussion is needed regarding
possible legislation so that society will be prepared in advance for
any increase in the use of these practices.
v) Continued reappraisal of practices - There would later be a need
for follow-up of individuals adopting the practices in order to detect
any unforeseen consequences such as those discussed in (d) above.
With these facilities there would be a possibility of long term
decreases in the incidence of genetic diseases at least in those
conditions for which there was no effective therapy where individuals
at risk would be more likely to avoid having affected offspring. In
diseases where therapy was cheap and effective possible longer term
increases in incidence might not be important. In diseases for which
therapy was expensive any increase in disease Incidence would place
a great burden on society. Although the increase in incidence of
any particular disease might be small the joint effect might be large.
In these diseases it would be in the best interests of society to
advise couples at risk not to have offspring.
I personally believe that genetic counselling must be firstly
devoted to the interests of particular individuals and that it would
not be right to introduce laws forbidding particular couples to have
offspring. I believe that with sufficient education couples would
take responsible decisions regarding parenthood. If they did so
relatively small reductions in fertility would be sufficient to offset
the dysgenic effects of improved treatments in AR diseases. In AD
and XR diseases longer term increases in gene frequency could be offset
by larger reductions in the fertility of heterozygotes or in the
latter case by a reduction in fertility of affected males. In MF
diseases changes in incidence could be offset by small reductions
in fertility of individuals at high liability to the disease.
APPENDIX 1
DERIVATION OF CHANGES IN DISEASE INCIDENCE AND GENE FREQUENCY FOR
CASES NOT CONSIDERED IN SECTION 5
In this appendix calculations of the effects of the practices
not considered in section (5) are described for diseases with AR, AD
(with coiqplete penetrance), XR and MF modes of inheritance. For AD
diseases with incomplete penetrance the effects of all practices are
calculated. Hie methods of derivation of the changes are given in
detail for early onset diseases and necessary modifications to the




Selection of mate (2)
Suppose a proportion w^ of heterozygotes is ascertained before
marriage and a proportion c^ of these subsequently seek a marriage
partner who is homozygous normal. Hie frequency of heterozygous
2 2 2 • 2 2
couples is then approximately Ip q" (l-w„ c ) = Iq (1-w C,)"
Aa i Aa i
(i) Disease incidence Following the method for practice (4) in
section (5B) the approximate net change in disease incidence
1
is -q"w. c^S-w C, )
Aa 1 Aa i
(ii) Gene frequency Assuming that all individuals are able to
find a marriage partner the only loss of ia genes from the gene pool
is by selection against aa individuals born. Therefore after
subtracting the effect of natural selection the approximate net
change in gene frequency is
2 2 2 2
-s q (1—w c ) + s q se q s w c (2-w c )
aa Aa i aa aa Aa i Aa i
Selective_abortion with reproductive compensation (3)
- retrospective
Suppose heterozygous couples are ascertained retrospectively.
The changes in disease incidence and gene frequency are equal to those
which occur for prospective ascertainment multiplied by P (the
r
proportion of offspring born after the first affected child).
(B) Eugenic practices
Family limitation by_carriers_at risk (5)
- prospective
Suppose a proportion w of heterozygous couples is ascertained
m
prospectively and of these a proportion c subsequently reduce their
m
intended family size by a proportion ff. Putting these terms together
zn
the fitness of heterozygous couples is (1-w c f'). The changes in
m m in
disease incidence and gene frequency can be derived by following the
method for practice (4) in section (5B).
(i) Disease incidence The approximate net change in disease
2 2 3 2
incidence is q" (l~w c f•) - q" + 2q s ^ -q~w c f*
ramm aa m m m
(ii) Gene frequency Since one half of the genes contributed by
heterozygous couples are a the reduction in gene frequency due to
12 2 2
family limitation is approximately —. 1p q w c f• = 2q w c f*
2 ramm M ramm
The reduction in gene frequency due to selection against affected
2
individuals born is approximately s q (1-w c f1)
aa m m m
Therefore the net change in gene frequency due to the practice is
2 2 2 2
approximately -2q w c f' - s q (1-w c f') + s q = -q w c f• (2-s )
m m m aa m m m aa m m m aa
- retrospective
If heterozygous couples are ascertained retrospectively the
changes in disease incidence and gene frequency are equal to those
calculated above multiplied by P^.
Family limitation by sibs of affected individuals (6)
P is the proportion of the offspring of heterozygous couples who
s
are normal sibs of affected individuals. In the grandparental
2 2
generation the frequency of these couples is approximately !p q .
Therefore in the parental generation at birth the proportion of
2 2
individuals who are normal sibs of affected individuals is !p q P .
s
Two-thirds of these are heterozygotes therefore the proportion of all
heterozygotes in the parental generation at birth who are sibs of
2 2 2 • 4
affected individuals is —. 1p q'p /2pq s —qP .
3 s 3 s
Suppose a proportion w of these heterozygotes is ascertained
ACi
prospectively and a proportion c^ of these subsequently reduce their
intended family size by a proportion f • . Putting these terms
Aa
4
together the fitness of heterozygotes is approximately (l-—q P w. c f' ).
3 s Aa i Aa
4
Let H = - P w, c f• so that the fitness of heterozygotes is3 s Aa i Aa
Cl-qH).
(i) Disease incidence Heterozygotes with an affected sib make up
a very small proportion of all heterozygotes. The number of offspring
born to affected individuals is not negligible compared with the
number born to their normal sibs. Mating® involving affected individuals
must therefore be considered. These could be ignored in the calculations
of changes when a proportion of all heterozygotes or of heterozygous
couples adopted a practice. Couples at risk of having affected
offspring have the following frequencies and fitnesses
bating type Frequency Fitness Proportions of offspring
AA Aa aa
Aa x Aa 4p2q2 (1-qII)2 ~ ^
Aa x aa 4pq3 (1-qHXl-s^) 0 2 2"
4 2
aa x aa q (l-s ) 0 0 1
aa
The incidence of affected individuals in the offspring is approximately
1 ,2 2 TT*2 1.3 . tt\f 1 \ . .2 . 2 3 3
—. 1p q (1-qH) + —. tpq (1-qHXl-s^) + q (l-s^) = q - 2 s^q - 2q H
Subtracting the incidence in the parental generation and the
effect of natural selection the net change due to the practice is
approximately
8 3
qPw c f »
3 s Aa i Aa
(ii) Gene frequency Following the method for practice (4) in
section (5B) the reduction in gene frequency due to family limitation
1 • 2
is approximately —. 2pq.qH = q"H. The reduction in gene frequency
due to selection against affected individuals born is approximately
s (q" - 2s q3 - 2q3H).
aa aa
therefore the net change in frequency due to the practice is
approximately
4 2
- —• q P wA c f*3 s Aa i Aa
Artificial insemination for spouses of carrier males (7)
Suppose a proportion w of heterozygous carrier males is ascert-AH
ained prospectively and the spouses of a proportion of these are
inseminated by donor sperm. Heterozygous couples have frequencies
as follows
Mating type Frequency Proportions of offspring
AA Aa aa
2 J) | 1
Practising AI Aa x Aa 4p q w. c. — — 0
Aa i 2 2
2 2
Not practising AI Aa x Aa Ip q (1-w c ) To" "TAH 1 i 2
(i) Disease incidence Following the same method as for practice
(4) in section (5B) the approximate net change in disease incidence
2 . .2 3.2
is q (1-w. c ) - q + 2q s = -q w, cAa i aa 4 Aa i
(ii) Gene frequency A proportion w^c^ of heterozygous males do
not transmit genes to the next generation if their spouses are insemin¬
ated by donor sperm. One half of heterozygotes are male and half
their genes are a. This practice therefore results in a reduction
in gene frequency of approximately 2pq ~.w c
2 2* AH X 2 AH X
Hie reduction in gene frequency due to selection against affected
2
individuals born is approximately s q (1-w c )
aa Aa i
Therefore the approximate net change in gene frequency due to the
practice is - ;|w. c - s q2 (1-w. c ) + s q2 4 -A* c2 Aa i aa Aa i aa 2 Aa i
Artificial insemination for spouses of carrier males at risk (8)
- prospective
Suppose a proportion w of heterozygous couples is ascertained
CI
prospectively and a proportion c ot these practise Al using donor
m
2 2
sperm. The frequency of couples using AI is then 4p q
(i) Disease incidence By the same method as above the approximate
2
net change in disease incidence is -q w c
m ra
(ii) Gene frequency If heterozygous couples do not practise Al
one half of the genes in their offspring are a. If they practise
AI only one quarter of the genes are a_. Therefore the reduction in
2 2 1 1.2
gene frequency due to AI is approximately 4p q*"w c f— ] = q"w Q
m m 2 4 mm
The reduction in gene frequency due to selection against affected
2
individuals born is approximately s q (1-w c )
aa m m
Therefore the approximate net change in gene frequency due to the
practice is -q2w c - s q2 (l-w c ) + s q2 = -q^w c (1-s )
mm aa mm aa mm aa
- retrospective
If heterozygous couples are ascertained retrospectively the
changes in disease incidence and gene frequency are equal to those
calculated above multiplied by P .
Selective abortion without reproductive compensation (0)
- prospective
Suppose a prqportion w of couples where both partners are hetero-
m
zygous is ascertained prospectively and a proportion c of these
m
practise selective abortion of affected fetuses but without compensation.
Family size is therefore reduced.
(i) Disease incidence The net change in disease incidence is the
same as for reproductive compensation (3).
(ii) Gene frequency The net change in gene frequency is the same
as for reproductive compensation except that there is no increase in
gene frequency due to the birth of additional heterozygotes. The
net change is therefore approximately
2 v 2 2 2 , v
-s q (1-w c)~qwc +qs « -qwc (1-s )
aa mm mm aa mm aa
- retrospective
If heterozygous couples are ascertained retrospectively the changes
are equal to those calculated above multiplied by P .
r
2a) AD diseases with complete penetrance
(A) Dysgenic practices
Selection of mate (2)
This practice is not relevant to AD diseases as all carriers of
the deleterious allele are at risk of having an affected child no
matter what is the genotype of their mate.
Selection abortion with reproductive compensation (3)
- retrospective
Suppose a proportion w of couples where one partner is affected
CD
is ascertained retrospectively and a proportion c of these practise
m
selective abortion of affected fetuses with reproductive compensation.
The changes in disease incidence and gene frequency are equal to those
when there is prospective ascertainment multiplied by P^.
(B) Eugenic practices
Family limitation by carriers at risk (5)
- prospective
All heterozygous carriers of the deleterious allele are at risk
of having affected offspring. The changes in disease incidence and
gene frequency are therefore identical to those calculated for
practice (4) in section (5B).
- retrospective
If couples where one partner is affected are ascertained after
the birth of an affected child the changes in disease incidence and
gene frequency are equal to those for practice (4) multiplied by P^.
Family limitation by sibs of affected individuals (6)
In AD diseases where there is complete penetrance none of the
normal sibs of affected individuals are carriers of the deleterious
allele and so if they restrict their family size there is no change
in disease incidence or in gene frequency.
Artificial insemination for spouses of carrier males (7)
Suppose a proportion w of heterozygous (affected) males is
A—
ascertained prospectively and the spouses of a proportion c^ of these
are inseminated by donor sperm. Couples where one partner is affected
have frequencies as follows




Practising AI Aa x aa 2p 0 1
3 11
Not practising AI Aa x aa 2p q(l-w. c ) (1-s ) — "T
A"" 1 A--
3 11
Not practising AI aa x Aa 2p q (l-sA_) — ~
(i) Disease incidence The approximate incidence of affected indiv¬
iduals in the offspring is q(l-s. ) (2-w. c )A— A— i
Subtracting the incidence in the parental generation and the effect
of natural selection the approximate net change due to the practice is
-qV°i a-aA-'
(ii) Gene frequency Following the same method as for AH diseases
the reduction in gene frequency due to carrier males not transmitting
genes to the next generation is approximately
i. 2Pq <1-V) K »A_0l i a-V)
The reduction in gene frequency due to selection against affected
individuals born is approximately — s q (1-s )(2-w c )
2 A- A- A- i
Therefore the net change in gene frequency due to the practice is
approximately w c (1-s ) - ~ s q (1-s ) (2-w. e ) + q s. (1-s. )2 A- i A- 2 A- A- A- i A- A-
4 -!vi (1-vr'
ArtificialJnsemination for spouses of carrier males at risk (8)
- prospective
Since all heterozygous carrier males are at risk of having affected
offspring the changes for this practice are identical to those
calculated for (7) above.
- retrospective
If couples are ascertained after the birth of an affected child
the changes are equal to those calculated for (7) above multiplied by
P .
r
Selective abortion without reproductive compensation (9)
- prospective
Suppose a proportion w of couples where one partner is affected
m
is ascertained prospectively and a proportion c of these practise
m
selective abortion but without reproductive compensation so that
family size is reduced. The changes in disease incidence and gene
frequency are identical to those when there is reproductive compensation.
This is because in the latter case none of the offspring born to
compensate for affected individuals carry the A gene.
- retrospective
The changes in disease incidence and gene frequency are identical
to those when there is reproductive compensation.
2b) AD diseases with incomplete penetrance
(A) Qysgenic practices
Improved treatment (1)
Suppose an improved treatment for the disease reduces selection
against affected individuals by an amount s» • The disease incidence
A—
and gene frequency changes are calculated by the same method as used
in section (5A) and the effect of existing forces is subtracted.
(i) Disease incidence The change in disease incidence between
2
parental and offspring generations is -2qy (s -s • ). .Subtracting
n"* A"*
the effect of natural selection the net change due to the practice is
approximately 2qy2s«
n"*
(ii) Gene frequency Similarly the approximate change in gene
frequency between parental and offspring generations is
-qy(s -s« ) (l-y<8. -s» )).A- A- A- A—
Subtracting the effect of natural selection the approximate net change
in gene frequency due to the practice is qys» (l-2ys. +ys* ),
A— A- A-
However, for the same reasons as for AD diseases with complete penetrance
it is more valid to compare the proportionate changes in the frequency
of A between parental and offspring generations. Without improved
treatment the proportionate change is -qys. (1-ys )/q(l-ys ) = -ys •A- A- A- A-
Similarly with improved treatment the proportionate change is
Therefore the net effect of inproved treatment is to diminish the
proportionate reduction in gene frequency by an amount ys' .
A—
Selection of mate (2)
As for diseases with complete penetrance this practice is not
relevant.
Selective abortion with reproductive compensation (3)
- prospective
Suppose a proportion w of couples, where one partner is
m
affected, is ascertained and a proportion c of these practise
m
selective abortion of heterozygous carrier fetuses with reproductive
compensation, It is assumed that the fetuses aborted are those
where the deleterious gene is penetrant and therefore are all
affected. This is not the case if fetuses are aborted who are
likely to be carriers of the deleterious allele because of their
genotype at a linked locus. In the latter case some heterozygotes
aborted are not affected. The reduction in disease incidence and
the increase in gene frequency, calculated on these assumptions are
however the maxima which could occur. This is because all the
carriers aborted are affected and therefore at a selective
disadvantage and any born to condensate for them have normal fitness.





































(i) Disease_incidence The approximate incidence of affected
y 3 t
individuals in the offspring is *-• 4p q [y(l-w c )(l-s ) + (1-y)]
2 mm A—
= 2qy (l~ys. -w c y+w c ys )A- mm mm A-
Subtracting the disease incidence in the parental generation and the
effect of natural selection the net change in disease incidence due to
2
the practice is = -2qy'w c (1-s. )
ra m A—
(ii) Gene frequency Ihe reduction in gene frequency due to
abortion of affected fetuses, half of whose genes are A, is approximately
3 V 1 2
4p qyw c (1-s )• r - qy w c (1-s. )
m m A— 22 mm A—
The reduction in gene frequency due to selection against affected
individuals born is approximately 2qy (1-ys. -w c y+w c s y). -^sA— ram ram A- 2 A-
= qys. (l-ys -w C y+wc ys )A— A— mm mm A—
2
To compensate for affected fetuses aborted there are 2qy w c (1-s )
mm A-
individuals born. A proportion [~(l-y)]/[~^-~(l-y)] = (l-y)/(2-y)
are unaffected carriers. The approximate increase in gene frequency
due to the birth of additional unaffected carriers is therefore
qy2w c (l-y)(l-s >/(2-y).
mm A—
SUbtracting the effect of natural selection the approximate net




Suppose a proportion w of all couples, where one partner is
m
heterozygous and who have had an affected child, is ascertained and
that a proportion c of these subsequently practise selective abortion
of affected fetuses with reproductive condensation. When there is
prospective detection ascertainment is assumed to be dependent on
one parent being affected. Mien detection is retrospective it is
only dependent on the child being affected. P is the proportion
r
of offspring born to couples» where one partner is a heterozygote,
after the first affected child. If there is selective abortion with
reproductive compensation these couples will have the following
proportions of offspring:-
affected heterozygotes (1-w c P )y/2
m m r
normal heterozygotes c P = [l + w c P . —]
2 (2~y) 2mrar 2 mmr 2-yJ
normal homozygotes ^ ^ • w c P =—[l+wcP. —]2 (2—y) 2 mmr 2 mmr 2—y
This is summarised in the table below




Aa x aa 4p3q (1-ys ) ^[l-wcP] (1-~y)[l+w c p . -*-] ^[l+w cP.A— 2 mmr 2 mmr 2-y 2 mmr
(i) Disease_incidence The disease Incidence in the offspring is
3 y
approximately 4p q (1-ys. ) *• (1-w c P ) = 2qy (1-ys. ) (1-w c P )A— 2 mmr A— mmr
As before, subtracting the disease incidence in the parental generation
and the effect of natural selection the approximate net change in disease
incidence due to the practice becomes -2qyw c P (1-ys )
mmr A-
(ii) Gene frequency Following the method of calculation for
prospective ascertainment the reduction in gene frequency due to
selective abortion of affected fetuses is approximately qyw c P (1-ys )
mmr A—
The reduction in gene frequency due to selection against affected
individuals born is approximately qys, (1-ys ) (1-w c P )
A— a— m m r
The increase in gene frequency due to the birth of additional unaffected
carriers is qyw c P yaA-)
m m r 2-y
The approximate net change in gene frequency is therefore
qyWmCmPT-(1~y)(1_y8A-)
~qyW™CmP^(1~ySA J ~ qySA (l_ySA + 7Tin m :r A— A— A— m m r 2—y
+ qys^ (l-y«A_)
(1-ys )(l-2s +ys )
—qyw c P i n A"",
m m r (2-y)
(B) Eugenic practices
Family limitation by carriers (4)
- prospective
Suppose a proportion w. of affected heterozygotes is ascertained
A—
prospectively and of these a proportion reduce the number of
offspring they would have had subsequently by a proportion f •.
A —
Couples where one partner is a heterozygote have frequencies and
witnesses as follows
Frequency Fitness Proportions of offspring
Aa aa
Affected Normal
One partner „ 3 w, . y l-y l
affected 4» <1-*A-°lfJU>tt-V> 2 2
Neither _
partner 4p q(l-y) l —
affected 2 2 2
(i) Disease incidence The approximate incidence of affected indiv¬
iduals in the offspring is 4p3q fy(l-w. c,f• )(l-s ) + (l-y)]•i A- i A- A-
i [x-jr (V"A.V;--A-VC1f;->1
After subtracting the incidence in the parental generation and
the effect of natural selection the net change due to the practice is
2
approximately -2qy w c f• (1-®. )
A™* X A"" A""
(ii) Gene frequency The reduction in gene frequency due to family
limitation is approximately 2pqy (l-s. ) w. of* . = qyw. of' (l-s )
A— A- i A- 2 A— i A- A—
Hie reduction in gene frequency due to selection against affected
individuals born is approximately — s. . 2qy[l-y (s +w. of• -s. w. of' )]
2 A- A- A- i A- A- A- i A-
After subtracting the effect of natural selection the approximate net
change due to the practice is -qyw. c.f' (l-s ) (1-ys )
A- i A- A- A-
Family limitation by carriers at risk (5)
- prospective
As in the case of diseases with complete penetrance all hetero¬
zygous carriers are at risk of having affected offspring. If only
affected heterozygotes are ascertained the changes are the same as
those calculated for (4) above.
- retrospective
Suppose a proportion w of all heterozygous carriers who have
A-
had an affected child is ascertained and of these a proportion c^
reduce the number of offspring they would have had subsequently by
a proportion f • . Couples where one partner is heterozygous haveA—
frequency and fitness as follows: -
Mating Frequency Fitness Proportions of offspring
tJ,Pe Aa as
Affected Normal
Aa x aa 4p3q ^""V-Va-V 2 2
The changes in disease incidence and gene frequency are calculated
as in (4) above.
(i) Disease incidence The disease incidence in the offspring is
approximately 2qy(1-ys. )(1-w c.f' P ). The approximate net change
A- A- i A- r
in incidence is therefore -2qyw c.f' P (1-ys )
A- i A- r A-
(ii) Gene frequency The reduction in gene frequency due to family
limitation is approximately qw. of• P (l-ys„ )A- i A- r A-
The reduction in gene frequency due to selection against affected
individuals born is approximately qys. (1-ys. ) (1-w. c.f* P )A— A— A— i A— r
The approximate net change in gene frequency due to the practice is
2
therefore -qw. c.f* P (1-ys. )A- i A- r A-
Family limitation_by sibs_of affected individuals (6)
A proportion P of the offspring of couples where one partner is
s
a heterozygous carrier are normal sibs of affected individuals. In
the grandparental generation the frequency of these couples is
3
approximately 4p q. Therefore in the parental generation at birth
the proportion of individuals who are normal sibs of affected
individuals is 4p3qPs> Of these a proportion are unaffected
carriers of the deleterious allele. Therefore the proportion of
all unaffected carriers in the parental generation at birth who are
normal sibs of affected individuals is
. 3 _ (1-y)
* qPs T^y) 2pq(l-y) = 2 P
2-y
Suppose a proportion w. of these unaffected carriers isA—
ascertained prospectively and a proportion c^ of these subsequently
reduce their intended family size by a proportion f• .
A-
Putting
these terms together the fitness of unaffected carriers is
2P
approximately (1 - ® . w. of' ),
2-y A- i A-
Couples where one partner is heterozygous have the following
frequencies and fitnesses:-

























The changes in disease incidence and gene frequency are calculated
as in (4) above,
(i) Disease incidence The approximate incidence of affected




The approximate net change due to the practice is therefore
—4qyP w. c f• (1-y)
s A- j A-
(2-y)
(ii) Gene frequency The reduction in gene frequency due to family
limitation is approximately ""qPsWA-CifA-^1'~y^
(2-y)
The reduction in gene frequency due to selection against affected
individuals born is approximately qysA [l-ysa -2P w c f •A- A- s A- i A- (2-y)
The approximate net change due to the practice is therefore
or, <i-y)<i-yeA_)-2qP w. of • : A
s A- i A- (2-y)
Artificial insemination for spouses of carrier males (7)
Suppose a proportion w of affected heterozygotes is ascertained
A-
prospectively and the spouses of a proportion c^ of these are
inseminated by donor sperm. Couples where one partner is a hetero-










































4p q(l-y) x q-y) 1
2 2 2
(i) Disease incidence The approximate incidence of affected
individuals in the offspring is qy(2-w. cj - 2ys +yw c.s )A- i A- A- i A-
Rubtracting the disease incidence in the parental generation and the
effect of natural selection the approximate net change in incidence due
to the practice is -qy' w c (1-s )
A- i A-
<ii) Gene frequency The reduction in gene frequency because
affected males do not transmit A alleles to the next generation is
approximately pqyU-s^)*^^ = ^
The reduction in gene frequency due to selection against affected
individuals born is approximately ~ s„ qy(2-w c v - 2yBA +ywA c.sA )
4* A** A- 1 A-* A**" jL A—
Subtracting the effect of natural selection the approximate net change
in gene frequency becomes qyw c (1-s, )(l-ys )A- i> A- A—
Artificial insemination for_spouses of carrier males at risk (8)
- prospective
Since all heterozygous affected carrier males are at risk of
having affected offspring the changes for this practice are the same;
as those calculated for (7) above.
- retrospective
Suppose a proportion w of all heterozygous carriers who have
Aft
had an affected child is ascertained and the spouses of a proportion
c^ of these are inseminated by donor sperm. Couples where one
partner is a heterozygote have frequencies and fitnesses as follows:
Mating type Frequency Fitness Proportions of offspring
Aa aa
Male Female Affected Normal .
(I - Uifl '/aC i + U)0 .C^Pr-)
Aa x aa 2p3q f(1""wA-cipr)
aa x Aa 2p3q (1-ys ) ^ —A- 2 2 2
The changes in disease incidence and gen© frequency are calculated
in the same way as in (7) above.
(i) Disease incidence The approximate incidence of affected
individuals in the offspring is
2p3q(l-y8AJ Cf<l-VeiPr) + f3 = qy(1-yV)<2"VCiPr)
1
The approximate net change in incidence due to the practice is therefore
-qyw. c P (1-ys )A- i r A-
(ii) Gene frequency Hie reduction in gene frequency because
heterozygous males do not transmit genes to the next generation is
approximately ~qw c P (1-ys )
A— X Z* A—
The reduction in gene frequency due to selection against affected
individuals born is approximately -j-s qy (1-ys )(2-w c P )
w A™ A— A— X I*
Hie approximate net change in gene frequency is therefore
-?'V0IV1-j"A-)2
Selective abortion without reproductive compensation (9)
- prospective
Suppose a proportion w of couples, where one partner is affected,
m
is ascertained and a proportion c of these practise selective
m
abortion of affected fetuses but without reproductive compensation.
(i) Disease incidence The net change in disease incidence is the
same as that when there is reproductive compensation.
(ii) Gene frequency The net change in gene frequency is the same
as that when there is reproductive compensation except that there is
no increase in gene frequency due to the birth of additional unaffected
carriers. The net change is therefore approximately
2
-qy w c (1-s ) - qys (1-ys - w c y + w c ys„ ) + qys. (1-ys. )
mm A- A- A- mm m m A- A- A-
2 »2
- -qy w c (1-s. )
mm A-
- retrospective
Suppose a proportion w of all copies where one partner is
m
heterozygous and who have had an affected child is ascertained and
that a proportion c of these subsequently practise selective abortion
01
of affected fetuses without reproductive condensation.
(i) Disease incidence The net change in disease Incidence is the
same as that when there is reproductive compensation.
(ii) Gene frequency The net change in gene frequency is the same
as that when there is reproductive compensation except that there is
no increase in gene frequency due to the birth of additional unaffected
carriers. The net change is therefore approximately
-qyw c P a-ySA ) - qys <l-ys )(l-wc P) + qys (1-ys )m ra r A- A- A- m a r A- A—
3) XR diseases
(A) Dysgenic practices
Selection of stale (2)
This practice is not relevant to XR diseases as all heterozygous
carrier females are at risk of having an affected child no matter what
is the genotype of their mate.
Selective abortion with reproductive compensation (3)
- retrospective
Suppose a proportion w of couples where the female is a carrier
m
is ascertained retrospectively and a proportion c of these subsequently
practise selective abortion of certain fetuses with reproductive
compensation. The chants in disease incidence and rene frequency
are equal to those which occur for prospective ascertainment multi¬
plied by Pf.
(B) Eugenic practices
Family limitation by carriers at risk (5)
- prospective
All heterozygous carrier females are at risk of having affected
offspring. Hie changes in disease incidence and gene frequency
are therefore identical to those calculated for practice (4) in
section (5B).
- retrospective
If heterozygous carrier females are ascertained retrospectively
the changes in disease incidence and gene frequency are equal to those
for practice (4) multiplied by P^.
Family limitation by sibs of affected individuals (6)
Let P be the proportion of the offspring of couples, where the
s
female is a carrier, who are normal sibs of affected individuals.
In the grandparental generation the frequency of these couples is
2
approximately 2p q. Therefore in the parental generation at birth
2
a proportion 2p qPg individuals are normal sibs of affected individuals.
The proportion of the parental generation who are carrier female sibs
of affected individuals is one third of this. Half the parents are
female and a proportion 2pq of them are carriers. Therefore the
proportion of carrier females who are sibs of affected individuals is
2 1 /
approximately 2p qP • ~ / . 08
y i . 2pq = ~ P/ 2 3 s
Suppose a proportion w of these females is ascertained pros-Aa
pectively and a proportion of them subsequently reduce their
family size by a proportion f* . Couples at risk of having: an
Aa
affected child have frequency and fitness as follows:-
Mating type Frequency Fitness Proportions of offspring:
Females Males
AA Aa AY aY
Aa X AY 2p2q W-fVAaW I 2 2 2
The changes in disease incidence and gene frequency are calculated
as for practice (4) in Section (5B)
(i) Disease incidence The approximate net change in disease
2
„-qP w c f»
3 s Aa i Aa
incidence is - A . *
(ii) Gene frequency The approximate net change in gene frequency
TqP w c f• (2-s )
9 s Aa i Aa a
2
is A )
Artificial insemination for spouses of carrier males (7)
In XR diseases males with the deleterious allele are affected.
Suppose a proportion w of these is ascertained and the spouses of
a proportion of these are inseminated by donor sperm.
(i) Disease incidence The only affected males at risk of having
affected offspring are those married to carrier females. Even if
their spouses are inseminated by donor sperm one half of their male
offspring are affected. The disease Incidence is therefore the
same as when only existing forces are operating i.e. q(l-qs ).
a
There is therefore no change in disease incidence as a result of this
practice.
(ii) Gene frequency The approximate frequency of a in the parental
generation at reproduction is q(l-^s ).
O a
As a result of AI for spouses of affected males (who contribute
one third of the genes at the locus) the reduction in gene frequency
is approximately iq(l-s )w c
3 a a 1
The reduction in gene frequency due to selection against affected
individuals born is approximately q(l-qs )
3 a a
Subtracting the effect of natural selection the approximate net change
in gene frequency due to the practice is therefore
-~qw c,(l-s ) - ^qs (l-qs ) + iqs = ~^qw c (1-s )
3 a i a 3 a a a 3 a i a
Artificial insemination for spouses of carrier males at risk (8)
As stated above, affected males at risk of having affected
offspring are those married to carrier females. One half of the
sons of these couples would be affected even if the females were
inseminated by donor sperm. This practice is therefore not relevant
to XR diseases as a means of preventing the birth of affected offspring.
Selective abortion without reproductive compensation (9)
- prospective
Suppose a proportion w of couples where the female is a carrier
m
is ascertained prospectively and a proportion c of these practise
m
selective abortion but without reproductive cooqaensation.
(i) Disease incidence The net change in disease incidence for
cases (a), (b) and (c) is the same as for practice (3), where there
is reproductive compensation.
(ii) Gene frequency The reduction in gene frequency due to
selective abortion of affected male fetuses and to selection against
affected individuals born is the same as when there is reproductive
compensation. There are no additional heterozygous carrier females
born in cases (a) and (b). Therefore the approximate net changes
in gene frequency are as follows.
(a) abortion_of all males
and (b) abortion of affected males
The net change in gene frequency is approximately
1 ^ T 1 T fm V
qs (1-w c ) - -qw c + —qs = -~qw c (1-s )3 a mm 3mm 3a 3mm a
(c) abortion_of affected males and carrier females
The approximate net change in gene frequency is the
same as that when there is reproductive compensation. This is
because even in the latter case no additional offspring are born who
carry the deleterious allele.
- retrospective
Suppose a proportion w of couples where the wife is a carrier is
m
ascertained retrospectively and a proportion c of these subsequently
m
practise selective abortion of certain fetuses without reproductive
compensation. The changes in disease incidence and gene frequency






Hi is practice is not relevant for MF diseases as several, often
unknown, factors are involved in the development of these diseases and
it is not possible for any individual to guarantee not to have an
affected child by the choice of a particular marriage partner.
Selective abortion with reproductive compensation (3)
- retrospective
Suppose a proportion w^ of couples who have had an affected child
is ascertained and of these a proportion c practise selective
m
abortion of affected fetuses with reproductive compensation. If
there is no selective abortion the incidence of affected individuals
2 2 2
in the offspring is approximately P - a P h~sf (as a result of
existing forces only). If P is the proportion of affected indiv-
rm
iduals born after the first affected child in the family then with
selective abortion and reproductive compensation the disease incidence
2 2 2 .
is approximately (1-w c P ) (P-a P h s ).
x m rm f
The change in disease incidence between parental and offspring gener-
2 2 2
ations is therefore approximately (1-w c P ) (P-a P h*s.) - P.
x m rm f
Subtracting the effect of natural selection the approximate net
2 2 2
change in disease incidence due to the practice is (1-w c P )(P-a p h
x m rm
2 2 2 2 2 2
- P + a p h s = —w c P (P-a P h s )
f x m rm f
(B) Eugenic practices
Family limitation by carriers at risk (5)
- prospective
Suppose it is possible to detect individuals of high liability
whose spouses also have a high liability such that the mean liability
of the two individuals exceeds a certain value x•' say. Suppose P
X
is the proportion of couples exceeding this liability and a proportion
w is ascertained and a proportion c of these subsequently reduce
x in
their intended family size by a proportion f*. Couples therefore
m
have frequencies and fitnesses as below:-
Liability not greater Liability greater
than x1* than x1*
Frequency (1-P ) P
X X
Mean liability /2n -zs„ ]2a -zs_
x f x f
Fitness 1 1-w c f*
x m m
The mean liability of the offspring is therefore
h" [(1-P )( |2n -zs ) + P (1-w c f')( ]2a -zs )]
x x f x x m m x f
(1-P ) + P (1-w c f*)
x x x m m
Following the method used in section (5A) the change in disease incid¬
ence between parental and offspring generations is approximately
z(=aP) times the mean liability.
Since the denominator is approximately equal to one the change in
disease incidence between parental and offspring generations is
approximately
-aPh2 [ J2a P w c f»+aPs (1-w c f«P )]
xxxmm f xmmx
Subtracting the effect of existing forces the approximate net change
2 i—"
due to the practice is -aPh w c f' [ j2a P -aPP s ]
xmm xxmf
- retrospective
Suppose a proportion w^ of cobles who have had an affected child
is ascertained and of these a proportion c reduce the number of
m
offspring they would have had subsequently by a proportion f •. The
m
change in disease incidence is calculated in a similar manner to
that in (3) above.
If there is no family limitation the incidence of affected
2 2 2
individuals in the offspring is approximately P - a"p'~h~sf.
With family limitation the disease incidence is approximately
(1-w c f'P )(P-a2p2h2s,)
x m m rm f
The approximate net change in disease incidence due to the practice
is therefore (1-w c f*P )(P-a2p2h~s.) - P + a2p2h~s,
x m m rm f f
= -w c f»P (P-a2p2h2s,)x m m rm f
Family limitation by sibs of affected individuals (6)
A proportion P of the parental generation at birth are normal
sm
sibs of affected individuals. Suppose a proportion w^ of these
sibs is ascertained and a proportion c^ of these subsequently
reduce their intended family size by a proportion f^. Sibs of
1 2
affected individuals have a mean liability of -^h' a measured from the
mean of the parental generation at birth. This is therefore the
approximate mean liability of the normal sibs of affected individuals.
The mean liability of the offspring of two normal parents where one
12 12 14
parent has an affected sib is -h~ [-h a] = rh a. Following the
method used for practice (3) in section (5B) the proportion of the
offspring of normal sibs of affected individuals who are affected is
1 4
P + ~zh a. Since there is no natural selection against normal
4
individuals the reduction in disease incidence due to family limitation
by normal sibs is independent of that due to existing forces. The
approximate disease Incidence in the offspring is
2 2 2 1 4
P - a"h P s - P w c f• (p+-zh a). Substituting for z the approximate
f sm x i x 4
net change in disease incidence due to the practice is
-w c f»P P <l+ih4a2)
x i x sm 4
Artificial insemination for spouses of carrier males (7)
Artificial insemination for spouses of carrier males at risk (8)
These practices are not relevant for MF diseases for the same
reasons as in (2) above.
Seleclt±ye_ab°rjt±°n. without_reproductive compensation (9)
- prospective
Suppose it is possible to detect prospectively couples where the
mean liability of the two individuals exceeds x*'. Suppose a
proportion w is ascertained and a proportion c of these practise
x m
selective abortion but without reproductive compensation. The method
of calculation of the change in disease incidence is very similar to
the case when there is reproductive compensation. As in the latter
case the proportion of the offspring of couples not practising
selective abortion who are affected is
2 r*
P + zh f-zs + w c (zs P - J2z ]f xm fx x
Similarly the proportion of offspring of couples practising selective
abortion who are affected and therefore aborted is
2 ( 2 2 2
P + zh [ = P[l+ [2aa^h -a h~Psf]. Offspring of couples
not practising selective abortion therefore make up a
. o 2 2
proportion 1-w c P Fl - P(l+ t2aa h -ah Ps_)] of all offspring.
x m x' x x
1-w c P P(l+ IZaa' h2-a2h2Ps )
x m x M x f
Since P is very small this approximates to 1 - w c P . Couples
x m x
practising selective abortion have no affected offspring therefore
the change in disease incidence is approximately the same as that
when there is reproductive compensation.
The net change is approximately
2 f" —
-w c PP [l + ah (-aPs. + 4 2a )]
x m x f x
- retrospective
Suppose a proportion w^ of couples who have had an affected child
is ascertained and of these a proportion c practise selective abortion
m
of affected fetuses but without reproductive compensation. As above
the method of calculation is similar to that when there is reproductive
compensation. If P is the proportion of affected individuals born
rm
after the first affected child in the family then with selective
abortion without reproductive compensation the disease incidence is
2 2 2
approximately (1-w c P )(P-a"p"h s^) _ „ _
i .V-S-S. ) ? (l-» c P XP-.Vh .,)1-w c P (P-a^p^h^s.) x m rm f
x m rm f
The approximate net change in disease incidence due to the practice
2 2 2
is therefore -w c P (P-a p'h s^)
x ta rm f
DISEASES OF LATER ONSET
The differences between the changes in disease incidence and
gene frequency for diseases of onset age (a) and for those of onset
ages (bf c) are basically the same for diseases of all modes of
inheritance. All classes of disease are therefore discussed together
here.
ONSET AGE (b)
The formulae for the changes are the same as those for diseases
of onset age (a). However if ascertainment is retrospective the
proportion of offspring born after the first affected child has been
diagnosed may be quite small. This proportion rather than P
r
(or P ) determines the changes in disease incidence and gene frequency,
rm
ONSET AGE <c)
The formulae for the changes in disease incidence and gene frequency
are the same as those for diseases of onset age (a) with s^ = 0.
This is because it is assumed that individuals destined to become
affected, only after they have completed their family, have normal
reproductive fitness. Retrospective ascertainment of couples at
risk depends on the detection of a child who is destined to become
affected only much later on in adult life. It is unlikely that many
such children would be ascertained and therefore the effect of this
practice would be slight. Similarly the effect of family limitation
by sibs of affected individuals would be small. Most of these
individuals would not be ascertained until their sib actually became
affected by which time many of them would have completed their family.
Hie proportion of carriers of the deleterious allele (in AD
diseases) or of carrier males (in XR diseases) who are ascertained
might be quite small unless there is a sensitive test to detect
preclinical cases. This would reduce any effect of AI in AD and
XR diseases and of family limitation and selective abortion in AD
diseases. For MF diseases, the proportion of individuals at high
liability ascertained before they have offspring, is dependent on
the age at which liability to the disease can be measured.
APPENDIX 2
FAMILY SIZE DISTRIBUTION
Figures from the British 1961 Census can be used to obtain an
estimate of the distribution of completed family size. From
Table 11(i) of the Summary Tables of the Census the proportions of
married women having families of different sizes were calculated for
women of seven age groups. These were, less than 20, 20-24,
25-29 40-44 and 45-49. The proportions for the last
four groups did not differ significantly from each other so the
figures for women aged 30-49 were pooled to obtain estimates of the
values of F (the frequency of families of size s in the population).
The values obtained are tabulated in Table A2.1 and shown in the
histogram (Figure A2.1).
Table A2.1
















Figure A2.1 Percentage of married women aged 30-49







AUTOSOMAL RECESSIVE DISEASES WITH HETEROZTOOTE ADVANTAGE
In this appendix formulae are given for changes in disease
incidence and gene frequency for AR diseases with heterozygote
advantage. The method of derivation is very similar to that for
diseases where there is no heterozygote advantage and so only a
brief outline of the method is shown here. The complete set of
formulae is given in Table A3.1. As an example of a disease in a
population where there is heterozygote advantage possible changes
have been calculated for sickle cell anaemia in African populations.
The results are plotted in Figures A3.1 and A3.2.
Method of derivation
Assume as in section (6) that the genotypes have Hardy-Weinberg
frequencies at birth. Let the coefficients of selection against





Frequency at birth p 2pq q
Fitness 1—s . 1 1-sAA aa
If there is random mating the mating types have frequencies and
fitnesses as follows:-






































(i) Disease Incidence The approximate incidence of aa individuals
amongst the offspring is
2 2 . 3„ . A 4 .2 2., .2
p q + 2pq (1-s ) + q (1-s ) q (1-s q)
HH' —* at*
„ 2 2.2 ,, 2.2
AAP " 'a." > AAP '
The change in disease incidence between parental and offspring gener¬
ations due to natural selection is therefore approximately
2 2




(ii) Gene frequency The frequency of a in the parental generation
2 "
at reproduction is approximately q~ aaq
W"SAAp2>
After selection the frequency of a in the offspring generation at
reproduction is approximately
q2(l-s )(l-s q)2 + pq (l-s^pHl-.^q)
1"3BAAp2
The change in gene frequency between parental and offspring generations
due to natural selection is therefore approximately
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Similarly changes in disease incidence and gene frequency can be
calculated for the various practices studied and the above changes
subtracted to obtain the net effect of a particular practice. The
results are given in Table A3.1.
Sickle cell anaemia in Africa
Falconer (1960) has calculated that in parts of Africa the
frequency of the sickle cell gene is about 0.2 and that the coefficients
of selection against normal and affected homozygotes are approximately
0.2 and 0.75. Possible net changes in disease incidence and gene
frequency can be calculated by substituting p= 0.8, q = 0.2, s = 0.2
AA
and s - 0.75 into the formulae in Table A3.1. The results are
aa
plotted in Figures A3.1 and A3.2 and are discussed in section (6).
Figure A3.1 The effect of various practices on the
incidence of an autosomal recessive disease
where there is heterozygote advantage
e.g. sickle cell anaemia in Africa.
Absclssa:-
Change in fitness of affected individuals (l)
Proportionate reduction in fertility <4, 5, 6)
Proportion adopting practice (2, 3, 7, 8, 9)
Netchangeindiseaseincid nce(perc ntq2) I en
Figure A3.2 The effect of various practices on the
frequency of an autosomal recessive gene
where there is heterozygote advantage
e.g. sickle cell anaemia in Africa.
Abscissa
Change in fitness of affected Individuals (1)
Proportionate reduction in fertility (4, 5, 6)
Proportion adopting practice (2, 3, 7, 8, 9)
Netchangeingfrequency(perc nt2)
APPENDIX 4
THE JOINT EFFECT OF IMPROVED TREATMENT AND OTHER PRACTICES ON THE
FREQUENCY OF AR AND XR GENES
Hie joint effect on gene frequency of improved treatment and one
or more of the other practices is not simply the sum of the individual
effects. This is because the other practices cause a reduction in
the number of affected individuals born and hence there are fewer
individuals who can benefit from the treatment. The joint effect
can however easily be calculated using the formulae derived in
section (5) and appendix (1). The change resulting from improved
treatment is calculated for the particular value of s'. This is
then added to the changes calculated for the other practices when s^
is replaced by (s^-s^) in the formulae.
Fbr example for AR diseases the joint effect of an increase in
the fitness of affected individuals and a simultaneous voluntary
CoiApWs
reduction in the fertility of heterozygous carriers would be a change
2 2
in gene frequency of q s • - q*"w c f* (2-s +s' ).
aa m m m aa aa
If s = 0.9 as in section (6) there would be no net change in
aa
gene freauency if w c f * = saa
m m m ~ r-
1.1 + s•
aa
Substituting in the above formula it can be calculated that if
s* =0.9 (affected individuals have normal fitness) there would have
aa
CO'-k-pl e-S
to be a 45 percent reduction in the fertility of heterozygous oarriers
to prevent an increase in gene frequency. If s' =0.1 only a
aa
9 percent reduction in fertility would be required. As an example for
XR diseases consider the effect on gene frequency of improved treatment
and selective abortion of affected male fetuses without reproductive
compensation.
The Joint effect is given by ^qs1 - ■|qw c (1-s +s')3 ft 3 n B Ad
If • ss 0.9 there would be no net change In gene frequency If
If s' = 0.9 there would be an increase in gene frequency unless about
A
90 percent of carrier females selectively aborted affected male fetuses.
If s* = 0.1 the corresponding value would be 50 percent.
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Individuals at Risk in Families with Genetic Disease
CHARLES SMITH, SUSAN HOLLOWAY, and ALAN E. H. EMERY
From the University Department of Human Genetics, Western General Hospital, Edinburgh
With the control of many infectious diseases and
improvement in medical care, there have been
dramatic changes in the pattern of mortality and
morbidity in society. As a result, genetic diseases
have been increased in their relative importance in
the population. For example, Roberts, Chavez,
and Court (1970) have found in hospital deaths
among children that genetic conditions were
directly or indirectly involved in over 40% of cases.
Since the liability to genetic disease is inherited and
intrinsic to the individual and to his family, rather
than acquired or extrinsic as for non-genetic
diseases, quite different systems of prevention and
control are required. To some extent, these sys¬
tems will require new departures from the estab¬
lished methods of medical practice.
Until recently the main application of medical
genetics has been in counselling the parents of
affected children. The possibility of extending the
scope for application has been examined recently.
Fraser and Motulsky (1968) estimated what propor¬
tion of cases of genetic disease might be prevented,
and Smith (1970) has examined the value of different
routes of prevention and the possibility of a genetic
register system. McKusick (1969) has also discussed
a medical record system for family follow-up in the
detection and early treatment of cases of genetic dis¬
ease. In a previous study (Emery and Smith, 1970),
it was shown that only a small proportion of individ¬
uals 'at risk' of having affected children were in fact
referred specifically for genetic counselling. Many
were referred only after the birth of an affected
child which otherwise could have been prevented.
These results confirmed the need for a genetic
register system in preventing genetic disease.
The object of this paper is to outline our experi¬
ences in recording and storing relevant data on fami¬
lies with genetic disease and in assessing risks to
various members of the family. Details of the
procedure used and a summary and interpretation of
the data collected so far are presented.
Methods and Material
Assessment of Risks. Roberts (1962) grouped
genetic diseases into those with a high risk of recurrence
(greater than 1 in 10) and those with a low risk of rec-
currence (less than 1 in 20). This convention is now
generally accepted and is adopted here. Thus, an in¬
dividual was defined to be 'at risk' if he had a greater than
10% risk (1) of becoming affected or (2) of having affected
children or children who will be 'at risk'. Those un¬
likely to have children in the future either due to their
disease condition or due to their age (over 40 years) are
excluded from category 2.
The methods of assessing the risks to family members
are best described from some examples (Fig. 1).
In family A with an autosomal recessive (AR) con¬
dition, the mother was the first contact. She came
for counselling retrospectively, ie, after the birth of her
Received March 8 1971.
Fig. 1.
text).
Pedigrees illustrating the methods of assessing risks (see
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affected son, the proband. The risk of the next
child being affected is high (25%) and this risk is allo¬
cated to the mother. There are no others at risk in the
family.
In family B, suppose the autosomal dominant (AD)
condition is Huntington's chorea. From a cumulative
graph by onset age of cases of this disease (Emery, 1969),
the risks of becoming affected are about 40% for the
mother and 20% for the son; the risks of having children
with the abnormal gene are then 20% and 10% re¬
spectively, so both are deemed to be also at risk of having
children who may become affected. Since the mother
(II. 1) has been known to be at risk since her father's
diagnosis some 10 years ago the birth of her 'at risk' son
could have been prevented.
A more complex case (family C) is illustrated for an
X-linked recessive (XR) condition, eg, Duchenne muscu¬
lar dystrophy. With two affected sons, the mother is a
definite carrier. The risks of her next having an
affected boy or carrier daughter are each 25%. These
risks have been summed in the XR conditions so that the
combined risk in this case is taken as 50%. Similarly
the daughter (III.2) is taken to be at risk since she has a
50% chance of being a carrier. Assuming the proband
was diagnosed early, the birth of his affected brother
(III.3) might have been prevented. Is the contact's
sister (II.4) at risk? The probability that the grand¬
mother (1.2) is a carrier is 33%, so the sister (II.4) has a
17 % chance of being a carrier. Her risk of having an
affected son or a carrier daughter is thus 18%. Further
information on her carrier status could be obtained by a
serum creatine kinase test (eg, Fig. 2) leading to a more
precise estimate of her risk (see Emery, 1969).
Material. The families studied were from either the
Edinburgh or the Manchester region during 1965-70.
Many of the families were referred for genetic counsel¬
ling, but some were seen for other reasons: diagnosis,
teaching purposes, or research work. Some of the
families were traced from hospital or health department
records or through members of certain societies (eg,
Muscular Dystrophy Group). The kinds and frequency
of the diseases studied thus reflect the work and interests
of this Department rather than the spectrum of genetic
disease in the population. No attempt was made to
ascertain all cases of genetic disease in a region so that
this is essentially a study of ascertained families rather
than a population study.
Details about the family were usually obtained from
the first person to be seen in the family, the first con¬
tact. This verbal report about the pedigree and the
ages and disease status of family members provided
most of the information on which the following analyses
are based. To systematize the form of information
collected, a special record card was designed (Fig. 2)
and this was used for coding and punching the data on
punch cards. Details on name, address, general prac¬
titioner, etc were recorded. At examination the
clinician gave a summary of the clinical report and
findings, filled in other relevant details and circled the
appropriate responses. Each family was allocated a
separate family number. Separate cards were completed
for any further members of the family who were judged
to be at risk. A special two-part disease code was de¬
veloped but, to conform with common usage, the Inter¬
national Disease Classification (with an additional 5th
digit to allow for discrimination between different
genetic conditions) will be used in future. A second
disease category was available, to record associations
of different diseases in one family. The remainder of
the first side of the card dealt with details on sex, dates of
birth, details of the visit, and the mode of referral.
On the reverse side of the card (Fig. 2 below), the
pedigree and further details were recorded as shown.
NAME
FAMILY
few* II lJ DIAGNOSIS: li Mn.n! 1 oq Muscular . ,,H 1'
210 Main Street,
Bdinburgh, 4.
H0SP. NO. " 17 307,0 VISIT DATE WHY WHERE SEEN BY•u ^inl2
D.of B. " 1 5 0714 6 1 '
D.ofB. OF PARENTS 2
FATHER 1920 2p 3
MOTHER 1925 2,5 4
REFERRAL JG.P. 2) Con li. 3) •1,
Always good health. No »iacai-riagesNo muscle weakness
Allstalr KcRoberts (brother)
Died 1969. Diag. Duchenne K.D. 1959 (RHSC. 170656)
John Kerr (nephew)
b. 3.2.66.
Diag. Duchenne K.D. 1970 (W.3.H. 20531)





•{jj)CounMl. 2) R... 3) D,ofl. 4)
. OERlffflWGH 3) RHSC 4)MRI 51B.H
Mrs. I. KcRoberts(45) CPU = 90.5 IF.tf,.,""wp:
Kre. J. Dewar (25) CFK = 42.0 l.U.(Proh=










ATTITUDE: 0) A'V 3'
NO. OF RELATIVES AT HIGH RISK
"^THT
ADVICE: 1) TAKEN 7) NOT TAKEN
I. 51 A.I.D. 6) Adopt. 7)
Fig. 2. Example of a completed family record card. The details
are purely fictitious and are used only for illustration.
These included social class (5 groups); marital status
(not married, married with no children, married with
children); consanguinity (none, mild, close); status
(affected, no risk, high risk, medium risk, low risk);
number of first-degree relatives affected; relationship of
the proband; mode of inheritance; risk of having an
affected child (high, medium, low—and as a percentage);
and whether the record was made before (prospective)
or after (retrospective) the birth of an affected or 'at risk'
child to the individual concerned.
If the person was counselled, the advice given was
noted, together with any method of family limitation
advised and the person's attitude to the counselling.
Finally, for the first contact in the family, the number and
relationship codes of relatives at risk were recorded.
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Further columns were left for any revision of the risks
and for details of follow-up.
The information obtained on the families was not al¬
ways complete because the cards for relatives at risk were
prepared from the information given by the first contact
at interview. Moreover some of the families were
ascertained before the present recording scheme was
developed, so past files had to be used and these were
often incomplete. This may have led to some under¬
estimation of the numbers affected and at risk, for only
recorded information could be used. For analysis on a
particular topic all data available on that topic were used.
Almost all families ascertained were included in the
analysis. These included conditions that were either not
serious or not genetic or whose nature was not resolved,
and form the 'other' category in Table I. The term
'multifactorial inheritance' in Table I refers to familial
diseases which are possibly due to many loci plus the
effects of environment and include some of the con¬
genital malformations, diabetes mellitus, and schizo¬
phrenia (Carter, 1969).
Results
Families. Reasons for ascertainment and other
details about the families studied are given in the
series of histograms in Fig. 3. Over half of the
families were referred for genetic counselling and
the rest mainly for diagnosis or research. The
chief source of families referred was the hospital
consultant who contributed almost two thirds of the
total. Most of the remainder were referred directly
by the family's general practitioner. The distri¬
bution of the families by social class, though not
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Fig. 3. Distributions of families and of first contacts (for serious genetic conditions) by various classifications of the data.
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population (1961 Census) because of age and other
differences, shows an apparent excess of families in
social classes 1 and 4 and a corresponding deficit in
class 3. However all social classes are well repre¬
sented in the families ascertained.
First Contacts. The remaining histograms in
Fig. 3 refer specifically to the first contact in each
family. Most of these were either the affected pro¬
band (usually in families referred for diagnosis or
research) or the proband was the child of the first
contact (usually in families referred for genetic
counselling). This indicated that few other rela¬
tives in affected families were referred about their
possible risk (c/, Fig. 6). The age distribution of
first contacts shows that they were largely in the
reproductive age groups. This reflects concern
about their risks of having affected children and
about affected children born. Two thirds of the
contacts at risk of having affected children were seen
retrospectively, that is after the birth of an affected
or at risk child. Among first contacts who were
married and at risk of having affected children, al¬
most 40% had no children (MNC) or had only
affected children (MAC) so far. Genetic counselling
was thus very relevant to them at this stage in their
family life.
Risks and Mode of Inheritance. A tabulation
by mode of inheritance of the numbers affected and
the numbers at risk is given in Table I. In some
114 of the families recorded, the disease was not
serious or judged to be not genetic. No further
persons in these families were considered to be at
risk. Among the families with chromosomal ab¬
normalities or with multifactorial inherited condi¬
tions, there were relatively few persons at risk. By
contrast, for diseases inherited in a simple Mendelian
manner, a high proportion of the families had per¬
sons at risk; autosomal dominant (AD) 90%, auto¬
somal recessive (AR) 53%, X-linked recessive
(XR) 84%- This confirms theoretical calculations
(Smith, 1970) that preventive methods will be most
effective for the simply inherited genetic diseases.
The numbers affected reflect the burden of the
genetic conditions on these families. There was an
average of over three persons affected per family for
the AD conditions, two persons for the XR con¬
ditions, and about 1 -5 persons for the AR and multi¬
factorial conditions. Moreover, the burden to the
family is a continuing one in that a high proportion
(over two thirds) of the affected persons are still
alive.
The future prospects for these families are also
serious because many have further members at risk
either of becoming affected themselves or of having
affected children. The distribution of the num¬
bers at risk is shown in Fig. 4. Half the families
with persons at risk had more than one member at
risk and some families had many members at risk.
In Table I, the three categories listed under 'number
at risk' are mutually exclusive so their total indicates
the total number at risk in these families. This
averages 4-0 persons for AD conditions, 3-5 persons
TABLE I
MODE OF INHERITANCE OF NUMBERS AFFECTED AND NUMBERS AT RISK IN
559 FAMILIES ASCERTAINED
Serious Genetic Conditions
Mode of Inheritance Others*
Autosomal Autosomal X-linked Multi¬ Chromo¬
Dominant Recessive Recessivef factorial somal
Families
Number 124 112 102 78 29 114
Number with someone at riskifc 111 59 86 18 2 0
Persons
Number affected
All 361 157 198 113 32 90
Alive 255 119 137 68 24 72
Number at risk
Only of becoming affected 39 5 15 4 0 0
Both of becoming affected and of having
affected children** 239 0 15 2 0 0
Only of having affected children* *»ff 158 54 272 16 2 0
Births since 1960 at risk a priori
Number of children
Affected 23 14 21 3 0 0
At riskft 77 2 77 3 0 0
Not at risk 8 15 12 1 0 0
* Not serious, not resolved, not genetic, f 93 Families with muscular dystrophy. $ Risk 10% or higher. ** Persons
under age 40. ft Includes carrier daughters in X-linked disorders. (For other details see text.)
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Fig. 4. Distribution of families by the number of persons at risk.
for XR conditions, and about one person for AR and
multifactorial conditions.
Individuals at Risk. People at risk of be¬
coming affected were largely in families with AD
conditions with late onset (Table I), where a parent
becomes affected after his children (and even grand¬
children) have been born. With increasing age the
risks to the children (if still unaffected), and to the
grandchildren, will gradually fall. These patterns
are reflected in the distribution by age of the num¬
bers at risk of becoming affected (Fig. 5).
predominate. The distribution of the risks also
changes with age (x2 = 35, p< 0-001) with the pro¬
portion in the highest risk category increasing with
age. This was largely because such high risks
occur firstly, in AD conditions when the person is
diagnosed as affected and onset is often late and
secondly, in XR conditions when a mother is proven
to be a carrier after the birth of an affected son.
TABLE II
NUMBERS, BY AGE AND RISK, OF

















The distribution by relationship of the proband
to those at risk in the family is given in Fig. 6.
There is a strong contrast with the equivalent dis¬
tribution for first contacts (Fig. 3). This demon¬
strates that many kinds of relatives who are at high
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Fig. 5. Distribution by age of persons at risk of becoming affected.
For individuals at risk of having affected children
or children at risk, all three simple modes of in¬
heritance (AD, AR, and XR) were involved, al¬
though the AD-inherited conditions again
predominated. The distribution of risks by age is
given in Table II. The risks fall naturally into 3
groups ; at about 50%, at around 25%, and from 10
to 19%. The latter group represent only 14% of
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Fig. 6. Distribution of persons at risk of having affected children,
by relationship of the proband.
Births at Risk a priori. The results for children
born since 1960 to parents who where at risk a priori
of having affected children confirm the risks in¬
volved. Of 256 births in this category, some 61
(24%) of the children were affected while a further
159 (61%), though normal so far, are still at risk of
becoming affected themselves or of having affected
children.
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Discussion
In this department a genetic register system is
being developed and is referred to by the acronym
'RAPID' (Register for the Ascertainment and Pre¬
vention of Inherited Disease). Here we report re¬
sults for the initial stage of developmentof theregister,
using some 559 ascertained families. The objec¬
tives in this stage were (1) to gain experience in re¬
cording and handling family data and in assessing
risks to family members and (2) to examine the need
and scope for a preventive system in practice. Our
results clearly show the area where preventive
effort can be best applied and justify the imple¬
mentation of a genetic register system in practice.
The main scope for preventing genetic disease
lies, at present, with the simply inherited diseases
despite the fact that other diseases are much more
frequent in the population. This is because the
proportion of individuals at risk is greater, and the
risks are higher in families with simply inherited
conditions than in families with multifactorial or
chromosomal disorders. Thus it is proposed that
preventive effort should be largely restricted, at
least initially, to the simply inherited conditions.
Thus we have defined a discrete problem area which
should give worthwhile returns for any resources
committed. However, it should be emphasized
that even for the simply inherited disorders, it will
be possible to prevent only a proportion of cases,
since some will occur in families which have not
been ascertained previously (Smith, 1970).
In the 338 families with simply inherited con¬
ditions, there were some 716 affected individuals, of
whom 511 are still alive. This emphasizes the past
and continuing burdens on these families and their
need for medical care and supervision. Moreover,
and perhaps more disconcerting, is the fact that the
burden in these families is likely to increase in that
there are some 797 individuals still at risk, either of
becoming affected themselves or of having children
who may be affected. This shows the need for
genetic counselling and supervision to be extended
to all family members at risk (Fig. 6), rather than
only to the first contact in the family. That is, the
initiative in prevention should be undertaken as a
health service, rather than left to the individual who
may be unaware of his risk. This point was stressed
in a previous study (Emery and Smith, 1970) where
it was shown that only a small proportion (14%) of
those at risk was referred for genetic counselling.
There is at present no defined procedure or re¬
sponsibility for tracing and counselling individuals
known to be at risk. Herein lies the value of a
genetic register system.
The development of the RAPID system is now
proceeding in several areas. One is to follow-up
individuals who have been counselled, to keep in
touch with the family, and to assess the value of the
counselling methods in preventing genetic disease.
Another is to develop procedures for contacting and
counselling others at risk in the family, working al¬
ways through the general practitioner of the person
concerned. To extend the system to a population
basis, methods and sources for ascertaining families
with simply inherited genetic disease are being ex¬
amined. Through linkage with hospital, GP, health
department, and other records, relevant families will
be screened for investigation and counselling. The
data storage and handling operations are being
organized around a computer, and much of the sys¬
tem software has been written. The procedures
include data vetting, monitoring, listing, updating,
scheduling for follow-up, and other items. Several
hurdles are foreseen. Among them are the geo¬
graphical dispersion of family members, security of
data on file, the privacy of the individual, the atti¬
tude of healthy individuals to possible genetic
risks, the effectiveness of counselling, and the
organizational details required to make the register
an effective preventive system.
Summary
This report concerns data on 559 families with
genetic disease referred for genetic counselling,
diagnosis or research. It summarizes our work on
the initial stages in the development of a genetic
register system (RAPID) for the ascertainment and
prevention of genetic disease. The procedures for
assessing risks to individuals in ascertained families
are described, and methods of recording and handl¬
ing the relevant family records and details on indi¬
viduals 'at risk' are also shown.
Data are presented on reasons and routes of re¬
ferral and on social class of the families ascertained
and on the age, marital status, risk etc of individuals
referred. In the 559 families studied there were
951 affected individuals (of whom 70% were still
alive) and some 821 individuals who were judged to
be at risk themselves or at risk of having affected
children. The analyses confirm the need for a gene¬
tic register system in practice and show that the
simply inherited genetic diseases offer the best scope
in prevention.
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Equilibrium Frequencies in X-linked Recessive Disease
Susan M. Holloway1 and Charles Smith1
Haldane's [1] formula for the equilibrium frequency of rare X-linked recessive
diseases maintained by mutation can be extended to cover a wide variety of
situations in genetic counseling, antenatal diagnosis, and eugenic consequences
of different medical practices. Some of these have been considered already [2-4]
but the studies have dealt with the effects of changing one factor at a time. In
this paper, formulas are developed so that the net effect of any combined set of
factors can be considered, in order to study the balance among different factors
and their combined equilibria. The initial sections of the paper introduce the
form of the procedure for simple cases; then the methods are generalized to take
into account several variables concurrently. Finally, the use of the formulas is
illustrated and discussed.
simple equilibria
To introduce the methods and notation used (see Appendix), simple cases
dealing with survival rates of affected males and reproductive practices of affected
males and carrier females are considered. Let M and F be the equilibrium fre¬
quencies at birth of affected males and carrier females, respectively. Let the relative
reproductive fitness (number of offspring born relative to the number of offspring
born from normal individuals) of affected males and of carrier females be m and
/, respectively. Note that this deals with the actual or achieved fertility, rather
than with the potential fertility, genetic or otherwise.
Affected males are either the result of a new mutation or are the offspring of
carrier females (half of whose sons are affected). Then, if fju is the mutation
rate per gamete,
M = n + Ff/2. (1)
Similarly, carrier females can arise by a new mutation (in either gamete), from
carrier mothers (half their daughters are carriers), or from affected males (all
daughters are carriers), so
F = 2[x -f- Fj/2 -)- Mm. (2)
The equilibrium frequencies can then be found, in terms of the mutation rate (/jl),
by substituting equation (1) in (2) and solving for F, giving
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and similarly for M.
These formulas can deal with changes in the fitness of affected males and carrier
females as a result of genetic counseling or through improved treatment or survival
of affected males. For example, if the fitness of affected males became 0.5 and
that of carrier females was 0.8, then from equations (1) and (3) the equilibrium
frequencies of affected males and carrier females would be 3.5 /x and 6.3 /x,
respectively.
The formulas can be extended to deal with different mutation rates in males
(/x,„) and females (/x/). The contribution of mutation to M is /tx/ and to F is
(jim /if). The solution for F then becomes [/Um fxf( 1 -|- WQ]/[1 — (//2) (1 +
m) ], and similarly for M.
In practice, many other factors are likely to affect the net reproductive fitness
of affected males and carrier females, so that the equilibrium frequency will
usually be a complex function of several factors. Each of these will first be con¬
sidered separately. Then the joint effect of the different factors will be considered,
and general expressions from which the complex equilibria can be calculated will
be derived.
Stage of Detection
If there is a previous family history of a disease or if carrier tests are available,
carriers may be detected before any affected offspring are born. Following Fraser
[2], this will be called prospective detection. However, most carriers of X-linked
conditions will be detected only after the birth (or diagnosis) of an affected son;
that is, detection is retrospective. Note that a proportion of carrier females will
remain undetected since they have no affected offspring.
Among all carriers not detected prospectively, the proportion of cases born (or
preventable) after the first case can be derived as follows. With family size n, an
average of n/4 affected sons is expected. In a proportion (3/4)" of families of
carrier females, there will be no affected sons. In the remainder [1 — (3/4)"],
there will be at least one affected son, the first case in the family. Thus, the pro¬
portion of first cases among all cases in families of size n from carrier females is
as shown by Fraser [5]. Table 1 illustrates this result for families of size three.
The proportion of first cases among all affected is 37/48, which is equal to z„ for
n = 3. The proportion of cases born after the first case is, of course, (1 — zn).
Since z„ is dependent on family size (n), the distribution of family size in the
population must be taken into account. Fraser [5] has evaluated the weighted
mean value (z) for different distributions of family size. For example, for a Poisson
COMPLEX EQUILIBRIA
zn = [1 - (3/4)»]/(b/4) (4)
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TABLE 1
Proportion op First Cases in Families of Size Three
No. Normal
Family Order Frequency No. First No. Born before Total Normal
1-2-3 (X 64) Cases Affected First Case Born
NNN* 27 0 0 3 3
NNA 9 1 1 2 2
NAN 9 1 1 1 2
ANN 9 1 1 0 2
NAA l 1 2 1 1
ANA 3 1 2 0 1
AAN 3 1 2 0 1
AAA 1 1 3 0 0
Total 64 37 48 111 144
* N — normal; A = affected.
distribution with mean family sizes of two and three, the proportions of first cases
among all cases are 79% and 70%, respectively. With the negative binomial, the
other distribution commonly used to describe distribution of family size, the figures
are somewhat higher [S].
It can be shown that z also measures the proportion of normal individuals born
before the first case. For example, in table 1 this proportion is 111/144. The
quantity z also gives the average fitness of carrier females if they have no further
children after the first case in their family.
Reproductive Fitness
The relative fitness of carrier females will depend on their reproductive practices
after detection. Some may terminate their family, others may have normal family
size, and still others may compensate for the birth of affected children. A propor¬
tion of all carrier females in the population will not be detected, and these are
assumed to have normal family size. This group is included implicitly in all the
results derived below.
Carrier females who are detected prospectively may have no children and will
have a zero fitness. Any who partially restrict their family after detection will have
a fitness of less than one, while those who go on to have their normal family size
will have a fitness of one. Those terminating their families after the birth of an
affected child will have a mean fitness of z.
Some carrier females may compensate for the birth of a affected children so as
to have the intended number n of normal children, so-called full reproductive
compensation. The total number of children born will be (a + »). The ratio
a/(a % n) will be equal to p, the segregation ratio, so n = a(l — p)/p. The mean
fitness for such carrier females is then (a -f- n)/n, which is equal to 1/(1 —p);
this result holds for any family size.
Some carrier females may wish for the intended number of living children. If a
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proportion d of affected children do not survive, the total number of children born
will be (n-\-ad). By repeating the above argument, the fitness of such carrier
females can be shown to be 1/(1 — dp).
Selective Abortion
To deal with selective abortion, the class of offspring selectively aborted must
be considered. Various classes of offspring could be selectively aborted: (1) affected
males, (2) all males, or (3) affected males and carrier females. Consider the repro¬
ductive fitness /* of carrier females detected prospectively, measured in terms of
number of offspring conceived (omitting natural abortions). The observed fitness
/, in terms of numbers born, is then
/ — (xnf Xnm -f- %CF 4" %AM)/4, (5)
where xNF) xCf, and xAm refer, respectively, to the proportions born of normal
females, normal males, carrier females, and affected males conceived. Thus the
value of /* can be derived. Similarly for affected males, female offspring (all
carriers) could be selectively aborted. The observed fitness m in terms of offspring
born is then
m — m*(2yNM + 2yOJ?)/4, (6)
where ynu and ycF are the proportions born of normal males and carrier females
conceived.
If the family is detected retrospectively, a proportion z of offspring will be born
before detection, as shown in the previous section. The observed fitness / of carrier
females in terms of offspring born then becomes
j — z -f- (/* — z) (xNF -f- Xnm + %cf + ^ir)/4. (7)
Combined Equilibria
All the factors considered above can now be combined into a single set of
formulas covering a wide range of situations and can deal with the various factors
either singly or in combination.
As discussed earlier, all carrier females are unlikely to adopt the same reproduc¬
tive practices after detection. To deal with this, let the subscript i refer to the 7th
group of carrier females who make up a proportion Pt of all carrier females.
Similarly, let the subscript j and Pj refer to a particular group of affected males.
The procedure then is to calculate, for each group i, the fitness /*» in terms of con¬
ceptions (given the observed fitness /»in terms of births) and to weight the values
according to the proportion in the group. The equilibrium frequencies can then be
written as for equations (1) and (2), namely,
M = fx -|—— 2 Pi\Zi (/*j — Z^XamJ ; (8)2 x
-p
F = 2/J, / X Pi [zj + (/*i — Zi) xCF ] + M 2 PjinjycFj- (9)2 1 2
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By substituting in these formulas, the equilibrium frequencies can be easily derived.
If there is no selective abortion, then /% = /,, and all x and y — 1. The formulas
can be extended to deal with different mutation rates in males and females as before.
Application
To illustrate an application of the previous sections, consider a rather complex
case—deriving the equilibrium frequency for an X-linked condition, say hemophilia.
Affected males now tend to survive longer and may have more offspring than previ¬
ously. Genetic counseling is available, and carrier tests and accurate diagnosis can
be made. Selective abortion of males from carrier females and of daughters of
affected males is also possible and may be used in a proportion of families.
Details of an example are given in tables 2 and 3. Among affected males, suppose
10 % do not survive to reproduction, a further 20% have no offspring, and 60%
have normal fitness. Suppose the final 10% of the affected males opt for selective
abortion of their female offspring, half with no reproductive compensation and half
with full reproductive compensation. However, since affected males do not pass
X-linked genes to their sons and, using selective abortion, have no daughters, their
actual fitness in this case need not be considered.
Among carrier females, those detected prospectively and those detected retro¬
spectively must be treated separately (table 3). For prospective detection the
details are similar to those for affected males. If carrier females terminate their
family retrospectively, their average fitness (z) will be about 70%-80%, as dis¬
cussed earlier. If they use selective abortion of males but have the normal number
of pregnancies, the relative fitness for conceptions (/*) will be 1.0, and for offspring
born (/) it will be 0.88. With selective abortion of males and normal family size,
the fitness for numbers born (/) will be 1.0. The fitness for numbers conceived
(/*) is then given by / = 1.0 = 0.75 + (/* — 0.75) (1 + 1 + 0 + 0)/4, so that
j* is 1.25. With selective abortion of males and a full family (n) of unaffected
TABLE 2
Possible Reproductive Practices for Affected Males Showing
Proportion and Fitness for Each Type
Relative Fitness
Proportion No. Born No. Conceived
Affected Males (/>,.) (m.) (»«*,.)
Not surviving 0.10 0 0
No offspring 0.20 0 0
Normal family size 0.60 1.0 1.0
Selective abortion of female offspring 0.05 0.5 1.0
(n offspring conceived)
Selective abortion of female offspring 0.05 1.0 2.0
(» offspring born)
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TABLE 3
Possible Reproductive Practices for Carrier Females Showing
Proportion and Fitness for Each Type
A. Detection
Detection of Carrier Females
Prospective Retrospective
Proportion 0.20





Prospective No. No. Retrospective No. No.
Reproductive Practice Proportions Born Conceived Proportions Born Conceived
after Detection (Ft) (/,) (/'%) (/',) (/,) (/*<)
No further offspring 0.30 0 0 0.40 0.75 0.75
Normal family size 0.10 1.0 1.0 0.10 1.0 1.0
(re offspring born)
Selective abortion of males . 0.40 0.5 1.0 0.25 0.88 1.0
(re offspring conceived)
Selective abortion of males . .. 0.10 1.0 2.0 0.10 1.0 1.25
(re offspring born)
Selective abortion of males . . . 0.10 1.0 2.0 0.15 1.19 1.63
(re unaffected offspring born)
children, the relative fitness for offspring born (/) is equal to 1 + z/4, since one-
fourth of the children at detection will be affected, and the relative fitness for
offspring conceived (/*) is 1.63.
The values in tables 2 and 3 can be substituted directly in equations (8) and
(9) to derive the equilibrium frequencies. These were found to be 3.7 /x for males
and 8.4 /x for females. A computer program was written to derive the equilibrium
frequencies for any set of variables studied and is available on request.
Relative Importance of Factors
One reason for trying to combine various factors affecting an equilibrium was
to study their relative effects and to see where opposing forces would balance. A
large variety of comparisons could be made using the above procedures, but only
a few cases of special interest are considered here.
In the absence of selective abortion, the critical factor in determining the
equilibria is the average fitness of carrier females, and similarly the average fitness
of affected males. Thus, the combined effects of any group of fitnesses can be simply
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summarized by taking the average fitness for the group and substituting in equa¬
tion (3) to get the equilibrium frequency.
With selective abortion, the type of offspring born, as well as their number,
must be considered. So the average fitness does not summarize the effects of the
various factors, and the full procedure as summarized by equations (7), (8), and
(9) must be used. The effects of selective abortion with full reproductive compen¬
sation are of special interest, for these could theoretically give rise to a continuous
increase in frequency with time. However, this is unlikely in practice, for there
are other factors with balancing effects. The effects of a proportion of carriers
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Fig. 1.—Equilibria from selective abortion of all males from carrier females following de¬
tection. (Affected males do not reproduce.) Solid line — prospective detection; broken line =
retrospective detection; (z = 0.7).
increases the equilibrium frequency in each case falls. Case a shows the extreme
situation with prospective detection and full reproductive compensation. If only a
small proportion of detected carriers have no children, the frequency will not rise
continuously but will reach a new, though elevated, equilibrium value.
With retrospective detection and full reproductive compensation (case b), much
lower equilibrium frequencies are expected. However, a reduction in the number
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of births from detected carriers will be expected in practice, since with selective
abortion of males, two pregnancies are required on average for each female born.
If carrier females have only their intended number of pregnancies, the equilibrium
frequencies will be unchanged, or decreased if some carriers have no children after
detection (cases e and /). The two other cases (fig. 1, c and d) represent inter-
mediate situations. Case d refers to retrospective prevention where the intended
number of offspring, including the affected proband, is produced. Case c represents
prospective prevention where half the carriers practice full reproductive compensa¬
tion and the other half have only their intended number of pregnancies. These
result in only moderate increases in frequency above the original equilibrium value.
DISCUSSION
The equilibrium frequencies for X-linked diseases depend on many factors asso¬
ciated with survival and with reproductive practice of affected and carrier indi¬
viduals. Several workers, but especially Fraser [2], have discussed the effects of
changes in single factors acting in isolation, that is, assuming that other factors
remain unchanged. The estimated changes in frequency have been very relevant in
setting upper limits for the effect of each factor. In practice, several factors are
likely to change concurrently, so that to estimate new equilibrium levels more accu¬
rately, methods to take the various factors into account are required. The methods
outlined here allow combination of any set of factors in order to study and assess
their combined equilibrium.
Though the theoretical derivation of equilibria is clear, their determination in
practice may be more difficult because the statistics required may be difficult to
estimate reliably and will vary over time and place. If the disease is rare, the
numbers in various reproductive groups may be small and variable and thus con¬
tribute to unreliable estimates. The distributions of intended and completed family
size will only be known in retrospect, after reproduction has ceased and may also
vary with time. Similarly, the fitness of an individual cannot be measured until
the end of reproductive life. These derivations also assume that the disease is
caused by a single genetic entity. Both genetic heterogeneity and the existence of
phenocopies are factors that would affect the equilibrium values for the frequency
of the disease.
With X-linked conditions the approach to new equilibrium levels is reasonably
rapid [6], reaching halfway to the new equilibrium in 3-6 generations, compared
with hundreds of generations for autosomal recessive conditions. However, it is
likely that survival, reproduction, detection, selective abortion, and other factors
will change with time and will differ between countries, social groups, and so on.
Thus, the equilibria are unlikely to be constant but will continue to vary over
time and place.
SUMMARY
Formulas are developed to calculate the equilibrium frequency of X-linked
diseases in complex situations. These include the combined effects of survival of
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affected individuals, variable reproductive performance of affected males and carrier
females, variable stages of detection, and selective abortion. The net effect of any




NF, NM, CF, AM = normal females, normal males, carrier females, affected males
F = equilibrium frequency of CF born
M = equilibrium frequency of AM born
p = segregation ratio
= mutation rate per gamete per generation
n — family size
a = average number of AM
z — proportion of offspring born before detection of the family
Parameters Varying with Reproductive Class
Pi = proportion of CF in class (i)
Pj = proportion of AM in class (J)
fi = relative fitness of CF in class (i) in terms of offspring born
m,j = relative fitness of AM in class (J) in terms of offspring born
f*i — relative fitness of CF in class (f) in terms of offspring conceived
m*j = relative fitness of AM in class (j) in terms of offspring conceived
xNF. = proportion of NF born among those conceived by CF in class (z) after detection
yNMj — proportion of NM born among those conceived of AM in class (j)
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Title of Thesis Effect8 of n»dical and social prac tices on the fr^iwmcy of
deleterious genes in the population
Since the virtual eradication of many infectious diseases in civilised
populations, diseases which are at least partially genetic have increased in
their importance as the primary cause of death and morbidity. Much concern
has been expressed that current and future medical practices might further
increase the burden on medical services of genetic diseases by causing increases
in their incidence. In this thesis a study has been made of eugenic, as well
as dysgenic, effects of some of these possible practices.
Single generation changes in disease incidence and gene frequency have
been calculated for practices acting alone and in combination. No attempt
has been made to calculate possible effects of changes in existing forces such
as mutation and natural selection. All the changes calculated are those
which would result from the new practices acting alone and this makes it possible
to measure the relative effects of the new forces.
CXu-tosomcd- (XU-toScrncL Aonr\cwa.^t u ~ \JUAW
Formulae for calculating possible changes have been derived for ARt AD^
ubb. re cfco r*
XR and MF diseases and graphs drawn to illustrate the effects of the practices
for diseases of early onset where affected individuals have low fitness. Hie
theoretical changes calculated suggest that with the possible exception of AD
diseases and AR diseases where there is heterozygote advantage the overall effect
of the practices is likely to be a decrease in disease incidence in one generation.
The estimated changes in gene frequency indicate that there is likely to be a
longer term decrease in incidence of AR diseases but there might be an increase
in incidence of AD and XR diseases.
The realisation of these theoretical changes is dependent upon the feasibility
of the practices for particular diseases, the proportion of individuals ascer¬
tained and the proportion of these individuals adopting a particular practice.
Use other side if necessary.
At present the practices are only possible for a limited number of diseases
but prospects seem hopeful for their extension to other diseases particularly
those with AR and XR modes of inheritance. Most individuals to whom the
practices would be relevant are only ascertained at a stage when their
subsequent adoption of any of the practices would have a minimal effect on
the overall disease incidence. There is much scope for detecting more
individuals at risk by contacting relatives in families with AD and XR
diseases or by screening to detect heterozygous carriers in recessive diseases.
The results of the follow-up studies discussed in section (3) indicate that
couples would use the new practices if they were available.
Thus it seems that with advances in medical research and the detection
of more individuals at risk these theoretical changes might actually occur.
However in many cases the changes might be limited by some of the factors
discussed in section (10) particularly cost and availability of resources.
